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Abstract 
Newly released eggs of the parasitic worm Schistosoma mansoni either pass through the gut 
wall to escape from the host or are washed away in the host's bloodstream. In the latter 
scenario most eggs become lodged in the host's liver, where they become the focus of a 
granulomatous response which can have severe pathological consequences. In this study, 
the S. mansoni soluble egg proteome is described and characterised for the first time. 
Mature eggs were separated from immature eggs and then fractionated into their 
morphological components: the miracidia, the hatch fluid (which bathes the miracidia) and 
the egg-secreted proteins. Each egg preparation was subjected to two-dimensional 
electrophoresis and tandem mass spectrometry. Developmental proteomic changes were 
then described in terms of the egg's morphology so insights into the egg's natural history 
were gained. For example, acquisition of aerobic respiratory enzymes by the miracidium 
was seen, but nevertheless the miracidium still favours the use of energy-efficient heat 
shock proteins. Western blotting was used to show that the immature egg adopts the 
ubiquitin-proteasome pathway to degrade its nutritive vitelline cells. The hatch fluid 
contains host proteins but it also has a defensive role, although its most abundant 
constituent (a large, acidic glycoprotein) is of unknown function. The egg-secreted proteins 
consist of different variants of just four proteins, one of which has a pro-protein convertase 
domain and another of which appears to be a general purpose binding protein. A protocol is 
devised to purify each variant, so further functional studies into the individual secreted 
proteins can be carried out in the future. The secreted proteins induce a profound 
proliferative response in lymphocytes from acutely infected mice, indicating that they may 
work by activating granuloma T cells to secrete pro-proteases that are subsequently 
activated, enabling the egg to cross the gut wall. 
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Chapter 1 
General Introduction 
15 
Part 1: Schistosomiasis and Schislosoma mansoni 
1.1.1 Disease Burden 
Schistosomiasis is a tropical parasitic disease caused by trematode worms of the genus 
Schistosoma. Five species of schistosomes infect man (S. mansoni, S. haematobium, S. 
japonicum, S. intercalatum and S. mekongi), but S. mansoni, S. haematobium and S. 
japonicum account for the vast majority of infections. It is one of the world's most 
prevalent diseases, infecting over 200 million people, most of whom live in sub-Saharan 
Africa (WHO, 2002). 
The impact of schistosomiasis has been assessed in terms of its public health burden at 4.5 
million disability-adjusted life years (WHO, 2002). This was calculated by applying a 
"disability weighting" factor to the estimated prevalence of infection. The disability 
weighting was too low however, because its criteria did not include clinical sequelae - only 
the mortality directly attributable to schistosomiasis. An attempt was therefore made to 
better quantify the relationship between the clinical morbidity of schistosomiasis and the 
prevalence and intensity of infection (Van der Werfet al., 2003). The Van der Werf study 
concluded that 245 million people in sub-Saharan Africa had clinical symptoms that were 
consistent with a schistosome infection, 166 million were definitely infected and 280,000 
deaths per year were attributable to this disease. 
The paper by Van der Werfet al., (2003) was restricted in its geographical remit and didn't 
take more subtle morbidities into account, so the disability weighting factor for 
schistosomiasis was recalculated on a worldwide basis and included factors such as 
nutritional impairment and reduced working productivity (King et al., 2005). In King et al., 
(2005), meta-analysis of the data from 135 earlier papers was carried out and it was 
concluded that the disability weighting needed to be drastically increased from the WHO 
estimate of 0.5% to between 2 and 15%. Although the overall disease burden of 
schistosomiasis is clearly underestimated, the true impact of the disease is still unknown. It 
cannot be assessed because it is very difficult to tease apart the pathological consequences 
16 
of schistosomiasis from other concurrent factors that are prejudicial to health, such as 
access to a safe water supply and co-infections. 
1.1.2 The Schistosome Life Cycle 
Schistosomes infect two hosts during their life cycle -a mammalian definitive host and an 
aquatic snail intermediate host. For the snail to become infected it must be penetrated by a 
free-swimming miracidium. A period of asexual reproduction occurs in the snail (reviewed 
in Jourdane & Theron, 1987). Each miracidium transforms into a mother sporocyst, within 
which germinal cells multiply to produce many daughter sporocysts. Further replication 
occurs in each of these daughter sporocysts to produce germ balls, each of which develops 
into a cercaria. Thousands of free-living cercariae emerge from the snail each day on 
stimulation by light, most of which die, but those that are able to locate a suitable 
mammalian host penetrate it. 
The infection of and migration in the definitive host has been reviewed (e. g. see Wilson, 
1987). Penetration of the host skin is achieved by a combination of muscular contractions 
and the secretion of cercarial proteases from three sets of glands contained within the 
cercarial body. After penetration, the cercaria migrates through to the base of the epidermis 
within 30 minutes, losing its glycocalyx and tail as it transforms into a schistosomulum. 
The epidermal basement membrane appears to impede the progress of the parasite, because 
there is a delay of hours/days before it enters the vasculature, through which it migrates to 
reach the lungs. Here it elongates (presumably to traverse the lung capillaries) and 
continues its migration (via the heart) until it arrives in the hepatic portal vasculature. The 
transit time of this migration depends upon the host and how many circuits of the 
vasculature are required, but in the mouse model parasites are accumulating in the hepatic 
portal system 6- 21 days after skin penetration. Once established in the hepatic portal 
system the schistosomulum differentiates into a blood-feeding form. It matures, pairs and 
then the paired worms migrate (against the blood flow) to their final location in the host. 
The final location is the veins of the gut wall in S. mansoni and S. japonicum infections or 
the veins of the bladder wall in the case of S. haematobium. 
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Eggs are then released by the female, some of which penetrate the venous endothelium, 
cross the gut wall (or bladder wall in S. haematobium infections) to be voided with the 
faeces (or urine). If an egg emerges into fresh water it hatches and a single, motile 
miracidium emerges. The miracidium will actively seek out a suitable snail, penetrate it and 
thereby complete the life cycle. Only a proportion of the eggs are voided form the host in 
this way. Many are washed away by the blood stream to become lodged in other organs 
(particularly the liver) where they can induce an inappropriate host immune response. It is 
this immune response to trapped eggs that is responsible for the most severe forms of 
pathology. 
1.1.3 The Pathogenesis in S. mansoni Infections 
Schistosomiasis mansoni manifests itself in humans as a generally non-specific complex of 
acute and chronic sequelae, usually involving the gastrointestinal tract and liver. Although 
penetration of the skin by cercariae can cause dermatitis (Gonzalez, 1989), the initial onset 
of pathogenesis usually corresponds with parasite migration and the start of egg deposition. 
Also termed acute schistosomiasis or Katayama fever, these symptoms are generally a 
feature of individuals who have had no previous exposure to schistosomiasis. Acute 
schistosomiasis is caused by the immune system responding to worm and/or egg antigens, 
and produces a myriad of sequelae including fever, sweating, headache, cough, myalgia, 
lymphadenopathy, hepatomegaly, diarrhoea and blood in the stool (Rabello, 1995). 
The pathology associated with chronic infection manifests itself some time after the worms 
have become established. It is caused by the ongoing deposition of eggs that induce cellular 
foci and can lead to further complications, ranging in severity from scattered granulomata 
to gross hepatic periportal fibrosis. Clinical features are restricted to a small proportion of 
infected individuals and can include blood in the stool, diarrhoea, cramps and secondary 
symptoms such as cachexia (Savioli et al., 2004). 
Although egg-induced granulomata can occur in any part of the intestinal tract (Cheever et 
al., 1977), the major complication in chronic infection is periportal hepatic fibrosis. This 
occurs when eggs become lodged in the venules of the liver, initially causing cellular 
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infiltration and the formation of a granuloma. The granulomatous infiltration can spread to 
the connective tissue, causing the affected portal tracts to become distorted by 
inflammation and fibrosis, leading to portal enlargement and hypertension (Andrade, 2004). 
Hepatic fibrosis results from an increase in cellular, cytokine-induced collagen production, 
probably in conjunction with a reduction/imbalance in the secretion of matrix 
metalloproteases (Boros & Whitfield, 1999; Singh et al., 2004). Overtime, portal 
hypertension can induce gastro-oesophageal varices which can haemorrhage, causing 
potentially fatal haematemesis. 
1.1.4 The S. mansoni Egg and the Immunopathology of the Granuloma 
A proportion of the eggs released by the female worms in the mesenteric vasculature are 
washed away by the blood stream. They travel along the superior or inferior mesenteric 
veins (depending upon whether the worm is located in the small or large intestine 
respectively). The inferior mesenteric vein and the superior mesenteric vein join, forming 
the hepatic portal vein, and from here it is a short distance to the liver. The liver sinusoids 
are smaller than the eggs, so the vast majority of incoming eggs become lodged in the pre- 
sinusoidal vessels, where they form the foci around which the granulomata develop. 
The granuloma is the cellular response to the lodged egg, principally comprising CD4+T 
cells, macrophages and eosinophils (Iacomini et al., 1995; Warren & Domingo, 1970; 
Swartz et al., 2006). The CD4+cells comprise both Th2 (T-helper) cells (capable of 
secreting interleukin (IL)-4, IL-5, IL-10 and IL-13) as well as a smaller proportion of 
CD25+CD4+ regulatory T cells that are capable of ameliorating cytokine production (Hesse 
et al., 2004; Baumgart et al., 2006). The Th2 response generated by the CD4'cells of the 
granuloma is in stark contrast to the Thl response that dominated the infection up to this 
point, and its induction results in a more balanced and mixed Thl/Th2 response overall 
(Pearce et al., 1991). In the murine model, granulomata appear about two weeks after egg 
production commences, peaking in size 2-4 weeks later and then declining in an IL-10- 
dependent manner during chronic infection (Boros et al., 1975; Sadler et al., 2003). This 
pattern of a peak followed by a down-modulation is mirrored by the levels of cytokine 
production and proliferative capabilities of granuloma cells when stimulated with egg 
antigen (King, 2001). 
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The Th2 response to egg deposition is IL-4-dependent and has a host-protective function. 
In the mouse model, 20% of CD4+cells in the lymph nodes that are closest to the site of 
egg deposition expressed the IL-4 gene 7-days after the injection of eggs (Taylor et al., 
2006a). A Th2 response fails to develop in IL-4 knockout mice, resulting in increased 
iNOS and 02 expression in the liver, causing an inhibition of hepatocyte proliferation, 
smaller granulomata, a failure of the liver to enlarge, leading eventually to cachexia and 
death (La Flamme et al., 2001; Brunet et al., 1997). In T-cell deficient mice granulomata 
fail to develop and fatal hepatotoxic reactions to egg proteins occur (Doenhoff et al., 1981). 
It is therefore possible that by encapsulating the egg, the cells of the granuloma may be 
protecting the host by providing a physical barrier to localise hepatotoxic egg proteins prior 
to their detoxification. Balanced against these beneficial effects however is the pathological 
consequences of IL-13-induced collagen production as discussed in 1.1.3. 
There is no doubt that S. mansoni eggs can cause the pronounced Th2 response in the host 
because it is induced when live or dead eggs are injected via the intravenous, 
intraperitoneal or subcutaneous route (Pearce & MacDonald, 2002). Attempts to identify 
the egg antigens responsible for the Th2 induction indicate that glycans and lipids may be 
important. Deglycosylated egg antigens fail to induce a Th2 response, whilst 
unglycosylated, non-schistosome proteins modified with the schistosome egg glycan lacto- 
N-fucopentose III (LNFPIII) do (Okano et al., 1999; Okano et al., 2001). The S. mansoni 
egg version of the lipid lysophosphatidylserine can activate Toll-like receptor 2 (TLR 2) in 
dendritic cells (DCs), which in turn can induce the development of CD25+CD4+ T 
regulatory cells, whose secretory IL-10 potentially could induce hyporesponsiveness to the 
existing Thl response (Van der Kleij et al., 2002). The TLR 2-activating motif of the S 
mansoni lysophosphatidylserine appears to relate to the structure of the acyl group in its 
(uniquely single) tail as well as the phosphoserine head group. 
The mechanism that causes the general down-regulation of the granulomatous response 
when the infection becomes chronic is unknown, but it correlates with the reduced 
expression of CD80/CD86 co-stimulatory molecules on macrophages/DCs, prostaglandins 
and increases in the concentration of IL-10 and the soluble IL-13R (Rathore et al., 1996; 
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Chensue et al., 1983; Mentink-Kane et al., 2004; Sadler et al., 2003). IL-10 can control 
the growth and differentiation of several effector cells via different mechanisms and so is 
the prime contender for inducing hyporesponsiveness. It can inhibit the ability of antigen 
presenting cells to interact with both Thl and Th2 CD4+ cells by down-regulating both the 
Major Histocompatibility Complex II (MHCII) and its co-stimulatory molecules CD80 and 
CD86 (de Waal Malefyt et al., 1991; Flores Villanueva et al., 1994). 
Part 2: The S. mansoni Eim: Develooment to Escane/Seauestration 
1.2.1 The Female Reproductive System and the Development of the Egg 
Both the ovum and its nutrients are produced in the ovary in most animals. Trematodes 
differ fundamentally in that the nutrient-containing vitelline cells are produced in an 
entirely separate organ called the vitellaria (Smyth & Halton, 1983). The reproductive 
system of the female schistosome must therefore be capable of packaging the oocyte and 
vitelline cells together. Studies utilizing transmission electron microscopy (TEM) and 
confocal laser scanning microscopy have been able to explain how this happens, and show 
how glandular secretions, physical moulding and sperm form the male are used in egg 
production (Spence & Silk, 1971; Erasmus, 1973; Neves et al., 2005). 
A diagram of the female S. mansoni reproductive tract is reproduced overleaf as Figure 1.1, 
and it can be seen that in terms of volume, the vitellaria are by far the largest of the 
reproductive organs, occupying the posterior two thirds of the worm. The vitellaria consist 
of a single vitelline duct from which many much smaller ducts are linked to numerous 
vitelline follicles. These vitelline follicles produce the vitelline cells, which enter the 
vitelline duct once they have fully developed. There are four maturational stages in the 
development of a vitelline cell (Erasmus, 1975). Stage 1 consists of a small, 
undifferentiated cell, containing ribosomes and a nucleus. The endoplasmic reticulum 
appears in Stage 2 and Golgi complexes in Stage 3. Abundant protein synthesis is now 
apparent and vitelline droplets are starting to form in the cytosol, having budded from the 
Golgi. The vitelline droplets consist of membrane bound vesicles, inside which are many 
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Figure 1.1 The female reproductive system (from Spence & Silk, 1971). The vitellaria at 
the top of the diagram (comprising vitelline follicles and the non-ciliated vitelline duct) 
occupy the posterior two-thirds of the worm. 
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electron-dense granules that contain eggshell precursor proteins (Erasmus, 1973; 
Cordingley, 1987; Koster et al., 1988; Wells & Cordingley, 1991). Stage 4 vitelline cells 
are fully mature, with larger vitelline droplets and abundant lipid material (Erasmus, 1975). 
The vitellaria have a high production rate, so it is not surprising that they occupy such a 
large proportion of the volume of the female worm. Each egg contains 30-40 vitelline cells 
(Erasmus, 1987), and if (as discussed below) a female worm produces 300 eggs per day, it 
can be calculated that the vitellaria must produce 9,000 - 12,000 cells per day (i. e. 6-8 
cells/minute). Once mature, the vitelline cells pass along the vitelline duct towards the 
anterior of the worm, where the vitelline duct narrows to form a valve which regulates entry 
into the vitello-oviduct. The vitello-oviduct is where the vitelline duct joins the oviduct. 
The sole purpose of ovary is the production of the haploid ovum. It is an elongated organ 
situated centrally in the worm, adjacent to the vitelline duct and between the branches of 
the gut. The schistosome ovary is unusual in that it consists of a single organ (most 
trematodes have paired ovaries). The ovary consists of an epithelium, thinner at the (open) 
posterior end, surrounded by a fibrous inner layer and then a layer of muscle (Erasmus, 
1987). Its surface is covered with developing oocytes. A gradient of oocyte development 
can be seen, with the smaller undeveloped oocytes at the anterior end of the ovary and 
mature oocytes at the posterior end, nearest to the oviduct (Neves et al., 2005). 
The mature oocyte exits the ovary, travels along the oviduct and enters the seminal 
receptacle, which is a specialized area for the storage of sperm. Here it associates with 
spermatozoa from the male worm. It is not known at exactly what point the sperm 
penetrates the oocyte in S. mansoni. Erasmus (1987) assumed that fertilization occurs in the 
seminal receptacle itself, but fertilization was subsequently found to occur in the oviduct 
adjacent to the seminal receptacle in S. japonicum (Yang et al., 2003). In Schistosomatium 
douthitti, penetration of the oocyte by the sperm also takes place in the oviduct adjacent to 
the seminal receptacle, but nuclear fusion was not seen to occur until the egg had been 
released (Nez & Short, 1957). 
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The route that the sperm take to arrive in the seminal receptacle is not known either. In the 
schistosome genera Heterobilharzia, Dendritobilharzia, Trichobilharzia, Schistosomatium 
and Ornithobilharzia sperm travel through the Laurer's canal which provides a direct link 
between the tegument and the vitello-oviduct (Lee, 1962; Ulmer & van de Vusse, 1970; 
McMullen & Beaver, 1945; El-Gindy, 1951; Price, 1929). However, a Laurer's canal has 
not been found in Schistosoma, despite S. mansoni, S. japonicum and S. haematobium 
being the subject of more numerous and more detailed morphological studies (Faust et al., 
1934; Sakamoto & Ishii, 1977; Irie et al., 1987; Moczon & Swiderski, 1983; Leitch & 
Probert, 1984; Yang et al., 2003; Neves et al., 2005; Erasmus, 1987; Erasmus, 1973; 
Spence & Silk, 1971). So in S. mansoni, either the Laurer's canal remains to be discovered 
or the sperm must enter the female through the gonopore and swim through the 
reproductive tract (via the uterus, ootype, vitello-oviduct and oviduct) in the opposite 
direction to the exiting eggs. 
Both the oviduct and the vitelline duct unite to form the vitello-oviduct, so this is the point 
at which the oocyte, sperm and vitelline cells are packaged together, before passing into the 
adjacent ootype. The ootype is a specialized muscular chamber that reflects the size and 
shape of the egg, to include the very prominent, lateral spine. The ootype is surrounded by 
a network of unicellular gland cells called the Mehlis gland, which appear to discharge into 
it but whose function is unknown (Spence & Silk, 1971; Erasmus, 1973). It is in the ootype 
that the oocyte and vitelline cells are moulded to form the distinctive egg shape and where 
the eggshell is formed. 
As mentioned above, the eggshell is made from the precursor proteins that have been stored 
in the granules of the vitelline droplets. In S. mansoni, the shell precursors have not been 
fully characterized, but they are comprised of numerous proteins from three families, two 
of which are genus specific and the third shared with other trematodes (Ebersberger et al., 
2005). They have similar staining properties to the eggshell precursors of Fasciola, which 
have undergone a post-translational modification in which an intracellular tyrosine 
hydrolase has oxidized the majority of the tyrosine residues to 3,4-dihydroxyphenyl-L- 
alanine, producing "presclerotized" proteins (Waite & Rice-Ficht, 1987; 1989; Wells & 
Cordingley, 1991). These presclerotized precursor proteins later form the "sclerotized" or 
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"quinnone-tanned" eggshell of Fasciola, and consequently often the S. mansoni eggshell 
is also described in the same terms. Although formed in the vitellaria, the eggshell 
precursors are not activated until the cell mass enters the ootype. The regulatory mechanism 
preventing premature eggshell formation involves maintaining both a low pH within the 
vitelline droplet and also the integrity of the droplet membrane. Raising the pH inside the 
droplet causes fusion of the droplet's granules resulting in the formation of intra-droplet 
eggshell, and treatment with a calcium ionophore causes the granules to be exocytosed 
intact from the cell where they coalesce to form extracellular eggshell (Wells & 
Cordingley, 1991). The purpose of the Mehlis glad could therefore be to secrete ionophore- 
like factors that induce the vesicles within the vitelline droplets to exocytose their contents 
such that they fuse together around the cell mass to form the eggshell at the appropriate 
moment (i. e. in the ooytye). The newly completed egg then passes along the uterus and 
exits the worm through the gonopore. No developmental processes have been reported to 
occur during its transit along the uterus, but only one egg at a time is present in this organ 
(Bruckner & Schiller, 1974). 
Although the described features of the S. mansoni reproductive tract are the same in 
Erasmus (1973), Neves et al. (2005) and Spence & Silk (1971), differences in their 
interpretations are evident. Erasmus (1973) and Neves et al (1995) both describe the 
various organs as being clearly demarcated from one another, so that the reproductive tract 
can be divided into three distinct regions: vitellaria/vitelline duct, ovary/oviduct and the 
remainder. The paper by Spence & Silk (1971) differs in that the transition from one region 
to the next is considered to be more gradual, so that no such demarcations can be made. 
Various attempts have been made to establish the daily output of eggs per female worm, as 
summarised overleaf in Table 1.1. Calculating fecundity is difficult because it is necessary 
to accurately determine the number of pairs of gravid worms, pinpoint the time at which 
egg production commences and account for all of the eggs produced, whether they be 
lodged in the organs of the host, excreted in the faeces or destroyed by the host. Each of the 
studies detailed below account for a different selection of these criteria but none have 
accounted for them all, and furthermore, differences in S. mansoni isolates, host species and 
the intensity/duration of infection between the studies add another layer of complexity. 
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Table 1.1 The estimated fecundity of S. mansoni in seven studies. 
Study Host Host Sample 
Size 
Fecundity 
(mean eggs/female/day) 
Koura, 1970 Albino mice 24 362 
Pellegrino & Coelho, 1978 Albino mice 4 300 
Kloetzel, 1967 CF1 mice 94 257 
Moore & Sandground, 1956 Hamster 6 291 
Nelson & Saoud, 1966 Rhesus 
monkey 
2 211 
Damian & Chapman, 1983 Baboon 12 1107 
Cheever & Duvall, 1974 Grivet 
monkey 
40 598 
It is therefore not surprising that there is such a wide variation in estimates of fecundity 
between the studies. However, this collection of data suggests that fecundity may be host 
dependent and the often-quoted figure of 300 eggs per female per day is probably an 
underestimation. 
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1.2.2 The Physiology of the Egg 
TEMs of the S. mansoni egg in both its immature and mature state have been published by 
Neill et al., (1988) and are reproduced overleaf as Figure 1.2. When it is first released by 
the female, the S. mansoni egg consists of an ovum plus 30-40 vitelline cells, surrounded 
by the cross-linked shell. In addition to the (diagnostic) lateral spine, the outer surface of 
the shell is covered by microspines (Race et al., 1971; Neill et al., 1988; Ashton et al., 
2001). The mean dimensions of the immature, newly-released egg are 112µm x 44µm 
(Ashton et al., 2001). At an early point in its development one or two peripheral cells 
detach from the embryo and spread out as an epithelium around the inside of the shell, 
forming an envelope. As the egg matures, it increases greatly in size and acelluar material 
appears between the envelope and the shell. This material is secreted by the envelope 
(Ashton et al., 2001; Schramm et al., 2006), which by now is thicker and contains abundant 
rough endoplasmic reticulum, indicative of protein synthesis. Once fully mature, the 
average egg has increased in size to149pm x 69µm, equivalent to an increase in volume in 
excess of 300% (Ashton et al., 2001). The viable miracidium can be seen, bathed in liquid, 
which also incorporates large vacuoles. The eggshell must be permeable because the 
proteins synthesised in the envelope of mature eggs are actively secreted through the shell 
(Ashton et al., 2001). Pores in the shell have been reported, either taking the form of direct 
inner-outer perforations of 100nm in diameter (Race et al., 1969; Race et al., 1971) or 
oblique, branching channels of 34nm in diameter (Neill et al., 1988). However, it is 
possible that the "pores" described by Race et al. and Neill et al. are actually artefacts, 
resulting from the respective sectioning and slam freezing processes carried out during the 
preparation for TEM. In the study by Ashton et al., (2001) the fixative was allowed to 
penetrate the eggshell before sectioning was carried out and no pores could be seen, so it 
remains unclear exactly how material passes through the eggshell. 
1.2.3 Egg Escape from the Host: the Parasite's Requirement 
It is an absolute requirement for the schistosome that some of its eggs are excreted from the 
host in a viable state, so that the miracidia can infect a snail to continue the parasite's life 
cycle. The eggs are released into the bloodstream, so each egg must incorporate some kind 
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Figure 1.2 Transmission electron micrographs of the immature and mature 
egg. A: In the immature egg, the envelope (vL) forms adjacent to the inside of 
the shell from parent cells that have become detached from the embryo. The 
nucleus (N) of the parent cell is large. The developing embryo contains micro- 
nucleated cells (p) and is bathed in a liquid, sometimes called Lehman's lacuna 
(L). A residual vitelline cell (v) contains lipid droplets. B: In the mature egg, 
another layer of material (sometimes called Reynolds layer) can be seen (R), 
sandwiched between the envelope (vL) and the shell. Large vacuoles (C) are 
present. The miracidium is now fully developed. The images are from Neill et 
al., (1988). 
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of escape mechanism, enabling it to adhere to the wall of the blood vessel (to prevent it 
being washed away) and then to transport it through the tissues of the gut wall into the gut 
lumen. There are inherent difficulties in this because even if the physical distance is small, 
the egg must negotiate the various different tissues of the gut wall - namely the venous 
endothelium, the connective material that makes up the submucosa and lamina propria, the 
smooth muscle layer of the muscularis mucosae and the intestinal epithelium. The egg's 
escape must be timed such that the embryo has fully developed into a viable miracidium 
during its transit. Indeed, it takes eight days for an S. mansoni egg to cross the gut wall and 
emerge in the faeces (Cheever & Anderson, 1971), which is one day longer than its in vitro 
maturation time and three to five after egg-secretion commences (Ashton et al., 2001; Hang 
et al., 1974). 
Inevitably, many eggs are washed away, and the experiments aimed at assessing the 
proportion of eggs that do so have suffered with the same logistical problems associated 
with fecundity studies. The results of such studies vary, but it is estimated that in S. 
mansoni, between 3% and 27% of eggs released by females are excreted in the host faeces 
(Koura, 1970; Kloetzel, 1967; Moore & Sandground, 1956; Nelson & Saoud, 1966; 
Damian & Chapman, 1983; Cheever & Duvall, 1974). 
1.2.4 The Escaping Egg: Parasite-Derived Factors 
It has been known for some time that eggs actively secrete proteins through their shell 
(Oliver-Gonzalez, 1954; von Lichtenberg, 1964; Boros & Warren, 1970; Ashton et al., 
2001). This led to the hypothesis that these secretions had proteolytic activity which 
enabled the eggs to degrade host tissue and escape from the host (Kloetzel, 1967; 1968). 
Protease activity has been attributed to the egg secretions, initially in studies that failed to 
eliminate the possibility that the proteases were from bacterial contaminants or had leaked 
from dead eggs (Kloetzel, 1968; Curtis, 1991), and then in a study that did account for 
these factors (Ashton et al., 2001). Ashton et al., (2001) also established that proteins were 
only secreted by mature eggs. This is an important discovery, because if proteases secreted 
by the egg are responsible for enabling the egg to cross the gut wall and escape the host, 
then by tying the onset of protease secretion to a particular point in the egg's maturation 
process the parasite ensures that eggs will not emerge from the host prematurely. The 
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failure of immature eggs to secrete proteins also explains why intact, immature eggs are 
immunologically inert (Hang et al., 1974). 
As egg secretions are only produced by mature eggs, then it follows that they cannot be 
involved in any mechanism that enables immature eggs to adhere to the venous epithelium 
as they are released by the female worm. It has been suggested that the egg's spine impales 
the endothelium and secures the egg (Jourdane & Theron, 1987; Whitfield, 1993), but this 
theory is undermined to some extent by the morphology of S. japonicum eggs, which 
possess a small knob rather than a spine. However, the higher fecundity of S. japonicum 
compared to S. mansoni possibly allows for a less efficient egg attachment method in the 
former. 
1.2.5 The Escaping Egg: Host-Derived Factors 
A series of experiments have indicated that platelets could be involved in the egg-excretion 
process. Ngaiza & Doenhoff (1990) used mice whose platelet activity had been suppressed 
with anti-platelet drugs and/or anti-platelet serum. These mice were found to have an 
impaired ability to excrete eggs, which could be reversed if platelets were injected into the 
mice. Several experiments followed that intended to find out whether platelets caused the 
eggs to adhere to the venous epithelium, and if so what the mechanism of attachment was. 
Adherence was initially thought to involve the release of platelet products such as platelet 
factor 4 or eicosanoids which went on to activate other cells (Ngaiza & Doenhoff, 1990). 
Other, more direct binding mechanisms were also thought to be involved, such as 
endothelial P-selectin binding to the platelet's von Willibrand receptor complex or 
endothelial integrins binding to 03 integrins on the platelets (Gawaz et al., 2005). An in 
vitro assay was carried out in which the extent of egg adherence to human umbilical vein 
endothelial cells was monitored, with and without the presence of serum and platelet- 
release products (Ngaiza et al., 1993). Although both serum and (particularly) the platelet- 
release products both enhanced the ability of eggs to adhere to the epithelial cells, the value 
of the experiment was undermined because less than 10% of the eggs used in the 
experiment were in the immature state in which they would be released by the female. The 
maturation status of the adherent eggs was not noted either, so the platelet-enhanced egg 
attachment to the epithelial cells could have been restricted to the population of mature 
30 
eggs, via the proteins they secrete. This would not be relevant to the process that occurs in 
vivo in which immature rather than mature eggs would need to adhere to the vascular 
endothelium. In a later experiment, the ability of newly-released eggs to adhere to 
endothelial cells was studied by allowing paired worms to deposit eggs onto to human 
umbilical cord vein cells cultured in the presence of foetal calf serum (FCS), but not 
platelets (File, 1995). It was found that the endothelial cells started to migrate over the 
newly-released eggs, apparently as they were deposited, causing the eggs to be retained by 
the endothelium and then to be completely engulfed by it, such that the integrity of the 
endothelium was completely reinstated within four hours of egg deposition. However, 
gentle agitation of the culture plate severely impaired egg retention, so it remains 
questionable whether venous endothelial cells alone offer a high degree of retentive action 
in vivo. 
Scanning electron microscopy has been used to show eggs in the vascular endothelium with 
platelets adhering to their surface before a cellular inflammatory reaction has formed, 
thereby demonstrating the likely involvement of platelets in the very early stages of egg 
excretion (Doenhoff et al., 1986). Platelets have also been observed binding to immature 
eggs (Doenhoff, 2005 pers comm. ) and vascular endothelium (Gawaz et al., 2005), so the 
cascade of events leading to egg escape could commence with the egg adhering to the 
endothelium in a platelet-mediated or platelet-augmented manner. The eggshell itself is not 
immunogenic (Oliver-Gonzalez, 1954; Boros & Warren, 1970), so a different immunogenic 
mechanism must induce this platelet adhesion. This could consist of adult schistosome 
proteins, accumulated on the surface of the eggshell as it passes through the uterus. As 
explained in Section 1.2.2, the outer surface of the egg is covered with microspines as well 
as the large terminal spine (Race et al., 1969). It is easy to envisage this combination of 
spines scraping surface proteins from the uterus during the egg's passage through this 
organ, and perhaps these adult schistosome proteins could mediate the adherence of the egg 
to the endothelium, either directly or via platelets. This would explain the rapid response 
that File (1995) noticed when eggs were deposited onto umbilical vein endothelial cells. 
CD4+ cells have also been implicated in the escape of the egg from the host. Doenhoff et al. 
(1986) found that thymectomised mice failed to excrete eggs unless they were reconstituted 
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with a population of CD4+ cells. Ten years later a fieldwork-based study found that HIV 
positive individuals had fewer eggs in their stools compared to HIV negative individuals, 
despite a similar intensity of infection, as assessed by the concentration of circulating 
cathodic antigen in the serum (Karanja et al., 1997). These two papers are often quoted 
together as evidence that host CD4+ cells facilitate the egg's passage across the gut wall, 
although neither research group thought that sufficient experimental evidence had 
accumulated to be able to speculate as to the mechanism by which the CD4+ cells might be 
operating (Karanja et al., 1997: Doenhoff, 1997). It is known that CD4+ cells secrete matrix 
metalloproteases (MMPs) that enable them to traverse basal membranes and tissue (Goetzl 
et al., 1996), so S. mansoni eggs could be utilizing these host-derived MMPs to disrupt the 
integrity of the gut wall tissues through which they too must pass. 
It is probably too simplistic to conclude that T cells are an absolute requirement for eggs to 
cross the gut wall though. The Karanja et al., (1997) paper was based on 53 individuals 
with high intensities of infection, 16 of whom were HIV positive. The differences the 
authors found between the egg excretion rates of HIV positive and negative individuals 
were not supported by a subsequent study with a much larger sample size of 1545 
individuals (Kallestrup et al., 2005), in which no relationship was found between egg 
excretion rates and CD4+count. In the thymectomised mice model, Doenhoff et al., (1986) 
found a similar number of eggs in the intestines of the thymectomised mice as were in the 
normal controls, although only a few eggs were excreted in the faeces of the former. 
Therefore, eggs may well have been in the process of crossing the gut wall in the 
thymectomised mice, and the phenomenon that the authors reported could have been a 
delay (and probably a reduction in rate) rather than a complete cessation of egg excretion. 
Both the thymectomised mice and the normal controls were culled at 42 days post 
infection, so a slower egg transit time in the former could have manifested itself as a 
complete failure of excretion at this time-point. A reduction in egg transit time in the 
thymectomised mice would also be compounded by the delay in oviposition that occurs 
when schistosomes infect thymectomised mice (Dunne et al., 1983). 
Other work using the murine model has found that T cells are an important influence on 
egg excretion but not an absolute requisite. Dunne et al., (1983) found that although egg 
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excretion occurred in thymectomised mice it was delayed and the rate was slower. When 
the thymectomised mice were injected with serum from chronically infected mice, the egg 
excretion rate increased to an intermediate level rate between the thymectomised mice and 
normal controls. This could have been due to antibody binding to Fc receptors on 
macrophages and/or eosinophils, which induced protease secretion that carried out a similar 
role, albeit less efficiently than the MMPs derived from CD4+ cells. Indeed, it has been 
demonstrated that plastic-adherent (i. e. macrophage-enriched) cells taken from liver 
granulomata in chronically infected mice secrete collagenase (Truden & Boros, 1985). 
So, a likely process of egg escape would involve platelets and several classes of host cells. 
Platelets could mediate the initial adhesion of the immature egg to the vascular epithelium, 
macrophages act as antigen presenting cells and protease secretors, the protease milieu 
from which is augmented by those secreted by eosinophils and CD4+ cells. 
Part 3 The S. mansoni E Proteome 
1.3.1 "Soluble Egg Antigen" 
It has been evident for decades that in schistosomiasis the eggs induce the liver pathology, 
so it is not surprising that attempts to identify the immunogenic components of the egg 
stretch back to the 1970s. Boros & Warren (1970) made the first egg antigen preparation, in 
which intact eggs were sonicated in a 0.9% sodium chloride solution. They called the 
centrifuged-supernatant "Soluble Egg Antigen" (SEA) and established that small quantities 
could be used to sensitize mice to induce a more rapid granulomatous response following 
egg deposition. SEA has remained the principal egg antigen preparation ever since, 
although the sodium chloride solution has now been replaced with more effective buffers. 
1.3.2 "Major Serologic Antigens" 
The first attempt at characterising the immunogenic components of SEA was carried out 
when SEA was separated by electrophoresis and probed with serum from infected mice 
(Pelley et al., 1976). Three antigens were found and called "Major Serologic Antigens" 
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(MSA). After purification using chromatography, MSA1 and MSA2 were found to be 
glycoproteins of 137 kDa and 465 kDa respectively whilst MSA3 was an unglycosylated 
protein of 50 - 70 kDa. 
1.3.3 CEF6 and its components: al and col 
Following the identification of MSA 1-3, a detailed set of experiments was carried out that 
aimed to identify which SEA components could induce the production of protective 
antibodies in mice (Dunne et al., 1981). As discussed in Section 1.1.4, it was already 
known that T cell-deprived mice suffered fatal egg-induced hepatotoxic pathology at acute 
infection (Doenhoff et al., 1981). It was also known that this liver damage could be 
prevented by injecting serum taken from immunologically intact mice that were either 
chronically infected or had been immunized with SEA (Doenhoff et al., 1981; Byram et al., 
1979; Doenhoffet al., 1979). 
In order to identify which of the SEA components were responsible for inducing the 
humoral protection, Dunne et al., (1981) separated crude SEA using Wieme electrophoresis 
apparatus (Wieme, 1959). The Wieme protocol involves subjecting a crude protein mixture 
to electrophoresis at a fixed pH in an agar gel. The individual proteins migrate towards the 
anode or cathode at different rates, depending upon their charge at the chosen pH, and the 
electrophoresis is stopped as the most migratory proteins approach a terminal. The gel can 
then be stained for protein or probed with serum, and between-gel comparisons of the 
characteristic pattern that emerges can be made. When SEA was subjected to Wieme 
electrophoresis and then probed with serum from infected mice, Dunne et al., (1981) 
identified twelve different antigens. These were named according to their charge at pH 8.6, 
(al-3 migrated towards the anode, (oI-3 didn't migrate and xl-7 migrated towards the 
cathode). Crude SEA was also separated by cation exchange chromatography into six 
fractions, named Cation Exchange Fractions (CEF) 1-6, in the order that they were eluted 
from the column (i. e. decreasing acidity). Each CEF was then injected into naive mice, a 
humoral immune response allowed to develop and the serum used to probe Weime gels of 
crude SEA. This enabled the antibody responses induced by each CEF to be separately 
compared to that induced by crude SEA. The anti-CEF serum was then used to immunise 
infected, T cell-deprived mice so that the degree of protection each CEF offered against 
34 
hepatotoxic pathology could be assessed. It was found that CEF6 was the only fraction 
that induced a humoral response that protected T-cell deprived mice as effectively as anti- 
SEA serum. Anti-CEF6 serum was reactive against o1 (as was the anti-CEF5 serum) but 
unlike any other CEF, it was also reactive against al. 
Although important because it implicates CEF6 and potentially al as inducing the 
hepatotoxic reaction in the host, the paper by Dunne et al., (1981) has inconsistencies that 
make it difficult to assess the biochemical properties of al. The electrophoresis and the 
chromatography appear inconsistent with one another in that al migrated towards the 
anode at pH 8.6 (it was the third most acidic component) and col failed to migrate at all 
(indicating an isoelectric point of approx. 8.3) - yet both were eluted in the final fraction 
from the column (i. e. amongst the most basic SEA proteins). The seven most basic proteins 
(at pH 8.3) by Wieme electrophoresis (0-7) did not bind to the cation exchange column at 
all (the column was equilibrated at pH 7.2), thereby demonstrating their acidic nature. 
CEF6 was also shown to be capable of diagnosing schistosomiasis mansoni. When used in 
an Enzyme-Linked ImmunoSorbent Assay (ELISA), CEF6 was the most reactive fraction 
in terms of the antibody response in chronically infected humans, with very little reactivity 
with serum from patients suffering with S. haematobium or S. japonicum infections 
(McLaren et al., 1981). 
Further purification and characterization of the CEF6 components followed. A protocol 
using cation exchange chromatography and monoclonal antibodies purified aI and wl from 
crude SEA (Dunne et al., 1991). The antigen col was characterised as a 31 kDa monomeric 
protein of isoelectric point (pl) > 9.5 and al as comprising two subunits of 22 kDa and 18 
kDa and pI7.5 - 8.5. Both col and aIwere glycoproteins, but when de-glycosylated neither 
was recognised by serum from infected mice. Therefore, it was the glycans attached to 
these proteins that induced the humoral response. In a series of transfer experiments the 
paper went on to establish that the hepatocytes of T cell-deprived mice were protected if the 
mice had been immunised with anti-cal serum, but not with anti-al serum. 
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Neither al nor o1 was sequenced and no further characterisation studies were done for ten 
years. Then both antigens resurfaced in separate studies. Fitzsimmons et al., (2005) stated 
that they had sequenced wl and that it was a secreted ribonuclease and Schramm et al., 
(2006) stated that al was the same protein as an IL-4-inducing factor that was secreted 
from eggs and had been identified three years previously. These are both discussed in 
Sections 1.4.2 and 1.4.1 respectively. 
1.3.4 Sm-p40 
Sm-p40 is a 40kDa protein of 354 amino acids, first identified when it was precipitated 
from SEA with sera from infected humans, cloned and sequenced (Nene et al., 1986). 
About 10% of the total protein in SEA is Sm-p40 (Stadecker et al., 2001). It is a member of 
the small heat shock protein (sHSP) family, consisting of two heat shock protein (HSP)20 
homologues, each of which contains two alpha-crystallin domains. Sm-p40 contains three 
epitopes, one of which is immunodominant (Hernandez et al., 1998; Chen & Boros, 1998), 
but all three induce a proliferative Thl response, particularly in the C3H and CBA mice 
with the H-2' haplotype (Hernandez & Stadecker, 1999). This ThI response is in contrast 
to the Th2 response induced by crude SEA. 
1.3.5 HSP70 
HSP70 was identified when a recombinant cDNA expression library derived from S. 
mansoni adults was probed with serum from infected mice and reactivity to a 70kDa 
protein occurred (Lanar et al., 1985). A blot of SEA was then probed with serum from a 
rabbit immunised with the recombinant protein and it was thereby established that the 
protein was also present in eggs. HSP70 was then sequenced (Hedstrom et al., 1987) and it 
was at this point that the homology between the 70kDa protein and human/Drosophila 
melanogaster HSP70 became apparent. HSP70 is expressed in all stages of the S. mansoni 
lifecycle (Lanar et al., 1985; Neumann et al., 1993; Yuckenberg et al., 1987), but 
expression levels vary between the stages, with the egg being the stage at which HSP70 is 
most highly expressed (Curwen et al., 2004). 
A humoral response to S. mansoni HSP70 has been found in mice, humans and baboons 
(Lanar et al., 1985; Hedstrom et al., 1988; Kanamura et al., 2002). The baboon study 
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incorporated epitope mapping in which it was established that the schistosome HSP70 
contains multiple epitopes, the most immunoreactive of which by far are those at the 
carboxyl terminal of the protein. This section of the protein has the least homology to 
HSP70 from other species, thereby explaining the species-specific reactivity of antibodies 
to S. mansoni HSP70 - there being no cross-reactivity to S. japonicum HSP70 for example 
(Hedstrom et al., 1988). 
1.3.6 Phosphoenolpyruvate Carboxykinase 
S. mansoni phosphoenolpyruvate carboxykinase (SmPEPCK) was first described when 
CD4+ cells from acutely infected C57BL/6 mice were assayed for reactivity with SEA 
components that had been separated by electrophoresis (Asahi et al., 1999). The most 
reactive antigen was a 62kDa protein, which was digested and its fragments used to 
stimulate a T-cell hybridoma (also derived from C57BL/6 mice) known to be reactive to the 
native protein. The most antigenic fragment was sequenced and found to be identical to 
PEPCK of other species. SmPEPCK was then cloned and the extent of its antigenicity 
found to be strain-dependent - in CBA mice it was less immunogenic than Sm-p40 but in 
both B57BL/6 and CBA mice the native protein induced a mixed Thl/Th2 response, 
although no IL-4 was produced in response to the recombinant version (Asahi et al., 2000). 
1.3.7 SmE16 
When the protein products of an S. mansoni cDNA library were probed with serum from 
infected humans a 16.3 kDa, 143 amino acid calcium binding protein called SmE16 was 
identified (Moser et al., 1992). SmE16 had homology to troponin C (from chicken and frog 
muscle) and calmodulin (from Caenorhabditis elegans and Schizosaccharomycespombe). 
Although described by the authors as an egg-specific protein it is not known what function 
it performs. 
Part 4: Proteins Secreted by the S. mansoni Egg 
The idea that eggs secreted factors goes back decades - long before the first papers 
describing SEA were published. The idea was logical, because it would provide an 
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explanation as to how the cellular foci that were evident in infected people and mice were 
formed. Thus, egg secretions were first described as a "cytolytic fluid", secreted by the S. 
japonicum miracidium, which emerged through pores in the shell and glued leukocytes to it 
forming an "agglomeration" (Faust, 1946). The existence of egg secretions was first proven 
eight years later, when the precipitation test for schistosomiasis was first described (Oliver- 
Gonzälez, 1954). The precipitation test involved incubating serum on a slide with S. 
mansoni eggs for 24 hours. When the serum had been taken from infected humans or 
animals a precipitate formed around the shell. This precipitate only occurred around live 
eggs and the antibodies responsible for it were unreactive to lyophilized material from 
cercariae or adult worms. The precipitation test was subsequently repeated but with serum 
from acutely infected mice and cryostat liver sections rather than intact eggs (von 
Lichtenberg, 1964). When probed with labelled, rabbit anti-mouse globulin antibody a 
precipitate around the eggshell could be seen, and the egg was described as being 
"embedded in a glassy precipitate which fades outwards into granules". 
The first experiment designed to assign a function to the egg secretions was a protease 
assay in which S. mansoni eggs were incubated in azocollagen (Kloetzel, 1968). A time- 
dependent and egg density-dependent increase in protease activity was seen, which was 
interpreted as being evidence for a secreted collagenase. However, the proportion of dead 
eggs at the beginning and end of the experiment was not recorded, so it is possible that the 
phenomenon that was seen was the rate at which eggs were dying in the phosphate buffer 
and leaking their proteolytic contents. The azocollagen assay was subsequently repeated but 
the results could not be replicated (Asch & Dresden, 1979). The secreted protease theory 
was pursued further when eggs were incubated on a fibrin matrix overnight and the extent 
of substrate degradation measured (Curtis, 1991). Although an egg-density dependent 
protease activity was reported, antibiotics were not used and nor was the proportion of dead 
eggs assessed before or after the experiment. As in the Kloetzel (1968) paper, it is 
impossible to eliminate dead eggs or bacterial contamination as being the source of the 
protease activity in the Curtis (1991) study. 
A protocol for culturing eggs in sterile media (with antibiotics) to enrich for their secretions 
was established by Boros & Warren (1970). The authors also compared the priming 
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capabilities of the egg secretions with SEA. Nave mice were primed with either the egg 
secretions or SEA and challenged a week later with live eggs. Eight days after challenge 
the size of the granulomata were measured. By way of comparison, other mice were primed 
with diffusion chambers containing live eggs. When the granulomata sizes were compared, 
it was found that those from the mice primed with egg secretions and live eggs were of a 
similar size, and that this size was significantly larger than those from mice primed with 
SEA. Although the authors stated that they used an equivalent number of eggs in each 
preparation, it is difficult to assign any significance to the differences in granulomata size. 
This is because no protein quantification assays were carried out, so equalizing the total 
protein content of the egg (i. e. the SEA preparation) to the quantity of protein secreted by 
the egg over time (i. e. the cultured egg and live egg preparations) is impossible. However, 
Boros & Warren (1970) remains an important paper because it is the first report of eggs 
being cultured in vitro to enrich for their secretions. 
The subject then fell out of favour, in that only two papers of significance were published 
in the following thirty years. The first of these followed on from Boros & Warren (1970), 
repeated their sensitization assays and found that immature eggs were immunologically 
inert (Hang et al., 1974). The second paper established that anti-CEF6 serum could be used 
in a diagnostic precipitation test (Dunne et al., 1988), thereby demonstrating that 
immunogenic elements of CEF6 were secreted from live eggs. 
Then, interest in the subject of egg secretions was revitalised after the first detailed 
characterization of the secreted proteins was carried out (Ashton et al., 2001). In this paper, 
eggs were cultured using a protocol similar to Boros & Warren (1970) and their secretions 
subjected to one-dimensional electrophoresis (1-DE) and casein zymogram analysis. It was 
thereby established that the egg secretions were very different to SEA, comprising only 6 
bands on the gel, two of which had proteolytic activity. The secreted proteins were called 
Egg Secreted Proteins (ESPs). Immunohistological and transmission electron microscopic 
studies were also included in the paper, and these showed that ESPs are produced not by 
the miracidium as had previously been thought but by the subshell envelope, once the egg 
has started to mature. 
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ESP was then subjected to 2D electrophoresis (2-DE), glycan staining, mass spectrometry 
(MS) and phylogenetic analysis (Ashton, 2001). ESPs were found to comprise of 21 spots 
on a 2D gel, which could be grouped into six phylogenetically related clusters of spots. One 
of these clusters contained 6 very basic spots, four of which (ESP 3-6) were glycosylated 
isoforms of the same protein. They also comprised the bulk of the protein in the entire gel. 
ESP 3-6 was sequenced and the sequences deposited on GenBank. No homology was found 
between ESP and any previously characterized proteins. 
Most recently, a study has been published that claims to be a full proteomic 
characterization of the ESPs, where mass spectrometry was used to identify proteins in egg 
culture supernatants (Cass et al., 2007). The paper lists a total of 188 proteins and states 
that they make up the S. mansoni egg "secretome". However, list includes numerous 
proteins that are well known to be intracellular and which do not have a secretory signal 
peptide (such as glycolytic enzymes and histories). Unfortunately, the large number of 
obviously intracellular proteins on the list makes it impossible for the reader to be confident 
that any particular protein on the list is truly secreted from the egg and as such, the paper 
adds very little to the overall knowledge about egg secretions. 
1.4.1 ESP 3-6 (a. k. a. IPSE, SmEP25 and SmCKBP) 
Three independent groups have subsequently published research, each attributing a 
different function to ESP 3-6. Human basophils, cultured with a native and recombinant 
protein that turned out to be ESP 3-6 were found to secrete IL-4 when stimulated by either 
forms of the protein (Schramm et al., 2003). The protein was called IPSE (Interleukin-4- 
inducing principle of S. mansoni eggs) and the authors hypothesized that this IL-4 may be 
the trigger that caused the Th1/Th2 switch that occurs consequently with egg deposition. 
IPSE was then described as being the same protein as the CEF6 component al (Schramm et 
al., 2006). This connection between IPSE and aI was made because both proteins were 
basic, glycosylated heterodimers of a similar molecular mass. The connection is supported 
by Dunne et al., (1988) who had already demonstrated that at least one CEF6 component 
was secreted (because anti-CEF6 serum could be used in the precipitation test). However, 
IPSE has a pl of approx 9.5 (Ashton, 2001), which is higher than the p17.5 - 8.5 of al, as 
described by Dunne et al., (1991). Also, the Con A-affinity chromatography used by Dunne 
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et al., (1991) to purify al was rejected by Schramm et al., (2003) in the purification of 
IPSE because Con A is prone to non-specific binding and it only exhibits a weak affinity 
for the IPSE protein (Schramm, 2006 pers comm. ). It is therefore apparent that there are 
differences as well as similarities between IPSE and al, and so it may be premature to 
assign the same identity to both proteins at this point in time. 
The second research group measured the cytokines produced by T cells after they had 
been 
stimulated with recombinant ESP3-6 (Williams et al., 2005). The cells came from two 
different strains of mice with acute S. mansoni infections. A proliferative response to the 
antigen was seen as well as production of cytokines associated with both ThI (interferon 
(IFN)y, IL-2) and Th2 (IL-4, IL-5) responses. The authors called the protein SmEP25 (S. 
mansoni egg protein of 25kDa). 
The third group carried out chemokine binding and cell migration assays to investigate the 
interactions between ESP 3-6 and human neutrophils (Smith et al., 2005). This group found 
that ESP 3-6 could bind to chemokines, inactivate them and slow down the recruitment of 
cells to the developing granuloma. They called the protein SmCKBP (S. mansoni 
chemokine binding protein). 
The role that ESP 3-6 (aka IPSE, SmEP25 and SmCKBP) plays in the biology of 
schistosomiasis is still unclear because there is no consensus between the research groups 
working on it. For the purposes of simplicity and consistency this thesis will use the 
original nomenclature (i. e. ESP 3-6) when describing the protein. 
1.4.2 Omega-1 
Omega-1 was purified from SEA, sequenced and expressed in E. coli (Fitzsimmons et al., 
2005). As the sequence was found to be homologous to a family of extracellular plant T2 
RNAses, zymography was used to demonstrate RNAse activity in the native protein. 
Fitzsimmons et al. (2005) went on to state that omega-1 was the same protein as the 
potentially hepatotoxic CEF6 component wl (which had been originally described 
(concurrently with a1) in Dunne et al., (1991)), presumably because the same protocol was 
used to purify it from SEA. The fact that both the omega 1 of Fitzsimmons et al. and the wl 
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of Dunne et al. are both glycoproteins of the same mass and pI adds weight to this 
conclusion. As omega-I contains a secretory signal peptide, Fitzsimmons et al. (2005) 
hypothesise that the protein is secreted from the egg, whereupon the RNAse activity might 
modulate the cell-mediated response to schistosomiasis. However, the paper falls short of 
demonstrating such secretion. 
1.4.3 Thioredoxin Peroxidase 
Thioredoxin peroxidase-1 (Sm-TPx-1) was identified as a 26 kDa component of SEA, and 
after sequencing, homology to thioredoxin peroxidase in various other organisms was 
found (Williams et al., 2001). The S. mansoni native protein (obtained by electroelution 
from an SEA gel) induced a proliferative Thl/Th2 response as well as a humoral response 
in C57BL/6 and CBA mice. Western blots were used to demonstrate that Sm-TPx-1 was 
secreted from cultured eggs. The authors' hypothesis that Sm-TPx-1 was actively secreted 
from live eggs would be more convincing if the dead eggs had been separated from the live 
ones prior to the culture, and if a control blot of other SEA proteins had been carried out. 
To date, it has not been demonstrated that the Sm-TPx-1 in the culture medium wasn't a 
leakage product from the dead eggs. However, subsequent research investigating the role of 
thioredoxin peroxidase in F. hepatica has found it amongst the secretory products of the 
adult parasite and capable inducing the alternative activation of macrophages (Donnelly et 
al., 2005). 
1.4.4 S. mansoni Egg-Derived Pro-Angiogenic Factor 
"S. mansoni egg-derived pro-angiogenic factor" was described after SEA, ESP, intact eggs 
and soluble preparations from adults and cercariae had been placed on a fibrin matrix 
containing growth medium and bovine retinal endothelial cells (Kanse et al., 2005). After 
incubation, the endothelial cells had proliferated and become re-structured in the presence 
of SEA, ESP and live eggs, forming a capillary-like cellular matrix. The extent of matrix 
formation was found to be dependent upon the concentration of SEA, ESP or the number of 
eggs. The authors concluded that the eggs secreted this pro-angiogenic factor and although 
they do not offer a reason why it would be secreted it is logical that it would contribute to 
the vascular remodelling of the damaged liver and gut tissue, thereby reducing disease 
pathology, prolonging the life of the host and benefiting the parasite. 
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An identity for the pro-angiogenic factor was not ascertained, but various purifications 
procedures were carried out. These established that the pro-angiogenic factor was a heat- 
stable, protease-resistant non-lipid of between 30 and I OOkDa. Unfortunately, no measures 
of egg viability were taken during the experiment and nor were dead eggs removed prior to 
the matrix incubation or egg culture steps. It is therefore impossible to eliminate leakage 
products of dead eggs as inducers of the bioactivity in either the ESP or whole-egg assays, 
so the active principal could actually be an SEA component rather than an ESP one. Also, 
the most potent inducer of angiogenesis was SEA, so it is unlikely that the bioactive 
component is enriched in egg secretions. It is therefore difficult to accept that the pro- 
angiogenic factor is indeed secreted from live eggs. 
1.4.5 Egg Glycans 
Many of the SEA components are glycosylated, including some of immunological interest 
such as al and wl (Dunne et al. 1981) and ESP 3-6 (Ashton, 2001). The S. mansoni egg 
glycans are generally characterized by multifucosylated repeating units (Khoo et al., 1997). 
Various studies involving monoclonal antibodies have established that the principal targets 
in the humoral response in schistosomiasis are indeed these fucosylated glycans (Eberl et 
al., 2001b; Van Remoortere et al., 2003; Robijn et al., 2005). Although the glycoproteins 
themselves are developmentally regulated, the glycan epitopes are often shared and this 
means that there is a significant amount of humoral cross-reactivity between the life cycle 
stages. This means that when egg deposition commences, cross-reactive antibodies are 
already in circulation, derived from epitopes contained in the glycoproteins and glycolipids 
of the cercarial glycocalyx and secretions (Weiss et al., 1986; Dalton et al., 1987). 
The best characterized egg glycan is Galß1-4(Fucal-3)GicNAc (Lewis"). This is expressed 
in egg glycoproteins and cercarial glycolipids, but not in egg glycolipids (Robijn et al., 
2005). It is the major component of the glycans present in ESP 3-6 (Wuhrer et al., 2006). 
Lewis" has been shown to have immunomodulatory properties because the oligosaccharide 
Lacto-N-fucopentose III (containing Lewis") induces IL-10 and prostaglandin E2 
production in murine B cells in vitro whereas its nonfucosylated homologue lacto N 
neotetraose does not (Velupillai & Ham, 1994). Anti-Lewis" IgM and IgG are produced by 
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infected mice, hamsters and chimpanzees, but in the chimpanzee model the titre is low, 
possibly due to a lower antigen concentration in the blood (Nyame et al., 1997; Eberl et 
al., 2001 a). 
Part 5: Proteomics and Studyin2 the Proteome 
Chapter 2 of this thesis is comprised of a proteomic characterization of the S. mansoni egg. 
Therefore, some background with regard to proteomics follows, in order to put this work 
into context. 
A proteome is the entire set of proteins expressed from a genome and "proteomics" is the 
branch of science dedicated to its study (Wasinger et al., 1995). Originally consisting of the 
application of 2-DE and MS to separate and identify proteins, proteomics has now 
broadened to include the study of protein-protein interactions (Blackstock & Weir, 1999). 
The techniques of 2-DE and MS have been available for some time, but it is more recently 
that refinements have been made to improve their sensitivity and reproducibility. These 
refinements, in conjunction with the exponential increase in the quantity of sequenced 
genomic data have made proteomics a much more powerful tool. Proteomics enables the 
protein complement within and between organisms to be characterized and compared in 
terms of its distribution, expression levels, post-translational modifications and interactions. 
A proteomic study typically involves three steps. Firstly, the complex protein mixture is 
separated into its individual proteins. Then, each of the proteins is characterized by mass 
spectrometric methods and finally the proteins are identified by searching databases of 
sequenced genomic data. 
1.5.1 Two-Dimensional Electrophoresis 
2-DE is a method of separating proteins in a crude mixture by taking advantage of two of 
their unrelated properties - charge and size (O'Farrell, 1975; Klose, 1975). Proteins are 
initially separated according to their charge on an immobilised pH gradient. The original 
method of creating the gradient was by absorbing a liquid mixture of carrier ampholytes 
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(low molecular weight synthetic polyamino-polycarboxylic acids) into an agarose or 
polyacrylamide gel. The application of an electrical charge across the gel caused the 
ampholytes to arrange themselves in order of increasing p1, from the anode to the cathode. 
By using a multitude of different ampholytes a pH gradient could be generated. This 
liquid-ampholyte method of creating the pH gradient was improved upon when 
immobilized pH gradients (IPG) were introduced (Bjellqvist et al., 1982). Now, instead of 
applying the ampholytes in liquid form to the cast gel they could be covalently bound to 
acrylamide monomers incorporated into the structure of the gel itself. The gel was then 
bound to a plastic strip, dehydrated and could be purchased by the laboratory and stored in 
this form. When applied to the gel, proteins are absorbed into it and migrate, driven by the 
electric current until each protein reaches the point at which its p1 equals the pH of the gel 
and it has no net charge. If the protein then diffuses from this position it will gain a charge 
(positive if it diffuses towards the anode and negative if it diffuses towards the cathode). 
This charge will then drive the protein back to its original spot. The protein therefore 
cannot move from its p1 whilst the current is running and it becomes "focussed". The IPG 
strip is superior to the carrier ampholyte gel because the pH gradient is more stable, more 
reproducible, a larger quantity of protein can be applied and the strip itself is easier to 
handle and store. 
The principal problem with isoelectric focussing (IEF) is one of protein solubility. In order 
for the focussing to effectively separate the proteins, the entire protein content of the crude 
extract needs to be denatured and fully solubilized. However, this must be achieved without 
the use of strong ionic buffers because any inherent charge in the buffer will mask that of 
the protein itself and induce fluctuations in the current. It is difficult to solubilise proteins 
with large hydrophobic regions (such as membrane proteins) and therefore 2-DE is 
restricted to the study of the soluble proteome. 
After isoelectric focussing has completed the strip is transferred to the top of a 
polyacrylamide gel and sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS- 
PAGE) is carried out, separating the focussed proteins by their molecular masses. Then, 
after staining the gel, thousands of separate proteins can potentially be seen as individual 
spots. Each spot (containing one to a few proteins depending upon the complexity of the 
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sample) can be accorded x and y coordinates. These coordinates enable the molecular 
mass and p1 for the protein within that spot to be easily and accurately determined. 
1.5.2 Mass Spectrometry 
During the last decade, mass spectrometry has revolutionised the identification of proteins. 
Prior to this Edman Degradation was the favoured method (Edman, 1949). Edman 
Degradation is a somewhat laborious process involving the sequential removal of amino 
acids from the amino terminal of the protein and then identifying them one-by-one using 
High Performance Liquid Chromatography (HPLC). MS offers a faster, more sensitive 
procedure that can also cope with protein mixtures. 
A mass spectrometer is a device that measures the mass to charge ratio (nz/z) of a protein, or 
more usually its peptides. Peptides are almost always used because they are easier to ionize 
than intact proteins and furthermore, if the masses of several different peptides within a 
protein are known a much more confident identification can be made. The protein to be 
analysed is therefore enzymatically degraded into its peptides. The peptides must be short 
enough to be amenable to ionisation, long enough to contain a potentially unique amino 
acid sequence and must have been cleaved at a site that is predictable. Trypsin is the 
protease that best fits these criteria, cleaving at the carboxyl side of arginine and lysine 
residues (unless they are immediately followed by proline). Tryptic digestion of a protein 
typically results in peptides of about 10 amino acids in length - which are also amenable to 
ionisation because of the basic residue on the peptide's carboxyl terminus. 
A mass spectrometer generates the "peptide mass fingerprint" (PMF) of a protein. A 
protein's PMF is the unique set of peptide masses derived following its digestion by a 
protease (Cottrell, 1994). Various kinds of mass spectrometers are available, all of which 
produce PMFs, but in this thesis almost all of the mass spectrometry has been carried out 
using matrix-assisted laser desorption-ionisation time of flight mass spectrometry (MALDI- 
ToF MS). 
In a MALDI system, the tryptic peptides from each protein are mixed together in an excess 
of matrix and dried as a spot on a metal plate. The plate is inserted into the mass 
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spectrometer and a laser targeted at the spot. The energy from the laser is absorbed by the 
matrix and is transferred to the peptides. This causes the peptides to be desorbed from the 
plate as a plume. A high voltage is applied, which propels any positively charged peptide 
ions through a series of focussing electrostatic lenses into a mass analyser. The mass 
analyser separates the peptide ions according to their m/z. In ToF instruments the mass 
analyser consists of a flight tube, and the time taken for the peptide ions to travel the length 
of the tube is measured. Each of the peptide ions has the same kinetic energy and is singly 
charged, so the time taken for an ion to travel through the tube will be entirely dependent 
on its mass. This is shown in the equation t=L / (2v/miq)lrz (where t= transit time, L= flight 
tube length, V= voltage applied, m= peptide ion mass and q= ion charge). The peptide 
ions of a particular m/z exit the mass analyser together and strike the detector, which 
amplifies the signal and passes it to the data recorder. The data recorder plots the m/z of 
each ion against its intensity. This information is presented as a mass spectrum, showing 
the number of ions in the sample, their relative intensities and their m/z. This mass 
spectrum, incorporating all the peptide ions from the protein is the protein's PMF. The 
PMF is then searched against a database. The computer program carries out a theoretical 
digest of all the proteins in the database to produce a theoretical PMF for each one. A 
comparison is then made between this expected PMF and that obtained by the mass 
spectrometer. The results are presented as a list of the database proteins, ranked in order of 
the closeness of their match. 
A small amount of work in Chapter 2 has been carried out using an Electrospray 
Quadrupole-Time-of-Flight mass spectrometer. In such a system the ions are created by 
injecting the peptides into the mass analyser through a small-diameter needle in the 
presence of a strong electric field. The charged droplets are desolvated in a countercurrent 
of gas and transferred into the mass analyser. Mass sorting in the analyser depends on the 
motion of the ion between four rods that have either a constant current or a radio frequency 
electric field applied to them. Scanning is accomplished by systematically changing the 
field strengths, thereby changing the m/z value that is transmitted through the analyzer so 
that only ions of a particular m/z will exit the quadrupole. The ions then enter a flight tube 
to acquire the mass spectrum. 
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Tandem mass spectrometry can be used to obtain structural information from a PMF. A 
tandem mass spectrometer has more than one mass analyser, resulting in its ability to 
select a precursor ion (i. e. a peptide ion), fragment it and then to go on to calculate the m/z 
of its product ions. This fragmentation takes place in a collision cell containing an inert gas, 
after a timed ion selector has isolated the parent ions of the chosen m/z. The collision 
usually causes most of the precursor ions to fragment at one of the amide bonds because 
these bonds have the lowest energy (Steen & Mann, 2004), producing a series of y ions (if 
the charge is retained on the C-terminus) and b ions (if the charge is retained on the N- 
terminus). Other ions are also produced when the peptide fragments elsewhere as illustrated 
below (Johnson et al., 1987). The set of fragment ions produced by tandem MS (also called 
MSMS) of the chosen precursor ion can then be used to deduce the amino acid sequence of 
the precursor ion. The m/i of each of the fragment ions is combined into a spectrum and the 
distance between the y (or b) peaks represents the difference in mass between the amino 
acids in the precursor peptide. 
X3 Y3 Z3 X2 Y2 Z2 X1 Y1 Z1 ---, H+ 
R10 R2,0 R3,0 ," R4 
H2N--CTý-rN-T -T8TNTC-r1 
ýTNTC-C00H 
H; : H: H; : H: H; : H: H 
a, b, c, a2 b2 C2 a3 b3 c3 
Figure 1.3 Possible fragmentation points of a peptide in tandem mass spectrometry. If 
the charge is retained on the carboxyl-terminal of the peptide x, y or z ions will be produced 
and if the charge is retained on the amino-terminal a, b and c ions are generated. The 
subscript number denotes the number of peptides in the ion. From Johnson et al., (1987). 
The set of precursor peptide ion m/z values can then be compared with theoretical masses 
obtained from protein, EST or genome databases to identify the protein. The searches of 
48 
MSMS data in this thesis used the MASCOT search engine to search against the non- 
redundant NCBI protein database and a database of S. mansoni ESTs called Schisto CDS 
(discussed in detail in Chapter 2). MASCOT works by carrying out a theoretical mass 
fragmentation of all the peptides in the database, comparing them to the observed ions and 
presenting the results as a list, ranked in order of decreasing scores based on the Mowse 
algorithm (Pappin et al., 1993). The probability based Mowse score reports the result as 
-10 x log 10 (P), where P is the absolute probability that the match occurs 
by chance. 
Therefore, if an analysed protein matches a theoretically digested one from a database, and 
the probability of that match occurring by chance is 10"100, then this becomes a Mowse 
score, or "total ion score" of 100. 
Part 6: Regulated Protein Turnover 
Although the bulk of the experimental work in this thesis relates to characterizing the 
proteome of the S. mansoni egg and its secretions, Chapter 4 differs in that it investigates 
the ubiquitin-proteasome pathway (UPP) of protein turnover in the egg. The introduction to 
Chapter 4 provides a description of the ubiquitin-proteasome pathway, so it is therefore 
appropriate to provide some background information below as to the other, non- 
proteasomal mechanisms of protein degradation. 
There are many reasons why an organism must be able to degrade its proteins and recycle 
the amino acids. Proteins that have misfolded during their biogenesis or have been damaged 
whilst functioning need to be selectively destroyed. Fully-functional proteins need to be 
degraded if a physiological change in the cell's environment necessitates a reduction in 
expression levels. An ordered mechanism of protein degradation is required when cells die, 
so that the dying cell can collapse neatly and in a controlled manner, thereby avoiding 
damaging neighbouring cells and inducing an inflammatory response. Extracellular proteins 
taken up by endocytosis need to be broken up into their constituent amino acids for use in 
new protein synthesis. Although the reasons for protein degradation are varied, the 
mechanisms by which the process occurs can be divided into three distinct pathways - 
those of apoptosis, autophagy and the proteasome system. 
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1.6.1 Apoptosis 
Apoptosis is the genetically programmed mechanism by which a multicellular organism 
disposes of cells that are no longer needed. Rather than bursting as occurs in necrosis 
following an acute injury, apoptotic cells collapse in a regulated manner, so that its 
remnants can be phagocytosed by a neighbouring cell. Apoptosis utilizes a special set of 
cytosolic cysteine proteases called caspases, which quickly degrade as much intracellular 
material as possible. Caspases have a wide range of substrates and are synthesised as 
inactive precursors called pro-caspases, which are activated by other caspases, resulting in a 
very rapid amplification of the initial apoptotic signal and proteolytic capability in the cell 
(Thornberry et al., 1997). The caspase cascade is controlled by various pro and anti- 
apoptotic regulators, and so it is the balance between them that determines the life versus 
death fate of a cell (Bergmann et al., 2003; Nijhawan et al., 2003). There are pro-apoptotic 
signalling pathways that operate via cell-surface receptors and others that respond to 
various forms of intracellular stress. 
In the intracellular stress response, members of the Bcl-2 (B-cell lymphoma 2) family are 
the key mediators of apoptosis. There are three Bcl-2 subfamilies: a pro-apoptotic group 
and a pro-survival group that are both located in the outer mitochondrial membrane plus a 
cytosolic sensory group called BH3-only proteins. Different BH3-only proteins respond to 
specific stress stimuli such as DNA damage, the accumulation of unfolded proteins in the 
ER or the withdrawal of growth-factors (Shibue & Taniguchi, 2006). Following their 
activation, the BH3 proteins translocate to the mitochondrial membrane and bind to the 
Bcl-2 proteins in the membrane, neutralizing the pro-survival proteins and activating the 
pro-apoptotic ones (Shibue & Taniguchi, 2006). The membrane-bound Bcl-2 proteins then 
allow leakage of material from the space between the mitochondrial membranes into the 
cytosol. Some of these mitochondrial proteins (such as cytochrome c) interact with Apaf-I, 
pro-caspase 9 and deoxy-adenosine triphosphate to form complexes called apoptosomes 
which induce the caspase cascade and start the process of apoptosis (Thorburn, 2004; Green 
& Evan, 2002). 
There are six known cell-surface death receptors, characterized by a conserved intracellular 
signalling domain called a death domain (Thorburn, 2004). The death receptors are 
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members of the tumour necrosis factor (TNF) receptor super-family and include CD95 
(APO-1/Fas), TNF receptor 1 and TRAIL. The death receptor ligands are also membrane 
bound (although they can be cleaved to a soluble form by extracellular metalloproteases), 
an important example being CD95L, which is expressed by activated T cells and tumour 
cells and induces apoptosis in target cells (Debatin & Krammer, 2004). Stimulation of a 
cell's death receptors causes them to aggregate and recruit pro-caspase 8 via an adaptor 
protein called FADD (Fas-Associated Death Domain), forming an intracellular protein 
complex called the Death Inducing Signalling Complex (DISC). The dimerization of pro- 
caspase 8 within DISC causes their mutual cleavage and activation. Caspase 8 then cleaves 
pro-caspase 3 which in turn induces the caspase cascade (Hengartner, 2000; Thorburn, 
2004). 
Once a cell enters apoptosis a set of cell-surface, apoptotic-specific markers are expressed. 
These include phosphatidylserine, intracellular adhesion molecule 3 (CD50), complement 
ligands, and specific glycans (Savill & Fadok, 2000). There are also a range of soluble, 
intermediate factors such as the first complement component Cl q which create molecular 
bridges between receptors on apoptotic cells and phagocytic ones (Nauta et al., 2003). 
Apoptotic cells can then be readily identified and phagocytosed, most likely by professional 
phagocytic cells (principally macrophages) in mammals but also by any neighbouring cell 
with a phagocytic capability. How macrophages are able to distinguish apoptotic cells from 
pathogens and are able to phagocytose the former without becoming activated and secreting 
pro-inflammatory cytokines is thought to relate to the range and pattern of surface markers 
on the apoptotic cell. These "apoptotic-cell-associated molecular patterns" may have some 
homology to "pathogen-associated molecular patterns" and can therefore be recognised by 
macrophage pattern recognition receptors (PRRs), but not by TLRs (Gregory & Devitt, 
2004). Thus, TLR activation could be a key difference between pro-inflammatory 
activation of macrophages in response to the phagocytosis of pathogens and the non- 
inflammatory response seen in apoptotic phagocytosis. In support of this idea it has been 
demonstrated that macrophage phagocytosis is TLR 4 independent and phagocytosis of 
necrotic but not apoptotic cells induces expression of pro-inflammatory genes via TLR 2 
(Li et al., 2001; Shiratsuchi et al., 2004). 
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After it has been phagocytosed, the remains of the apoptotic cell are contained within a 
large vesicle called the phagosome, which then fuses with lysosomes to form a 
phagolysosome. Lysosomes contain the proteases, nucleases, glycosidases, lipases, 
phosphatases, sulfatases and phospholipases that are collectively called acid hydrolases. 
Acid hydrolases are active at circa. pH5. This phagocytic pathway is distinct from the 
endosomal pathway. In the latter, much smaller extracellular molecules are taken up by 
endosomal vesicles which develop via early endosomes to form late endosomes 
(accompanied by a decrease in pH). The late vesicles then fuse with the acid hydrolases 
delivered from the Golgi to form the lysosomes. Once inside the phagolysosome the 
proteolysis is completed and the protein content of the apoptotic cell is degraded into its 
constituent amino acids. 
1.6.2 Autophagy 
Autophagy is a dynamic process found in eukaryotic cells that operates as an important 
survival mechanism in short-term starvation by recycling non-essential cytoplasmic 
components. It is also involved in homeostasis and in tumour suppression (Eskelinen, 2005; 
Gozuacik & Kimchi, 2004). The principal autophagic pathway (also called 
macroautophagy) begins when an induction signal induces a portion of intracellular double- 
membrane (called a phagophore) to undergo invagination and then complete sequestration 
to form a vacuole, containing portions of cytoplasm (Dunn, 1990). These vacuoles are 
called autophagic vacuoles in mammalian cells and autophagosomes in yeast. The 
autophagic vacuole then fuses with endosomes that could be at any stage of maturation 
from endosomal vesicles to late endosomes, forming an amphisome (sometimes called a 
late/degenerative autophagic vacuole). During this fusion process the outer membrane of 
the autophagic vesicle is incorporated into that of the endosomal membrane, thereby 
maintaining the integrity of the autophagic vacuole within the inner membrane. The 
amphisome outer membrane then fuses with a lysosome (forming an autolysosome). The 
released lysosomal acid hydrolases proceed to degrade the entire contents of the 
autolysosome so that the raw materials can be released back to the cytosol where they can 
be reused for metabolism (Klionsky & Emr, 2000; Eskelinen, 2005). 
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Three other less important autophagic routes have been described. In microautophagy the 
portion of cytoplasm is sequestered by an invagination of the lysosomal membrane rather 
than by a phagophore (Ahlberg et al., 1982). Chaperone-mediated autophagy involves the 
chaperone-mediated transport of proteins from the cytosol into the lumen of the lysosome 
(Cuervo & Dice, 1996). In crinophagy secretory vesicles from the ER fuse directly with 
lysosomes, degrading their contents (Glaumann, 1989). 
Autophagic degradation is developmentally and nutritionally regulated, so that it is induced 
in conditions of starvation yet inhibited in conditions of growth. The method of regulation 
is not fully understood but one of the major regulatory routes is via the protein kinase Tor 
(Target of Rapamycin). Tor inhibits the initial induction of autophagy in growth conditions, 
by phosphorylating the autophagic protein Atgl and also by blocking the signal 
transduction cascade that controls transcription of several autophagic effector proteins 
(Klionsky, 2005). 
Autophagy is generally considered to be a non-selective response, delivering a random 
supply of cytoplasmic raw materials for reuse in the cytosol. However, the process has also 
been implicated in the more targeted degradation of proteins such as the cytoplasmic 
protein Ald 6 or organelles such as damaged mitochondria or peroxisomes (Onodera & 
Ohsumi, 2004; Lemasters et al., 1998; Hutchins et al., 1999). 
Part 7: Aims of the Project 
This project focuses on the S. mansoni egg. The egg is important for two reasons - it is the 
means by which the parasite continues its life cycle and it is the egg proteins that are 
responsible for the bulk of the pathology in schistosomiasis, including the most serious 
sequelae. 
A few of the egg proteins have been identified and papers published on these on a protein- 
by-protein basis. No study has been undertaken to look at the egg proteome as a whole, and 
so the relative abundance of each of these proteins in the egg is not known. This project 
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undertakes this study and characterises the egg proteome in terms of its development over 
time as well as its morphological constituents. Egg development over time is studied by 
comparing SEA preparations derived from immature and mature eggs. The immature egg is 
a relatively small entity consisting of a developing embryo surrounded by vitelline cells and 
is immunologically inert. The (much larger) mature egg is an immunogenic, protein- 
secreting capsule containing a viable miracidium, so significant differences were expected. 
The morphological components of the mature egg consist of the miracidium, the hatch fluid 
(i. e. the water-soluble contents of the egg that are flushed from the egg as it ruptures at 
hatching) and the ESPs. Each of these have a different biological function, so they are 
separated, purified where necessary and the proteome of each studied independently. 
By comparing the proteomes of each of these egg components a picture emerges as to how 
protein expression is linked to development, morphology and biological function, thereby 
providing a context in which to look at the previously described egg components. This is 
important because the pathology and immunology of schistosomiasis varies with time 
(changing from a ThI-dominant response to a Th2-dominant one and then subsequently 
down-modulating in chronic infection). An understanding of when and where proteins are 
expressed plus their abundance can then be accounted for in these processes. For example, 
exclusively miracidial proteins will not be accessible to the host's immune system until the 
egg has matured, died and disintegrated. This will be at a later time point than when the 
immune system can respond to ESPs, which are expressed when the egg is still alive but 
mature. Proteins present exclusively in the immature egg will not be accessible to the 
immune system at all, unless the eggs rupture before maturation for some reason, or the 
proteins are also expressed in the vitellaria of disintegrating female worms. The relative 
abundance of the vaccine candidates can also be assessed. This is of importance because 
there is a potential problem with tolerisation if a vaccine candidate is highly expressed in 
the mature egg, because large quantities of the antigen may be presented to the immune 
system as eggs degrade. 
ESPs are studied in more detail, because they are of particular interest in that they are the 
first egg proteins that are readily accessible to the immune system. ESPs probably play a 
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role in egg escape across the gut wall and so are likely to be inherently immunogenic. 
HPLC is utilized in an attempt to purify individual components from crude ESP and some 
assays are carried out to assess the extent of ESP immunogenicity. 
Finally, this thesis goes on to look at the proteasome/ubiquitin protein degradation pathway 
in the egg. It would be logical if protein degradation in the immature egg is fundamentally 
different from that in the mature egg, because the former requires a supply of amino acids 
from vitelline cells for growth and the latter needs to repair damage inflicted by the host 
leukocytes of the granuloma. This hypothesis is tested utilizing Western blots to compare 
the pattern of ubiquitination and proteasome expression in the different egg preparations. A 
functional assay to compare the amount of proteasome activity is also conducted. 
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Chapter 2 
A Proteomic Analysis of the Schistosoma mansoni egg 
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2.1 Introduction 
S. mansoni eggs are important because they are the means by which the parasite transmits 
itself between the definitive and intermediate hosts, as well as being a key contributor to the 
pathology of schistosomiasis when they become embolised in the liver. Describing the 
proteome of the egg is therefore of value because it could highlight proteins that are 
potentially capable of inducing pathology, which may be useful in ameliorating the disease. 
As discussed in Chapter 1, the egg needs the granuloma cells to cross the gut wall and 
emerge into the external environment, but while doing so it must defend itself from the 
toxic compounds that those leukocytes secrete. Therefore, some egg proteins are likely to 
be involved in the recruitment and activation of the granuloma cells whilst others will be 
required to protect the miracidium from the damage that the host cells could potentially 
inflict upon it. Understanding more about the egg proteome will therefore also increase our 
understanding of the biology of the egg in terms of its interactions with the host. 
2.1.1 Previous Work Studying the Schistosome Egg Proteome 
Chapter 1 details the research carried out to date focussing on the S. mansoni egg, including 
its morphology, protein components and their immunogenicity and function. The research 
can be summarised as consisting of various immunological assays using crude SEA plus a 
series of papers that identify some of the immunogenic SEA components on a protein-by- 
protein basis. There are also two papers that have compared the proteomes of different life- 
cycle stages in S. mansoni and S. japonicum (including the egg), and these have paved the 
way towards the more detailed characterisation of the S. mansoni egg-proteome which 
constitutes this chapter. The first of these papers (Curwen et al., 2004) compared the 2-DE 
pattern of spots across four S. mansoni life-cycle stages and then identified the forty most 
abundant soluble proteins in each using their PMFs. This work demonstrated that 34% of 
the SEA proteome was different to that of other life-cycle stages and that SEA was rich in 
glycolytic enzymes, structural proteins, calcium binding proteins and chaperones. The 
second paper is a proteomic study of S. japonicum that used Electrospray-MSMS to 
generate lists of proteins found in several life-cycle stages including the egg and the 
miracidium (Liu et al., 2006). A total of 1440 SEA and 918 miracidial proteins were 
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identified, but the list is so large and diverse in terms of protein function that it is 
impossible to draw meaningful conclusions from it. Relative abundances of the proteins 
were quantified by comparing the total MASCOT ion scores for each protein. The problem 
with measuring protein abundance in this way is that it overestimates the abundance of 
larger proteins (with more peptides, each contributing to the ion score) and proteins with 
more ionisable peptides. Large differences in ion scores are therefore required before 
comparisons can be made as to levels of protein expression. Unfortunately, the ion scores in 
the Liu et al study were too similar to make between-protein comparisons of abundance, 
but the S. japonicum egg certainly contains large quantities of actin, tubulin and heat shock 
proteins. The glycolytic enzymes that Curwen et al., (2004) found highly expressed in gels 
of S. mansoni SEA were less abundant in the S. japonicum egg according to Liu et al. 
(2006), but this probably reflects the highly soluble nature and intermediate size/pl of the 
glycolytic enzymes, which makes them more amenable to gel-based proteomics. 
2.1.2 The Miracidium, the Hatch Fluid and their Proteomes 
The miracidium hatches when the egg encounters fresh water, with the hatching rate 
decreasing if the salinity of the external environment is increased (Kassim & Gibertson, 
1976). As discussed below, the mechanisms that cause the egg shell to rupture have been 
the subject of most of the research focussing on the miracidium, but miracidial morphology 
and miracidial-snail interactions have also received attention. Apart from the Liu et al., 
(2006) paper discussed above, the miracidial proteome is unstudied. 
There are three different theories as to the mechanism by which the egg hatches. These are 
that the muscular activity of the miracidium causes the shell to break (Samuelson et al., 
1984), that an enzyme is secreted by the miracidium, envelope or vesicles and this degrades 
the shell (Kusel, 1970; Xu & Dresden, 1986) and that osmotic pressure causes cushions 
inside the shell to expand, rupturing the shell (Kassim & Gibertson, 1976). It has been 
proposed and disputed that hatching is induced by light (Standen, 1951; Kassim & 
Gibertson, 1976) and temperature (Samuelson et al., 1984; Standen, 1951). Thus, the 
mechanisms causing the shell to rupture remain unknown, but they certainly involve 
hydrostatic pressure. Only mature eggs containing fully-developed miracidia are capable of 
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hatching (Boros & Warren, 1970; Xu & Dresden, 1989) although one paper indicated that 
the miracidium does not necessarily need to be alive (Kusel, 1970). 
The overall ultrastructure of the miracidium has been studied using TEM (Pan, 1980) and 
its musculature described using confocal fluorescence microscopy (Bahia et al., 2006). Liu 
et al., (2006), found actin, Sm-p40, tubulin and adenosine triphosphate (ATP) synthase to 
be highly expressed in the S. japonicum miracidium. Thus, the miracidium appears to be 
principally concerned with energy production, motor function and the maintenance of its 
structural integrity. The miracidial transcriptome was included in the definitive S. mansoni 
transcriptome study carried out by Verjovski-Almeida et al., (2003) and more recently a 
microarray experiment comparing transcripts from miracidia and mother sporocysts 
claimed that only 6-8% of the transcriptome of these stages exhibited stage-specific 
expression (Vermeire et al., 2006). However, as that particular microarray only contained 
transcripts from adult worms, cercariae and eggs, any transcripts expressed purely in 
miracidia or sporocysts would have been undetectable. Thus the paper has a limited value 
in assessing the extent to which the miracidium differs from the following stage in its life- 
cycle, but it is evident that the S. mansoni miracidial transcriptome is rich in message 
encoding proteins involved in energy metabolism, motility and calcium-binding proteins. 
When the egg ruptures and the miracidium escapes, many other egg proteins will also be 
released. Some of these will be from the fluid layers found between the miracidium and the 
envelope and the envelope and the shell, including ESPs en route to secretion from the egg. 
The flooding of the shell with fresh water will induce an osmotic shock on the cells of the 
envelope, causing many to burst and release their intracellular proteins. The envelope is 
also torn as the miracidium emerges and can often be seen protruding from the empty shell. 
The vesicles, which can be seen to contain a viscous liquid under compound microscopy 
also regularly burst on hatching. The hatch fluid therefore represents a significant subset of 
egg proteins derived from several different structures in the egg, the proteome of which is 
likely to differ extensively from that of the miracidium. Despite its potential interest as a 
subset of egg proteins, hatch fluid remains relatively unstudied. Boros & Warren (1970) 
found hatch fluid to be capable of sensitizing naive mice to a subsequent injection of live 
eggs. Xu & Dresden (1986) found leucine aminopeptidase to be enriched for in hatch fluid 
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compared to miracidial and SEA preparations and thought that the protease could cleave 
shell proteins, causing the shell to rupture. However, protein concentrations were not 
measured, so the differences in protease activity between the hatch fluid and the other 
preparations could be attributable to different quantities of protein in each preparation. Xu 
and Dresden's decision to assay for leucine aminopeptidase (as opposed to any other 
proteases) was made because leucine aminopeptidase had been found in SWAP fifteen 
years earlier (Coles, 1970). Coles (1970) chose the assay because it was one of the few 
available at the time, so no significance can be attributed to finding leucine aminopeptidase 
as opposed to any other protease in hatch fluid. 
The only other paper relating to hatch fluid is a description of its use in diagnosing 
schistosomiasis (Linder, 1986). The procedure used hatch fluid from the eggs of an infected 
animal, adsorbed it onto nitrocellulose paper and then probed it with soybean lectin and 
anti-SEA antibody. As a diagnostic procedure it is completely pointless because the eggs 
themselves are diagnostic so there is no point in extracting hatch fluid from them. However, 
the paper has value in that it demonstrates that hatch fluid contains glycoproteins and it 
reinforces the Boros & Warren (1970) study that found hatch fluid to be immunogenic. 
2.1.3 The Proteome of ESP 
A general introduction to ESP forms Part 4 of Chapter 1, so the discussion that follows is 
restricted to its proteomic analysis. Ashton (2001) separated ESP using 2-DE and numbered 
the resulting gel-spots ESP1 to ESP22. A copy of the gel used to name the ESPs is 
reproduced as Figure 2.1. The spots were excised from the gel, subjected to tryptic 
digestion and MALDI-MS, but no homology to any other proteins was found when the 
resulting PMFs were searched against the NCBInr database. 
Guiherme Oliveira from Centro de Pesquisas Rene Rachou in Belo Horizonte, Brazil then 
deposited sequences covering parts of ESP3-6 and ESP 15 on dbEST. He then proceeded to 
provide the plasmids, which were amplified and completely sequenced by Peter Ashton at 
the University of York. The complete sequences were deposited in GenBank with 
Accession numbers AAM91992/gi22094805 (ESP3-6) and AAM91993/gi22094807 
(ESP15). 
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Figure 2.1. A reproduction of the gel from Ashton (2001), containing the original 
annotations for ESP 1- ESP22. There is no ESP7 or ESP 16. MALDI-MS 
demonstrated that the PMFs of ESPs 3,4,5 and 6 were identical, as were those of 
ESPI and ESP2, so in total there were sixteen different ESPs. ESP 3-6 and ESP 15 
were subsequently sequenced and the sequences deposited on GenBank. 
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As discussed in Section 1.4.1, ESP3-6 is the same as the IPSE protein described by 
Schramm et al., (2003), but there are small sequencing differences between them. 
Specifically, amino acid 29 of IPSE is leucine (it is methionine in ESP3-6), amino acid 41 
of IPSE is glutamic acid (it is unidentified in ESP3-6) and amino acid 56 of IPSE is valine 
(it is glutamic acid in ESP3-6). These sequence differences meant that IPSE was separately 
deposited on GenBank as a slightly different protein (accession number 
AAZ85122/gi73765569). 
2.1.4 Albumin and the S. mansoni Egg 
Albumin makes up about 50% of the protein content of vertebrate serum, in which it has 
ligand-binding, transport, antioxidant and osmo-regulatory roles (Quinlan et al., 2005). It 
has recently been proposed that an albumin gene has undergone lateral gene transfer from a 
mammalian host to S. mansoni, and that "S mansoni-albumin" benefits the parasite by 
protecting the schistosomula and adult worm against oxidative damage (Sayed et al., 2006; 
Williams et al., 2006). Albumin became relevant to the S. mansoni egg proteome during the 
course of the work involved in this chapter because host albumin was found to be present 
inside the egg. A further experiment was therefore carried out in which the amino acid 
sequence of "S. mansoni albumin" was compared to that of albumin from another common 
laboratory host - the hamster. 
In the Sayed et al., (2006) paper "S. mansoni albumin" was identified by subjecting mRNA 
from mechanically-transformed schistosomula and adult worms (perfused from a murine 
host) to reverse transcription-polymerase chain reaction (RT-PCR). A schistosomal origin 
for the albumin was then claimed because the translated message encoded a slightly 
different amino acid sequence to that of albumin from the murine host. Also, the 
mechanically-transformed schistosomula had not been derived directly from the mammal. 
However, the paper did not include a Southern Blot to demonstrate hybridization between a 
probe generated from "S mansoni albumin" cDNA and S. mansoni genomic DNA - an 
important experiment as no albumin gene has been found in the genomes of S. mansoni or 
those of any other non-vertebrates. Also, the process of lateral gene transfer in 
schistosomes is controversial. PCR-based studies have found murine retroviral and MHC 
sequences and sequences from salmonid fish in schistosome DNA (Imase et al., 2003; 
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Melamed et al., 2004), but other researchers reject these findings because contamination 
with host material could explain the results, bearing in mind the amplification power of 
PCR (Clough et al., 1996; Simpson & Pena, 1991). If the amino acid sequence of "S. 
mansoni albumin" was found to be the same as that of hamster albumin (which is not a 
natural host for S. mansoni) then the prospect of a schistosomal origin for albumin is yet 
more unlikely. 
2.1.5 The S. mansoni Genome and the SchistoCDS Database 
The identification of S. mansoni proteins by mass spectrometry depends upon the extent to 
which its genome has been sequenced and the number of matches that can be made to 
sequences from other species that have been deposited on searchable databases. The S. 
mansoni genome sequencing project has been carried out by the Sanger Institute 
(Cambridge, UK) and The Institute for Genomic Research (Rockville, USA). It is nearing 
completion, with a 6-fold coverage having assembled 300Mb of DNA, encoding about 
17,250 genes (Wilson et al., 2007). Gene finding has been greatly assisted by a separate 
project that characterised an estimated 92% of the transcriptome, culminating in the release 
of 163,586 ESTs, including 19,077 from the egg and 18,638 from the miracidium 
(Verjovski-Almeida et al., 2003). Thus, the searchable EST database is of sufficient size to 
facilitate proteomic studies of the parasite. The peptide searches in this chapter have used 
the nrNCBI and Schisto CDS databases. Schisto CDS is a database made up 14,000 
contigs, annotated with the ESTs (generating accession numbers prefixed with Sm) and 
genes predicted by the programs Glimmer, Phat and Snap. Once peptides have been 
matched to ESTs or gene predictions, functional properties for the protein are obtained by 
searching the whole protein sequence for matches in other organisms, including conserved 
functional domains. 
2.1.6 Analysing the S. mansoni Egg Proteome: the Approach 
The characterisation of the egg proteome was based on fractionating the egg and studying 
the proteome of each fraction separately using 2-DE followed by MALDI-MSMS. Changes 
in the egg proteome over time was studied by comparing preparations made from the 
vitellaria-containing region of sectioned females and SEA, made either from immature or 
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mature eggs. The mature egg was then fractionated into its constituents - the miracidium, 
its secretions (ESP) and the hatch fluid and the proteomes of each studied separately. 
The Phoretix Evolution software package (NonLinear Dynamics) was used to compare the 
2D gels. The program matches spot patterns between the different gels and highlights those 
spots that are common to more than one gel. When a quantitative stain such as Sypro Ruby 
is used, Evolution can calculate the volume of each spot as a proportion of the total spot 
volume in the gel, enabling between-gel comparisons of protein expression levels. 
Evolution works by copying the image of the gel which contains the highest number of 
spots and then using it as a theoretical "reference gel". The preparative gel that is most 
similar to the reference gel is then superimposed on top of it and the spots in each coloured 
differently. Where spots overlap (i. e. have a similar pl and mass) they appear black and a 
"match" is created. Once all of the shared spots have been matched, the unmatched spots on 
the preparative gel are added to the reference gel. The reference gel now contains all of the 
spots from two preparations, and the process can be repeated for a third preparative gel. 
Once this process has been completed for all of the gels, every spot in the experiment can 
be matched, via the reference gel, to any matching spots in any of the other gels in the 
experiment and the relative expression levels of shared spots can be calculated. 
Upon completion of the Evolution analysis, the spots of interest were chosen as per the 
following criteria and identities sought for them using MALDI-MSMS: 
all miracidial spots (because the proteome of the S. mansoni miracidium has 
not previously been studied). 
ii all hatch fluid spots (because hatch fluid is almost completely unstudied). 
iii all ESP spots (because the ESPs have not been subjected to MSMS). 
iv the "top forty" spots in terms of protein volume in the vitellaria-enriched 
preparation, immature SEA and mature SEA (so that the most significant 
maturational changes in the egg proteome can be seen). 
v any spots that are present in immature SEA but are not found in the mature 
egg (because they will be involved in the development of the egg rather than 
its function). 
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vi any spots present only in mature SEA (because they will not have been 
accounted for in any other preparation). 
With the identities of these spots known, a picture can be constructed of the soluble egg 
proteome which will reflect the eggs changing priorities as it develops. Then, when the egg 
is fully mature its functional priorities can be mapped to its morphological components via 
its proteome. 
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2.2 Methods 
2.2.1 The Infection of Mice and Recovery of Eggs 
Male C57BL/6xCBA (B6CBA) mice were infected with 180 cercariae/mouse of a Puerto 
Rican isolate of S. mansoni via the shaved abdomen as described previously (Smithers & 
Terry, 1965). Seven weeks later their livers were removed, homogenised (MSE blender) 
and incubated in 3mM KH2PO4 plus 63mM Na2HPO4 buffer containing a small quantity of 
trypsin (Sigma T0303) for 3 hours at 37°C. The degraded liver tissue was removed by 
sieving the livers sequentially through sieves of 300µm and then 180µm mesh size and 
cleaned several times with fresh buffer. 
2.2.2 Separating Eggs into Mature and Immature Populations 
Eggs were separated into mature and immature populations by centrifuging them in a 
Percol gradient in sterile conditions. The gradient was made using 6m1 Percol (Amersham), 
3.4m1 RPMI-1640 (Gibco) and 0.6m1 of 9% saline. After centrifugation for 15-min at 250g 
the mature eggs had collected at the bottom of the centrifuge tube, the immature eggs in a 
layer 1cm below the surface and empty shells and other debris remained on the surface. The 
mature and immature eggs were then collected separately, washed seven times in sterile 
RPMI and the viability and their maturation status assessed using compound microscopy. 
Almost all (96%) of the eggs in the mature egg fraction contained a live miracidium 
(muscular contractions and/or flame cell activity could be seen) and 92% of the immature 
eggs were visibly less developed in that the embryo had not yet become a miracidium. 
2.2.3 Preparing Immature and Mature SEA 
Aliquots of immature or mature eggs were ground for a total of three minutes in 200µl of 
M3 buffer (7M urea, 2M thiourea and 4% CHAPS) containing 20µl of PIC (a general 
purpose protease inhibitor cocktail (Sigma P 1860)). The grinding was carried out on ice 
with a polypropylene pestle (Sigma) attached to a Kontes motor (Fisher) in three cycles of 
one minute grinding followed by one minute rest on ice. This brutal treatment was needed 
to rupture the egg shells. Grinding rather than sonication was adopted because many eggs 
remained intact after repeated sonication steps and the sonication generated a considerable 
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amount of heat. The egg homogenate was then centrifuged at 25,000g and 20°C for one 
hour, the supernatant collected and stored at -18°C and the pellet at -80°C until required. 
2.2.4 Preparing ESP 
Aliquots of approx 250,000 mature eggs were incubated in 10ml of RPMI-1640 (Gibco) 
containing 3% penicillin/streptomycin sulphate (Invitrogen) and 0.1% gentamycin solution 
(Sigma) at 37°C and 5% CO2 for 72-hours. The culture media was then replaced and a 
further incubation step carried out. After each period of incubation eggs hatched 
successfully when immersed in fresh water and 96.5% of them contained viable miracidia. 
The culture media, containing the ESP was gravity-filtered through a 0.2µm filter 
(Sartorius), concentrated in a 5kDa cut-off polyethersulphone centrifuge concentrator 
(Vivaspin 20) and stored at -18°C until required. 
2.2.5 Making the Miracidial and Hatch Fluid Preparations 
Mature eggs were hatched in a 15m1, glass test-tube containing sterile, aerated water at 
25°C. Light was excluded from the bottom 12m1 of the water column and a cold light 
source used to illuminate the top 3m1. After one hour most of the eggs had hatched and the 
top 5ml and bottom 3ml of water were collected. The top 5m1 fraction (containing most of 
the miracidia) was filtered through a 0.2µm polyethersulphone filter (Millipore). As soon as 
the filtration was completed (retaining the miracidia in a negligible volume of water on the 
filter) the filter was washed with 800µl of M3 buffer containing 20µl PIC into a 1.5ml 
eppendorf. Aliquots of 200pl miracidia suspension were immediately ground and stored as 
in SEA (Section 2.2.3). 
The bottom 2ml fraction of water (which contained only a few miracidia) was gently 
agitated to flush any material from empty shells. Then, the liquid (containing hatch fluid, 
empty shells, some miracidia plus a few un-hatched eggs) was gravity-filtered (to avoid 
rupturing any miracidia) through a sterile 0.2µm cellulose acetate filter (Sartorius). The 
filtrate (containing the hatch fluid) was concentrated and stored as per ESP, but with the 
addition of 2Oµ1 PIC. 
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2.2.6 Making the Female, Vitellaria-Enriched Preparation 
Worms were recovered from 7-week infected B6CBA mice by portal perfusion with 
RPMI-1640 (Gibco) to which 10% FCS, 2.5% HEPES and 5 units heparin/ml (all Sigma) 
had been added. Adult, paired females were separated from the males using two fine 
brushes and then washed three times in RPMI-1640 to remove the FCS. The females were 
then severed laterally immediately below the ventral sucker. The posterior sections 
(containing the vitellaria) were immediately ground in M3 buffer containing PIC, 
centrifuged and stored as in the SEA protocol. 
2.2.7 Determining Protein Concentrations 
Protein concentrations in buffers other than M3 were quantified using the Coomassie Plus 
Bradford Assay Kit (Pierce). For m3-buffered samples (i. e. the SEA, miracidial and 
vitellaria-enriched preparations) the Bradford assay was found to be inappropriate because 
reproducible measurements could not be obtained (possibly due to the presence of 
urea/thiourea in the M3 buffer). The protein concentrations of these preparations were 
therefore assessed by separating 20gl of each sample by 1-DE in the same gel as a known 
quantity of S. mansoni soluble cercarial antigen preparation buffered in phosphate buffered 
saline (PBS). The gel was stained with Sypro Ruby stain (Biorad), imaged on a Molecular 
Imager (Bio-Rad FX) and between-lane comparisons of staining intensity used to assess 
protein concentrations. 
2.2.8 One-Dimensional Electrophoresis 
2.2.8.1 1-DE of Insoluble Egg Proteins 
The pellets containing the M3-insoluble material from the SEA, miracidial and vitellaria- 
enriched preparations (see 2.2.3,2.2.5 and 2.2.6) were washed twice in 40mM Tris HCl 
pH7.4 (30 min/wash) then solubilized for 20 min at 70°C in 12.5µ1300mM lithium dodecyl 
sulphate sample buffer (Invitrogen) plus 32.5pl doubly-distilled water (dd H2O) and 5µl of 
lOx reducing agent (Invitrogen). After centrifugation (30 min at 25,000g) the supernatant 
was separated according to molecular mass on a NuPAGE 4-12% Bis Tris gel (Invitrogen) 
at 200V for 40 minutes and stained with Biosafe Coomassie (Bio-Rad) 
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2.2.8.2 1-DE of All Other Samples 
Proteins were prepared for electrophoresis by adjusting their concentration to 750µg/ml 
and solubilizing them in 300mM lithium dodecyl sulphate sample buffer (Invitrogen) at a 
ratio of 3: 1. Proteins were reduced and denatured with Reducing Agent (Invitrogen 
NP0004) and heating at 65°C for 5 mins. A 10µg sample of denatured protein was applied 
per lane to a NuPAGE 4-12% Bis Tris gel (Invitrogen) and electrophoresis performed at 
200V for 40 minutes. Gels were fixed in 40% methanol/10% acetic acid solution and 
stained as indicated. 
2.2.9 Two-Dimensional Electrophoresis 
2.2.9.1 2-DE for Protein Staining 
To prepare samples for 2-DE, 250µg immature SEA, mature SEA, miracidial and vitellaria- 
enriched preparations were adjusted to 360µl with M3 buffer, to which 3.5µg dithiothreitol 
(DTT) (Amersham), 2.8µl of pH3.5-10 resolytes (BDH) and 1 µl bromophenol blue had 
been added. A 75µg sample of crude ESP was dialysed for 18 hours at 4°C into 20mM Tris 
HCl pH7.2 with a Slide-A-Lyzer dialysis unit (Pierce), concentrated to 35µl with an 
Amicon Ultrafree centrifugal concentrator (Millipore) and solubilized in 325µl of 
rehydration buffer (M3 containing 3.25µg DTT, 2.8µl pH3.5-10 resolytes and IPI 
bromophenol blue). A 250µg sample of hatch fluid was concentrated to 50µ1 and then 
solubilized in 310µl rehydration buffer. The preparations were then separated according to 
their charge by IEF in an 18cm, pH 3- 10 strip (Amersham) at 20°C, utilizing an IPGPhor 
system with in-gel rehydration (Amersham). After allowing 12 hours for the strip to 
rehydrate, the IEF protocol involved three focussing steps at a constant 50µA/strip: 3 hrs 
gradient to 3500V, 3 hrs at 3500V and finally 64000Vhrs. Focussed proteins were reduced 
(1% DL-dithiothreitol (Sigma)) and alkylated (4% iodoacetamide (Sigma)) in-gel and then 
the IEF strips were transferred to the top of 20cm x 24cm x 0.1cm, 9-16% SDS-PAGE gel 
(containing piperazine di-acrylamide (Bio-Rad) rather than bis-acrylamide). Separation in 
the second dimension by molecular mass was then carried out in a Protean Plus Dodeca cell 
system (Bio-Rad) at 200V until the dye approached the bottom of the gel (approx 7 hours). 
The gels were then fixed in 40% methanol/10% acetic acid solution, stained with Sypro 
Ruby and imaged on a Molecular Imager (Bio-Rad FX). 
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2.2.9.2 2-DE for Glycoprotein Staining 
A 35µg sample of hatch fluid was prepared for 2-DE using the protocol described above, 
except a 7cm, pH 3- 10 IEF strip (BioRad) was used. After 12 hrs strip rehydration, IEF 
was carried out at a constant 50µA with the following voltage changes: 30 mins at 500V, 
30 mins at 1000V and finally 3 hours at 8000V. After reduction and alkylation (as 
described above) the strip was transferred to a precast, 7cm NuPAGE 4-12% Bis-Tris gel 
(Invitrogen) and protein separation by molecular mass was carried out for 40 mins at 200V. 
The gel was stained with Sypro Ruby, then with Pro-Q Emerald 300 glycoprotein stain 
(Molecular Probes) as per the manufacturers instructions and imaged on a Versadoc 3000 
(BioRad). 
2.2.10 Protein Digestion and Preparation for MALDI-MSMS 
Sypro Ruby-stained gels were restained with Biosafe Coomassie so that the spots could be 
seen without an imager. All discernible spots were excised from the gels and destained with 
40% methanol/10% acetic acid solution. The gel pieces containing spots selected for 
MALDI-MSMS were washed in 20mM ammonium bicarbonate/50% acetonitrile solution, 
dehydrated in 100% acetonitrile (ACN), dried in a Speedvac (Thermo Lifesciences) and 
then digested into peptides overnight at 37°C with 20µl of 1011g/ml sequencing grade 
porcine trypsin (Promega). The peptides from each spot were then absorbed onto a C18 
ZipTip (Millipore) by repeated pipetting, desalted by three washing steps with 0.1% 
trifluoroacetic acid (TFA) (Fluka) and then eluted with 80% ACN/0.1% TFA solution into 
5µl aliquots. The peptide solution (2µl aliquots) were then mixed with l µl of matrix 
solution (a-cyano-4-hydroxycinnamic acid (Sigma)) saturated in a 50% ACN/0.1% TFA 
solution) and dried onto a MALDI plate. The gel spots were prepared for mass 
spectrometry in spot sets of 40 spots per MALDI plate, with the 16 spot sets taking ten 
months to complete. 
2.2.11 MALDI-MSMS 
An Applied Biosystems 4700 MALDI-ToF-ToF mass spectrometer operating in positive 
ion reflector mode was used to analyse the tryptic peptides. The mass spectrometer was 
calibrated using a mix of des-Arg bradykinin (m/z 904.4681), angiotensin (m/z 1296.6853), 
glu-fibrino-peptide B (m/z 1570.6774), adrenocorticotropic hormone clip 1-17 (m/z 
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2465.1989) and adrenocorticotropic hormone clip 7-38 (m/z 3657.9294) and its settings 
adjusted for optimum efficiency. Each spectrum was acquired using 1500 laser shots/spot 
at 2800-3500V and calibrated using tryptic autolysis peaks at m/z 842.510 and 2211.104. 
Protein identification was performed using the Mascot search engine 
(http: //www. matrixscience. com) which uses a probability-based scoring system (discussed 
in Section 1.5.2). The searching parameters were set so that only MSMS fragmentation data 
with a tolerance < 0.2Da was used. One missed cleavage was allowed for, as were 
carbamidomethylation modifications to the cysteine and oxidation of the methionine 
residues. The searches were made against the NCBInr and SchistoCDS databases and 
matches only accepted if the total peptide ion score confidence intervals were >99.9%. A 
more recent version (v 4.0) of the S. mansoni genome has recently become available and so 
the identified proteins have also been searched against it using GeneDB (Hertz-Fowler et 
al., 2004). Version 4.0 of the genome uses the same Sm numbers as Schisto CDS, but 
different gene prediction programs: Augustus, Evidence modeller (EVM3 and EVM7), 
Glimmer and Twinscan predictions, prefixing all the predicted gene annotations with Smp. 
2.2.12 Electrospray-MSMS of Mesocricetus auralus Albumin 
Serum from an uninfected Golden Hamster (M. auratus) was separated by 1-DE as 
described in 2.2.8.2, the gel stained with Biosafe Coomassie and the prominent 60-65kDa 
band excised from each lane and pooled. The gel pieces were destained with 40% 
methanol/10% acetic acid solution, the proteins reduced (50mM DTT at 65°C for 30 mins), 
alkylated (100mM iodoacetamide for 1 hour), washed and digested overnight using the 
protocol detailed in 2.2.10. Immediately after digestion the peptides were applied into a 
100µm x 5cm Monolith nano LC column (Dionex) in 2% ACN plus 0.1% formic acid and 
then eluted over 15 minutes with 100% ACN plus 0.1% formic acid in a 0-50% linear 
gradient. The eluate was injected into an Applied Biosystems QSTAR Pulsar mass 
spectrometer, which carried out MS and MSMS analysis in repeated 0.5 second cycles. The 
entire Elecrospray-MSMS run was then repeated. Mascot was used to search the peptide 
fragmentation data against the nrNCBI database using 99.5% confidence limits. 
71 
2.3 Results 
2.3.1 Gels of Egg Proteins 
2-DE was used to separate the soluble proteins in the vitellaria-enriched preparation, 
immature SEA, mature SEA, miracidium, hatch fluid and ESP (Figures 2.2-2.7). Apart 
from in the ESP gel, spots covering a wide range of molecular masses and charges were 
evident in all of the gels. The ESP gel differed in that it had clusters of spots comparable to 
those previously described by Ashton (2001) (whose gel is reproduced as Figure 2.1 on 
page 61). Despite the complex nature of the gels, the immature and mature SEA 
preparations were quite similar with shared patterns of spots. The gel images were initially 
analysed by Phoretix Evolution's automatic spot-detection function, but the program 
incorrectly identified every pin-point of speckling as a separate protein spot (instead of 
ignoring them as artefacts of the staining process) and so manual spot-detection was 
undertaken instead. After spot detection, the automatic cross-gel spot matching function 
grossly warped and distorted the gels in ways that could not possibly be correct, so an 
extensive amount of manual intervention was required throughout the spot-matching 
process as well. Manual editing potentially introduces error and bias, but this could be 
minimised because three-dimensional imaging of small sections of the gel are possible with 
the software, enabling speckling to be distinguished from protein spots and for overlapping 
or smeared spots to be separated (see Figure 2.8). Three-dimensional imaging was also 
useful during cross-gel spot matching because each protein spot had a different shape, so 
patterns of distinctive shapes could be seen in the different gels, thus providing another 
parameter that could be used to match spots. 
It became apparent during the spot-editing and spot-matching processes that a reasonable 
amount of similarity between the gels was an absolute requisite for spot-matching to be 
carried out with any degree of confidence. Unfortunately, the gels of the female, vitellaria- 
enriched preparation and ESP differed extensively from the other gels in the experiment, so 
their spots could not be matched. However, spots in the immature SEA, mature SEA, 
miracidia and hatch fluid gels could be matched with confidence. The accuracy of the spot 
matching was subsequently demonstrated because spots that had been matched using 
Evolution were then assigned the same identities following separate MALDI-MSMS runs. 
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Figure 2.2. Sypro-stained gel of 250µg vitellaria-enriched protein preparation. The 
identities for the numbered spots are shown in Table 2.1 and the peptide fragmentation 
data is in Appendix I. 
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Figure 2.7. Gel of 75µg ESP stained with Sypro Ruby. The identities for the 
numbered spots are shown in Table 2.3 and the peptide fragmentation data is in 
Appendix 1. * denotes spots that do not have ESP numbers. 
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Figure 2.8. Visualising gel spots using 
Phoretix Evolution software. A: A protein 
(later identified as Smp 170410) can be seen in 
Sypro Ruby-stained gels of immature SEA 
(Fig 2.3, spot 289), mature SEA (Fig 2.4, spot 
99) and hatch fluid (Fig 2.6, spot 519). B: 3D 
images of the spots from A. Mature SEA has 
increased expression of Smp 170410 compared 
to immature SEA. Significant enrichment can 
be seen in hatch fluid, allowing four isoforms 
to be determined. The spikes are speckling 
artefacts of the stain. C: Evolution uses spot 
volume to calculate protein expression levels. 
There is 7 times the quantity of Smp 170410 in 
mature SEA compared to immature SEA and 
4.4 times more in hatch fluid than in mature 
SEA. 
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2.3.2 Most Spots Were in Several Gels 
In total there were 1 107 different spots in the immature SEA, mature SEA. miracidial and 
hatch fluid preparations, most of which were present in more than one preparation (Figure 
2.9). Immature SEA and mature SEA were the most alike, their shared spots accounting for 
84% and 81 % of their total protein content respectively. Hatch fluid contained fewer spots 
than the miracidial preparation (433 as opposed to 602 spots). Hatch fluid and the 
miracidial preparation differed significantly in that only 33% of the hatch fluid spots 
(equating to 21% of the total spot volume) were found in the miracidial preparation. 
2.3.3 1-DE of M3-Insoluble Proteins 
The number spots in a 2D gel does not equate to the number of different proteins present in 
it. Some proteins have several isoforms, resulting from amino acid substitutions or post- 
translational modifications such as phosphorylation or glycosylation. Other proteins might 
contain several disulphide-bonded subunits. These isoforms/subunits would appear as 
separate spots after 2-DE if they have different isoelectric points and/or molecular masses, 
and so for these proteins the number of spots that can be seen in the gel will exceed the 
number of proteins present in the preparation. However, there will be many other proteins 
whose expression levels are too low to be detected in the gel and a further set of proteins 
that failed to focus or were insoluble in the 2-DE buffer (see Figure 2.10). It is difficult to 
assess the extent to which the insoluble material differs between the preparations, 
especially as different quantities of protein were present in the pellets from each 
preparation. It is clear from Figure 2.10 however, that significant numbers of proteins are 
not represented in the 2-DE gels, and therefore the 1107 different spots present on the 2D 
gels are an underestimate of the number of proteins actually present in the egg. 
2.3.4 MALDI-MSMS of 2-DE-Separated Proteins 
The criteria by which spots were selected for MALDI-MSMS is explained in Section 2.1.6 
(pages 64-65). However, not all of the spots that were originally detected on the gels (using 
Sypro Ruby stain) could be excised because the Coomassie stain that was subsequently 
used was less sensitive. 
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Figure 2.9. The distribution of the 1] 07 different spots as matched by Phoretix 
Evolution in the egg preparations. A: immature SEA contains 467 spots, 95 of which 
(equating to 16% of the total protein in the gel) are not present in mature SEA, and so 
will have been degraded during the maturation of the egg. In contrast, mature SEA has 
314 spots that are not found in immature SEA, but they only represent 19% of the total 
protein in the gel. Thus, the differences between the immature egg and mature egg are 
large in terms of numbers of spots but relatively small in terms of protein quantity. B: 
the morphological components of the mature egg are very different from one another. 
There were 143 spots that were shared between the miracidial and hatch fluid 
preparations (equating to 42% of the miracidium and 21 % of the hatch fluid in terms of 
total protein in the gel). Both the miracidial and hatch fluid preparations contain a 
significant number of spots that were not found in mature SEA. As the miracidium and 
hatch fluid are inherent parts of the egg, these spots must be present in mature SEA but 
were probably insufficiently abundant to have been detected in the mature SEA gel (i. e. 
they have been enriched for in the miracidial and hatch fluid preparations). There were a 
further 215 mature SEA spots (representing 10% of the mature SEA protein) that were 
not present in the miracidial or hatch fluid preparations. Sixty-four (representing 5% of 
the mature SEA protein) were also present in immature SEA, so are probably shell 
proteins or were derived from immature eggs that were present in the mature egg 
population. The remaining 151 spots that were only found in mature SEA are likely to 
be envelope or vesicle proteins that are insoluble in water and so were missing from 
hatch fluid. Spots from the female, vitellaria-enriched preparation and ESP could not be 
matched to the other preparations because they differed too extensively. 
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Figure 2.10 Separation of the proteins too insoluble for 2-DE. Pellets of M3-insoluble 
material from the vitellaria-enriched preparation (V), immature SEA (I), mature SEA (E) 
and miracidial preparation (M) were solubilized in SDS, separated by I -DE and stained 
with Biosafe Coomassie. Most of the bands from immature SEA can also be seen in 
mature SEA, but there are exceptions such as the immature SEA proteins of I50kDa and 
22kDa which are absent from mature SEA. The immature SEA I50kDa band is also present 
in the vitellaria-enriched preparation. 
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2.3.4.1 Protein Identification in the Female, Vitellaria-Enriched Preparation 
As stated in Section 2.3.1, spot-matching using Phoretix Evolution could not be 
undertaken in the vitellaria-enriched preparation. Spots were therefore selected for 
MALDI-MSMS because they contained a large quantity of protein. Protein identities with 
sufficiently high ion scores to have a confidence interval > 99.9% appear in Table 2.1, 
along with the other gels in which the protein has been identified using MALDI-MSMS. 
The most abundant protein in the gel was bovine serum albumin (BSA), which was used in 
the preparation protocol (see Section 2.2.6). BSA was used as a lubricant during the 
separation of the paired worms, and although the females were washed after separation this 
clearly was not carried out thoroughly enough. As shown in Table 2.1, eleven of the 
nineteen S. mansoni proteins identified in the female, vitellaria-enriched preparation were 
also found in other egg preparations. These included ATP synthase, HSP60 and two 
isoforms of HSP70 that were found in immature SEA, mature SEA and the miracidial 
preparation but not in the hatch fluid. Ferritin was the only protein found exclusively in 
immature SEA and the vitellaria-enriched preparation. Proteins from the vitellaria-enriched 
preparation that were not found in the egg are highlighted as such in Table 2.1, but as the 
gel of the vitellaria-enriched preparation was not included in the Phoretix Evolution 
analysis it is possible that these spots were in fact present in the other gels, but were 
amongst the unidentified spots. 
2.3.4.2 Protein Identification in the SEA, Miracidial and Hatch Fluid Preparations 
Between-gel spot matching was successfully completed in the gels of immature SEA, 
mature SEA, the miracidial preparation and hatch fluid (Figures 2.3-2.6). The combination 
of Evolution and MALDI-MSMS generated identities for 90 immature SEA spots, 103 
mature SEA spots, 102 miracidial spots and 58 hatch fluid spots, equating to 67 different 
proteins as detailed in Table 2.2. Some of the proteins (such as disulphide isomerase and 
Sm-p40) had different isoforms resulting from amino acid substitutions and others (such as 
tubulin) had multiple subunits, so in total 78 different ESTs were found. An example of two 
spots overlapping in the gel was found in the miracidial preparation, where Spot 323 was 
found to contain both actin and tropomodulin. Some proteins were present in all of the gels 
(such as actin, enolase, superoxide dismutase and ubiquitin) whilst others (such as lactate 
dehydrogenase and the host proteins) can be assigned to the miracidium or hatch fluid. 
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Table 2.1. Identities assigned to the gel-spots in the vitellaria-enriched preparation 
(Figure 2.2, page 73). Spot numbers, corresponding to those indicated in Fig. 2.2 were cut 
from the gel and identified by MALDI-MSMS. Only protein identities with sufficiently 
high ion scores to have a confidence interval >99.9% were accepted. The peptides, ions 
scores, confidence intervals etc. are detailed in Appendix 1. 
Spot 
no. 
Accession 
no'. 
Protein identity Other gels containing the 
protein2 
50 Sm12452 14-3-3 epsilon none 
51 Sm0900 actin all gels 
52 SmO1315 aldehyde dehydrogenase all gels 
53 Sm00685 ATP synthase imm SEA, mat SEA, miracidial 
54 Sm01126 ATP synthase none 
55 gi74268269* bovine apolipoprotein none 
56 gi30794280* BSA none 
57 gi74267962* BSA none 
58 Sm00296 chaperonin none 
59 Sm11433 superoxide dismutase all 
60 Sm11876 leucine aminopeptidase none 
61 Sm08285 disulphide isomerase all 
62 Sm12193 enolase all 
63 Sm04735 exportin 7 none 
64 Sm12942 ferritin I imm SEA 
65 Sm05684 fructose bisphosphate aldolase imm SEA, mat SEA, hatch fluid 
66 Sm05684 fructose bisphosphate aldolase imm SEA, mat SEA, hatch fluid 
67 SmO1537 HSP60 imm SEA, mat SEA, miracidial 
68 SmO1537 HSP60 imm SEA, mat SEA, miracidial 
69 Sm00325 HSP70 imm SEA, mat SEA, miracidial 
70 Sm00325 HSP70 imm SEA, mat SEA, miracidial 
71 Sm09042 HSP70 imm SEA, mat SEA, miracidial 
72 Sm09042 HSP70 imm SEA, mat SEA, miracidial 
73 Sm11575 14-3-3 epsilon none 
74 Sm12294 myosin heavy chain none 
75 SmO1066 myosin light chain none 
76 Sm04779 Sm14 fatty acid binding protein all 
77 Sm00101 Sm20.8 none 
78 gi76445989* BSA none 
79 gi74267962* BSA none 
'Accession numbers are CDS unless *, which denotes NCBI. 2 Phoretix Evolution analysis was not carried out. 
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Table 2.2. Identities assigned to the numbered gel spots in the immature SEA, mature SEA, 
miracidial and hatch fluid preparations. Spot numbers, corresponding to those indicated in 
Figs. 2.4-2.7 were cut from the gels, identified by MALDI-MSMS and matched between 
gels by Evolution software analysis. 
Protein ID Accession 
no 
imm SEA2 Mat SEA2 Miracidia2 
Hatch 
fluid 
aconitase Sm07278 258 97 358 
actin Sm00900 217-219 220 126-128 129 322-325 326 
adenylate kinase Sm06837 158 359-361 
aldehyde dehydrogenase Sm01315 226 135 332 524 
aldo keto reductase Sm03515 241 147 348 558 
alpha-N-acetylgalactosaminidase Sm06626 253 157 357 
alpha-N-acetylgalactosaminidase Smp179250 286 196197 321 549 
ATP synthase Sm00685 215 216 124 125 320 
calmodulin Sm03962 243 149 
calreticulin Sm00636 211212 119120 316 520 
chaperonin 60kDa Sm00497 210 118 315 
citrate synthase Sm01548 234 140 340 
cysteine protease inhibitor Sm01636 235 141 341 
dihydrolipoamide dehydrogenase Sm00414 209 115 312 
disulphide isomerase Sm00980 221 130 
disulphide isomerase Sm08285 261262 169170 373 374 536 
elongation factor 1 alpha Sm01686 237 143 343 
enolase Sm12193 276 277-279 184-186 187 388-391 542 543 
ESP3-6 giJ28894857* 101.104 501-503 
ESP15 Sm00193 108 516 
ferritin heavy chain Sm12942 283 
fructose bisphosphate aldolase Sm05684 248 249 153 531-533 
GAPDH Sm01185 225 134 331 
GST (26kDa) Sm00145 203 106 304 515 
GST (28kDa) Sm02267 238 -240 144 145 344 345 526-528 
HSP10 Sm00296 205 110 307 
HSP60 Sm01537 231232 138139 337-339 
HSP70 Sm00325 206 111 112 308 309 
HSP70 Sm01676 236 142 342 
HSP70 Sm09042 264-266 267-270 172-175 176 376-379 380 
HSP86 Sm01524 229 230 
HSP90 Smp069130 287 194 399 548 
lactate dehydrogenase Sm00165 107 305 
malate dehydrogenase (cytosolic) Sm00407 207 208 113114 310 311 518 556 
malate dehydrogenase (mitochondrial) Sm00493 117 314 
mouse albumin gil29612571" 506-511 
mouse haemoglobin alpha subunit gi1122385* 504 
mouse haemoglobin beta subunit gi131982300' 512 
mouse hsc70 9i11661134' 505 
mouse regucalcin gi 6677739* 555 
nucleoside diphosphate kinase Sm12959 284 191 396 
p25 homologue Sm03199 347 
p40 Sm07196 254-256 257 159-163 164 362-366 367-371 534 
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Table 2.2 continued 
Protein 
ID 
Accession 
noI 
Imm SEA2 Mat SEA z z Miracidia 
Hatch 
fluidz 
p40 Sm07598 259 165 403 535 
paramyosin Sm11278 272 273 178 179 382 383 
peptidyl prolyl cis trans isomerase Sm12777 282 190 394 395 545 
phosphoenolpyruvate carboxykinase Sm00203 204 109 306 517 
phosphoglycerate kinase Sm01343 227 136 333-335 
plant pathogenesis family (PRI) Smp154260 271 198 199 550-552 
proteasome alpha 6 subunit Sm08991 263 171 375 
proteasome alpha 7 subunit Sm02321 244 146 346 
Sm14 fatty acid binding protein SmO4779 245 150 350 529 530 
Sm21.7 Sm03938 242 148 349 
SmE16 Smp096390 201 105 301302 513 
succinate-CoA ligase Sm00415 116 313 
superoxide dismutase Sm11433 275 181 182 385 386 538 
thioredoxin Sm11767 183 387 
539 540 
541 
thioredoxin peroxidase SmPrx3 
mitochondrial 
Sm00674 214 123 319 521 
thioredoxin peroxidase SmPrxl 
(cytosolic) Sm12448 280 188 
544 
universal stress protein Sm05431 247 152 400 553 
translationally controlled tumor protein Sm11405 274 180 384 537 
triose phosphate isomerase Sm00999 222 223 131 132 327 328 523 
tropomodulin Sm08082 168 323 
tubulin alpha chain Sm00654 213 121 122 317 318 
tubulin beta chain Sm06624 250-252 154155 156 351352-356 
tubulin beta 04 chain Sm10465 177 381 
tubulin beta chain Smp035760 288 195 401 402 
ubiquitin Sm01509 228 137 336 525 
unknown function Sm00115 202 100 303 514 
unknown function Sm01135 224 133 329 
unknown function Sm05001 246 151 351 
unknown function Sm14608 233 98 546 
unknown function Sm05341 554 
unknown function Sm07933 260 166167 522 
unknown function Smp089370 192 557 
unknown function Smp059660 285 193 397 547 
unknown function Smp170410 289 99 519 
valosin-containing protein Sm12453 281 189 392.393 
'Accession numbers are CDS unless *, which denotes NCBI. 2 Spot numbers in bold denote identities obtained by MALDI-MSMS (the peptides, ions 
scores, confidence intervals etc. are detailed in Appendix 1). Only identities with 
sufficiently high ion scores to have a confidence interval >99.9% were accepted. Spot 
numbers in italics denote identities obtained utilizing Phoretix Evolution software analysis. 
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2.3.4.3 Protein Identification in the ESP Preparation 
The fourteen ESP identities found by MALDI-MSMS are annotated on the gel in Figure 
2.7 as Spots 1-14 and are listed in Table 2.3. The peptide fragmentation data are in 
Appendix 1. 
Table 2.3. ESPs identified using MALDI-MSMS. The spot numbers correspond to those 
annotated on the gel of Figure 2.7. 
Sot no. Accession no' Protein Identity' Original ESP no .2 
I Sm19482 omega 1 ESP1-2 
2 gi73765569* IPSE* not annotated 
3 173765569* IPSE* ESP3 
4 173765569* IPSE* ESP4 
5 gi73765569* IPSE* not annotated 
6 gi73765569* IPSE* ESP5 
7 173765569* IPSE* ESP6 
8 Sm 193860/ i82400502*/ i8245004* omega 1* ESP12 
9 Sm00193 / 122094807* ESP15 none 
10 Sm11845 unknown function ESP13 
11 Sm11845 unknown function ESP14 
12 Sm12949 unknown function ESP17 
13 Sm12949 unknown function ESP19 
14 Sm00193 / i22094807* ESP15 ESP15 
' Accession numbers are CDS unless*, which denotes NCBI. 2 Original ESP numbers are those assigned to 
the gel-spot by Ashton (2001). The peptides, ions scores, confidence intervals etc. are detailed in Appendix 1. 
Only identities with sufficiently high ion scores to have a confidence interval >99.9% were accepted. 
As the spot pattern on the ESP gel of Figure 2.7 is visually comparable with that used by 
Ashton (2001) to originally number the ESPs, accession numbers can now be assigned to 
twelve out of the original nineteen ESPs. Some additional spots could be seen that bring the 
number of ESPs to at least 27. The "new" ESPs include a series of six faint spots which 
were basic and larger than the other ESPs plus another isoform of ESP 15 (Spot 9 in Figure 
2.7). The reason that these "new" ESPs can now be seen is probably because the gel in 
Figure 2.7 contained more protein than Ashton (2001) used (75µg as opposed to 50µg) and 
also because the stain used was a more sensitive one (Sypro Ruby as opposed to Coomassie 
Blue). 
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Spot 1 consisted of two isoforms, corresponding to ESP 1 and ESP2, but the protein from 
each spot had merged in the gel too much to be separated. Searching the three fragmented 
peptides from Spot 1 against the NCBInr database demonstrated that ESP1-2 was Omega 1 
(accession nos. ABB73002/gi824005802 and ABB73003/gi82400502). The protein 
sequences for these two Omega I annotations are identical, apart from amino acid 
differences at residues 26 and 136. Although a peptide covering residue 136 was 
fragmented, the correct sequence could not be ascertained because the discrepancy 
consisted of lysine (in gi82400502) and glutamine (in gi82400504), whose molecular 
masses are almost identical. The slightly less basic l OkDa protein ESP 12 (Spot 8) was also 
found to be Omega 1, but as the full-length Omega 1 is a protein of 225 amino acids, 
ESP 12 must be a truncated version of it (the single fragmented peptide consisted of the 
final eight amino acids). There are no SchistoCDS annotations that are sufficiently long to 
match the entire Omega I sequence, but Sm19482 covers amino acids 108-185 and 
Snap42294 covers amino acids 108-225. The complete length of Omega 1 is not annotated 
in v 4.0 of the S. mansoni genome either, the most complete annotation being Smp193860 
(which is identical to Snap42294). 
ESP3-6 was the most abundant ESP, its six isoforms (Spots 2-7) representing 83% of the 
total protein in the gel (Spots 2 and 5 are isoforms not described previously). The sequence 
YCLQLYDETYER was particularly amenable to MALDI-MSMS as it was fragmented in 
each of the spots 2-7 (see Appendix 1). The second leucine of this sequence (amino acid no. 
34 in IPSE and no. 39 in ESP3-6) is one of the amino acid discrepancies between the 
GenBank entries for ESP3-6 and IPSE (see Section 2.1.3). The fragmentation spectra 
include the requisite y and b ions which demonstrate that the amino acid is indeed leucine 
(as per IPSE) rather than methionine (as per ESP3-6). Thus, IPSE is the only significant 
match when using the NCBInr database to search for ESP3-6 fragmentation ions. ESP3-6 is 
not annotated in SchistoCDS but the full IPSE nucleotide sequence is annotated in v 4.0 of 
the genome as Smp112110. 
2.3.5 The Egg Proteome: Protein Function 
The proteomes of immature SEA, mature SEA, the miracidial preparation and hatch fluid 
were compared in terms of protein function by assigning each identified protein to one of 
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eleven categories. The volume of protein in each spot was then calculated as a percentage 
of that in the gel. The results are shown in Tables 2.4-2.7, ranked in order of functional 
category expression level and then by accession number expression level. Figure 2.11 then 
combines all this data and presents it as four comparable pie charts. Where several spots 
were found to have the same accession number, their volumes were combined. 
It can be seen that identities could be assigned to 52% (by volume) of immature SEA, 66% 
of mature SEA, 55% of the miracidial preparation and 64% of hatch fluid. HSP70 is the 
most abundant protein in immature SEA, its three isoforms (Sm09042, Sm00325 and 
SmO 1676) accounting for 9.3% of the total protein. Sm09042 (the most abundant isoform) 
is cytosolic whilst Sm00325 and Sm01676 are mitochondrial. In mature SEA, Sm-p40 is 
the most abundant protein, accounting for 10.9% of the total (as opposed to 3.9% in 
immature SEA). The Sm-p40 found in the mature egg can be assigned to the miracidium 
because 15.2% of the miracidial preparation consisted of Sm-p40, compared to only 1% in 
hatch fluid. Chaperones were found to make up a greater percentage of mature SEA than in 
immature SEA (23.4% vs. 18.5%), but this could be because a smaller percent of mature 
SEA constituted unidentified spots. In terms of the percentage of the identified protein, 
chaperones make up 35% in both the mature and immature SEA preparations. Even 
allowing for the between-gel differences in the proportions of unidentified spots, mature 
SEA contains more defence proteins than immature SEA. Similar quantities of cytoskeletal 
proteins are present in the two preparations, although no miracidium is present in the 
immature egg. An additional functional category (secretory proteins) is also found in 
mature SEA. 
The differences between the miracidial and hatch fluid preparations in the Venn diagrams 
of Figure 2.9 are reflected in the pie charts of Figure 2.11, so they can now be seen in terms 
of protein function and mapped back to the proteome of mature SEA. Almost all of the 
chaperones and cytoskeletal proteins of the egg are found in the miracidium whilst 
secretory proteins and host proteins are found in the hatch fluid. The hatch fluid also 
contains many more defence proteins, but fewer proteins dealing with ATP production, 
protein turnover and calcium-binding. Hatch fluid also contains a large proportion of the 
proteins of unknown function. 
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Table 2.4. The proteins in immature SEA, categorised in terms of their molecular 
function and expression levels. 
Functional Accession % Total 
category no. 
Protein identity 
spot vol. total sof vol. 
Unidentified 
47.8% None unidentified spots 47.8 
Sm09042 HSP70 (cytosolic) 6.6 
Sm07196 p40 3.8 
Sm01537 HSP60 2.6 
Sm00325 HSP70 (mitochondrial) 1.8 
Chaperone Sm01524 HSP86 1.6 
(18.5%) Sm01676 HSP70 (mitochondrial) 0.9 
Smp069130 HSP90 0.5 
Sm00296 HSP 10 0.4 
Sm00497 chaperonin 60kDa 0.2 
Sm07598 0 0.2 
Sm06624 tubulin beta chain 6.3 
Cytoskeletal Sm00900 actin 3.1 
(10.4%) Smp035760 tubulin beta chain 0.8 
Sm00654 tubulin alpha chain 0.1 
Sm12193 enolase 2.2 
Sm00685 ATP synthase 1.9 
Sm01343 phosphoglycerate kinase 1.0 
ATP production 
Sm01185 GAPDH 0.7 
(7.7%) SmO1548 citrate synthase 0.6 
Sm05684 fructose bisphosphate aldolase 0.5 
Sm00414 dihydrolipoamide dehydrogenase 0.4 
Sm00999 triose phosphate isomerase 0.4 
Sm07278 aconitase 0.0 
Sm00407 malate dehydrogenase (cytosolic) 1.8 
Smp179250 alpha-N-acetylgalactosaminidase 0.8 
Sm00203 phosphoenolpyruvate carboxykinase 0.6 
Other Sm04779 Sm14 fatty acid binding protein 0.5 
(4.7%) Sm11278 paramyosin 0.3 
Sm06626 alpha-N-acetylgalactosaminidase 0.3 
Sm12942 ferritin 1 heavy chain 0.2 
Sm01686 elongation factor 1 alpha 0.1 
Sm12959 nucleoside di hos hate kinase 0.1 
Sm02267 GST (28kDa) 1.4 
Sm01315 aldehyde dehydrogenase 0.5 
Sm12448 thioredoxin peroxidase (SmPrxl) 0.5 
Sm11433 superoxide dismutase 0.4 
Defence Sm03515 aldo keto reductase 0.3 
(4.0%) Sm00145 GST (26kDa) 0.2 
Sm05431 universal stress protein 0.2 
Sm00674 thioredoxin peroxidase (SmPrx3) 0.2 
Smpl 54260 plant pathogenesis related (PR1) family 0.2 
Sm01636 cysteine protease inhibitor 0.1 
90 
Table 2.4 continued 
Sm00980 disulphide isomerase 1.0 
Sm08285 disulphide isomerase 0.9 
Protein turnover Sm12453 valosin containing protein 0.5 (3.1 /o) 
Sm01509 ubiquitin 0.4 
Sm08991 proteasome alpha 6 subunit 0.2 
Sm02321 proteasome alpha 7 subunit 0.0 
Sm03962 calmodulin 1.0 
Calcium binding Sm11405 translationally controlled tumor protein 0.3 (1.5'/°) Sm03938 Sm21.7 0.1 
Phat12638 SmE 16 0.1 
Smp170410 unknown function 0.6 
Sm01135 unknown function 0.3 
Unknown function Smp059660 unknown function 0.1 
(1.4%) Sm05001 unknown function 0.1 
Sm00115 unknown function 0.1 
Sm14608 unknown function 0.1 
Sm07933 unknown function 0.1 
Export pathway Sm00636 calreticulin 0.5 
(1%) Sm12777 e tid l-roll cis trans isomerase 0.5 
Table 2.5. The proteins present in mature SEA, categorised in terms of their 
molecular function and relative abundance. 
Functional % Total 
category Accession Protein identity spot vol. 
total spot vol. no' 
Unidentified (33.9%) none unidentified spots 33.9 
Sm07196 p40 10.6 
Sm09042 HSP70 (cytosolic) 8.7 
Sm00325 HSP70 (mitochondrial) 1.8 
Chaperone Sm01537 HSP60 1.2 
(23.4%) Sm01676 HSP 70 (mitochondrial) 0.4 
Sm00296 HSP10 0.3 
Sm07598 p40 0.3 
Sm00497 chaperonin 60kDa 0.1 
Sm 069130 HSP90 0.0 
Sm06624 tubulin beta chain 5.1 
Sm00900 actin 3.0 
Cytoskeletal Sm10465 tubulin beta chain 1.6 
(10.9%) Smp035760 tubulin beta chain 0.9 
Sm00654 tubulin alpha chain 0.3 
Sm08082 tro omodulin 0.0 
Sm12193 enolase 2.1 
Sm00685 ATP synthase 1.8 
Sm01548 citrate synthase 1.1 
Sm01343 phosphoglycerate kinase 0.8 
ATP production 
Sm05684 fructose bisphosphate aldolase 0.6 
(7.9%) Sm01185 GAPDH 0.6 
Sm00999 triose phosphate isomerase 0.5 
Sm00414 dihydrolipoamide dehydrogenase 0.1 
Sm07278 aconitase 0.1 
Sm00415 succinal CoA ligase 0.1 
Sm00493 malate deh dro enase (mitochondrial) 0.0 
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Table 2.5 continued 
Sm12448 thioredoxin peroxidase (SmPrxl) 2.0 
Sm02267 GST (28kDa) 1.9 
Sm01315 aldehyde dehydrogenase 0.7 
Smp154260 plant pathogenesis related (PRI) family 0.5 
Defence Sm00145 GST (26kDa) 0.4 
(6.9%) Sm03515 aldo keto reductase 0.4 
Sm11767 thioredoxin 0.3 
Sm00674 thioredoxin peroxidase (SmPrx3) 0.3 
Sm11433 superoxide dismutase 0.2 
Sm05431 universal stress protein 0.2 
Sm01636 cysteine protease inhibitor 0.1 
Smp179250 alpha-N-acetylgalactosaminidase 1.4 
Sm00407 malate dehydrogenase (cytosolic) 1.1 
Sm06626 alpha-N-acetylgalactosaminidase 0.6 
Sm04779 Sm14 fatty acid binding protein 0.3 
Sm11278 paramyosin 0.3 Other Sm00203 phosphoenolpyruvate carboxykinase 0.2 (4.3%) Sm12959 nucleoside diphosphate kinase 0.2 
Sm00165 lactate dehydrogenase 0.1 
Sm06837 adenylate kinase 0.0 
Sm01686 elongation factor 1 aplha 0.0 
Sm00980 disulphide isomerase 1.9 
Sm08285 disulphide isomerase 1.3 
Protein turnover Sm08991 proteasome alpha 6 subunit 0.2 (3.7%) 
Sm12453 valosin containing protein 0.2 
Sm01509 ubiquitin 0.2 
Sm02321 proteasome alpha 7 subunit 0.0 
Smp170410 unknown function 1.8 
Sm07933 unknown function 0.5 
Unknown Smp089370 unknown function 0.4 function Smp059660 unknown function 0.3 (3.5%) 
Sm05001 unknown function 0.2 
Sm01135 unknown function 0.1 
Sm14608 unknown function 0.1 
Sm00115 unknown function 0.1 
Secretory (2.5%) 9iJ28894857* 
ESP3-6 2.5 
Sm00193 ESP15 0.0 
Smp096390 SmE 16 1.2 
Calcium binding Sm03962 calmodulin 0.4 
(2.0%) Sm11405 translationally-controlled tumor protein 0.4 
Sm03938 Sm21.7 0.0 
Export pathway Sm00636 calreticulin 0.8 
(1.0%) Sm12777 peptidyl prolyl cis trans isomerase 0.2 
'Accession numbers are from CDS unless *, which denotes NCBI. 
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Table 2.6. The proteins present in the miracidial preparation, categorised in terms of 
their molecular function and expression levels. 
Functional % 
category Accession Protein identity Total 
(% total spot no. spot 
volume) vol. 
Unidentified (45%) none Unidentified spots 45.0 
Sm07196 p40 15.1 
Sm09042 HSP70 (cytosolic) 3.9 
Sm01537 HSP60 1.7 
Sm00296 HSP10 0.8 
Chaperone Sm03199 p25 homologue 0.5 (22.9%) Sm00325 HSP70 (mitochondrial) 0.4 
Sm01676 HSP70 (mitochondrial) 0.3 
Sm07598 p40 0.1 
Smp069130 HSP90 0.1 
Sm00497 chaperonin 60kDa 0.1 
Sm00900 actin 3.5 
Sm06624 tubulin beta chain 2.5 Cytoskeletal 
(9.0%) Sm00654 tubulin alpha chain 1.8 
Smp035760 tubulin beta chain 1.1 
Sm10465 tubulin beta chain 0.1 
Sm08082 tro omodulin 0.0 
Sm12193 enolase 2.9 
Sm01343 phosphoglycerate kinase 1.7 
Sm00685 ATP synthase 1.0 
Sm00999 triose phosphate isomerase 0.9 ATP production Sm01185 GAPDH 0.5 (7.7%) 
Sm00493 malate dehydrogenase (mitochondrial) 0.3 
Sm00414 dihydrolipoamide dehydrogenase 0.1 
Sm07278 aconitase 0.1 
Sm00415 succinate-CoA ligase 0.1 
Sm01548 citrate synthase 0.1 
Sm00407 malate dehydrogenase (cytosolic) 0.9 
Sm06837 adenylate kinase 0.9 
Sm06626 alpha-N-acetylgalactosaminidase 0.7 
Smpl 79250 alpha-N-acetylgalactosaminidase 0.6 Other 
(4.5%) ') Sm04779 Sm14 fatty acid binding protein 0.5 
Sm11278 paramyosin 0.4 
Sm12959 nucleoside diphosphate kinase 0.2 
Sm00165 lactate dehydrogenase 0.2 
Sm00203 phosphoenolpyruvate carboxykinase 0.1 
Sm01686 elongation factor 1 alpha 0.0 
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Table 2.6 continued 
Defence Sm02267 GST (28kDa) 0.7 
(3.2%) Sm01315 aldehyde dehydrogenase 0.4 
Sm11433 superoxide dismutase 0.4 
Sm00674 thioredoxin peroxidase (SmPrx3) 0.4 
Sm05431 universal stress protein 0.4 
Sm11767 thioredoxin 0.4 
Sm01636 cysteine protease inhibitor 0.2 
Sm00145 GST (26kDa) 0.2 
Sm03515 aldo keto reductase 0.1 
Calcium binding Smp096390 SmE 16 1.9 
(2.9%) Sm03938 Sm21.7 0.5 
Sm11405 translationally controlled tumor protein 0.5 
Export pathway Sm12777 peptidyl prolyl cis trans isomerase 1.6 
(2.1%) Sm00636 calreticulin 0.5 
Sm12453 valosin containing protein 0.8 
Protein turnover Sm08285 disulphide isomerase 0.5 
(1.9%) Sm02321 proteasome alpha 7 subunit 0.3 
Sm01509 ubiquitin 0.3 
Sm08991 proteasome alpha 6 subunit 0.1 
Smp059660 unknown function 0.3 
Unknown Function Sm01135 unknown function 0.2 
(0.9%) SmO0115 unknown function 0.2 
Sm05001 unknown function 0.2 
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Table 2.7. The proteins present in hatch fluid, categorised in terms of their molecular 
function and expression levels. 
Functional category Accession Protein identity 
% 
Total (% total spot no. ' spot volume) vol. 
Unidentified 
(35.8%) none unidentified spots 35.8 
Smp170410 unknown function 18.2 
Sm14608 unknown function 0.7 
Sm05341 unknown function 0.3 Unknown function Sm00115 unknown function 0.2 (19.7%) Sm07933 unknown function 0.1 
Smp059660 unknown function 0.1 
Sm 089370 unknown function 0.1 
Sm02267 GST (28kDa) 4.4 
Sm11767 thioredoxin 4.1 
Smpl 54260 plant pathogenesis related (PR1) family 3.7 
Sm03515 aldo keto reductase 1.0 
Defence Sm12448 thioredoxin peroxidase (SmPrxl) 0.7 
(15.7%) Sm00145 GST (26kDa) 0.6 
Sm05431 universal stress protein 0.7 
Sm11433 superoxide dismutase 0.4 
Sm01315 aldehyde dehydrogenase 0.1 
Sm00674 thioredoxin peroxidase (SmPrx3) 0.0 
Secretory giJ28894858* ESP3-6 11.7 
(11.9%) Sm00193 ESP15 0.2 
gi129612571 * mouse albumin 4.3 
Host proteins 9iJ31982300* mouse 
haemoglobin beta subunit 1.1 
(6.6%) gi11161134* mouse hsc70 0.5 
giJ6677739* mouse regucalcin 0.4 
i 122385* mouse haemoglobin alpha subunit 0.3 
Sm00999 triose phosphate isomerase 1.5 
ATP production Sm05684 fructose bisphosphate aldolase 1.5 
(4.0%) Sm12193 enolase 1.0 
Sm04779 Sm14 fatty acid binding protein 1.8 
Other (2.8%) Smp179250 alpha-N-acetylgalactosaminidase 0.5 
Sm00407 malate dehydrogenase (cytosolic) 0.3 
Sm00203 hos hoenol ruvate carboxykinase 0.1 
Export pathway Sm12777 peptidyl prolyl cis trans isomerase 0.8 
(1.3%) Sm00636 calreticulin 0.4 
Sm07196 p40 1.0 
Chaperone (1.1%) Sm07598 p40 0.0 
Sm 069130 HSP90 0.0 
Protein turnover Sm01509 ubiquitin 0.8 
(0.9%) Sm08285 disulphide isomerase 0.1 
Calcium binding Smp096390 SmE16 0.1 
(0.2%) Sm11405 translationally controlled tumor protein 0.1 
'Accession numbers are CDS unless *, which denotes NCBI. 
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Figure 2.11. Relative protein 
expression in the egg. Functional 
categories and % protein within 
them were taken from Tables 2.4 - 
2.7. ESP is not included because all 
of the proteins are secreted but none 
have a known function. 
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The most abundant protein in hatch fluid is Smp170410, which has no homology to any 
proteins of known function (the only significant match on the nrNCBI database being a S. 
japonicum homologue). Accounting for 18.2% of hatch fluid, Smp170410 is a 55-8OkDa, 
very acidic protein (pI3.5) with two distinct isoforms, each of which can be split into sub- 
isoforms (see Fig 2.8). Smp170410 is not present in either the miracidial preparation or 
ESP (so it will be stored between the miracidium and the envelope). It constitutes 1.8% of 
mature SEA and 0.6% of immature SEA, so it is present at the earliest stages of egg 
development but increases in abundance as the egg develops. The ten-fold difference in the 
abundance of Smp170410 between the hatch fluid and mature SEA preparations 
demonstrates the extent to which protein enrichment in the hatch fluid has occurred, and 
therefore that the hatch fluid makes up a relatively small proportion of the total protein in 
the egg. 
As hatch fluid contains the greatest proportion of proteins of unknown function, a 2D-gel 
was stained for glycoproteins to establish the extent to which its proteome is glycosylated 
(Figure 2.12). The pattern of spots indicated that the two most abundant glycoproteins are 
the abundant protein of unknown function discussed above (Smp170410) and ESP3-6. In 
addition, there is a row of distinct basic spots of approx. 15OkDa that are heavily 
glycosylated but were not sufficiently abundant to have been fragmented and identified 
using MALDI-MSMS. 
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Figure 2.12 2-DE of 35µg of hatch fluid stained for protein and glycoprotein, 
with the identifiable glycoproteins shown in pink. (A) Pro-Q Emerald stain 
reveals several glycosylated hatch fluid proteins including a very acidic protein of 
60-100kDa and two very basic proteins of 30-40kDa. (B) Sypro Ruby protein 
staining the gel allows the location of the glycoproteins to be seen relative to non- 
glycosylated proteins, thereby demonstrating that Smp170410 and ESP3-6 are the 
major glycosylated components of hatch fluid. 
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2.3.6 Host Albumin and "S. mansoni Albumin" 
In order to establish whether "S. mansoni albumin" is of host or parasite origin, albumin 
from the common laboratory host Mesocricetus auratus (Golden Hamster) was isolated by 
1-DE, trypsinised and subjected to MALDI-MS and Electrospray-MSMS. The PMF and 
peptide-ion data were then searched against the NCBInr database. As hamster albumin has 
not been sequenced, albumin from other rodents should have been the highest-scoring 
matches. However, as shown in Figure 2.13, hamster albumin was found to have complete 
homology to "S. mansoni albumin" (AAL08579/gi15808978). Electrospray-MSMS 
fragmented 38 different peptides that were matched to "S. mansoni albumin" with a total 
ion score of 1520 (the peptides and their fragmentation data are detailed in Appendix 2). 
The match to "S. mansoni albumin" was considerably better than that to the next most 
homologous proteins, which were albumin from Rattus norvegicus (11 matching peptides, 
total ion score 498) and the Reed Vole Microtus fortis (12 matching peptides, total ion 
score 455). Although R. norvegicus albumin was a better match than M fortis albumin in 
terms of the total ion score, M fortis albumin was a better match in terms of the numbers of 
matching peptides. The amino acid sequence of "S. mansoni albumin" was found to have 
better homology with M fortis albumin (78 different residues) than with R. norvegicus 
albumin (94 different residues). The principal reason R. norvegicus albumin matched with a 
higher total ion score was because the fragmented peptide TPVSEKVTK matched it 
perfectly (generating an ion score of 65) whilst it matched less well to the M fortis albumin 
sequence (generating an ion score of 35). The M fortis version of the peptide had a lower 
ion score because glutamine is substituted in place of the lysine residue at amino acid no. 6. 
The molecular weights of glutamine and lysine are very similar (146.15Da vs. 146.19Da) 
so both residues fell within the tolerance parameters of the MASCOT search, but their 
different molecular weights were reflected in the peptide's ion scores. Thus, the correct 
residue in the sequence can be identified as lysine. The "S. mansoni albumin" version of 
the peptide is the same as the M fortis version (i. e. with the lower-scoring glutamine 
residue) and is highlighted in Figure 2.13. This glutamine residue-substituted peptide is the 
only peptide from M auratus albumin that had more homology to albumin from another 
rodent than it does to "S. mansoni albumin". 
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BLUE: secretory-signal peptide. RI. U: peptides identified by MSMS are in red. 6Rl: l. N: peptides 
identified by MS are in green. BLACK: unidentified amino acids are in black. Boxed residues: 
amino acids that are diagnostic for "S. mansoni albumin" in that they are different in albumin from 
Rattus norvegicu or Microtus fortis. * denotes the lysine and arginine residues discussed in the 
text. The peptide TPVSEQVTK discussed in the text is denoted with a grey background and its 
glutamine residue boxed. 
Figure 2.13. Mesocricetus auralus (Golden Hamster) albumin. A: Serum from an 
uninfected animal was separated by electrophoresis, the bands at 60kDa excised, pooled 
and subjected to Electrospray-MSMS and MALDI-MS analysis. B. The nrNCBI sequence 
of "S. mansoni albumin" (AAL08579/gi 15808978), showing the homology with M. 
auralus albumin. The peptide-fragmentation data are shown in Appendix 2. 
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The amino acid sequence of "S. mansoni albumin" contains 608 amino acids (as does that 
from M fortis and R. norvegicus). Eighteen residues form the signal peptide (3% of the 
total protein) which will be missing from the serum-derived albumin used in this 
experiment. Out of the remaining 590 amino acids, 386 (constituting 65% of the total 
protein sequence) have been fragmented and identified by Electrospray-MSMS and a 
further 40 amino acids (7% of the sequence) match PMFs generated by MALDI-MS. Only 
155 amino acids (26% of the sequence) remained unidentified. Eighty-nine residues that are 
specific for "S. mansoni-albumin" were fragmented and identified by MSMS. These 
include 53 that are different in M fortis albumin, 61 that differ in R. norvegicus albumin 
(including the lysine residue discussed in the previous paragraph) and 22 that are different 
in both. Another 10 of the "S. mansoni-albumin" amino acids that are missing from one or 
other of the rodent sequences are incorporated into peptides identified by MALDI-MS (one 
of which is different in both of the rodent sequences). Six of the residues (denoted by * in 
Figure 2.12) must be either lysine or arginine because they form cleavage points of tryptic 
peptides, yet they are differently annotated in the R. norvegicus or M fortis albumin 
sequences. 
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2.4 Discussion 
Overall, the 1107 different spots visible on 2D gels fall well short of the estimated 6-7000 
genes expressed in each S. mansoni stage (Verjovski-Almeida et al., 2003), but compare 
favourably with the 465 spots previously found in SEA (Curwen et al., 2004). The number 
of spots are broadly comparable with the S. japonicum proteome study, where 1441 egg 
proteins were identified (Liu et al., 2006). It was evident that some proteins contained 
peptides that were more amenable to ionisation than others, because some relatively 
heavily-stained gel spots failed to generate good spectra and vice versa. For example, in the 
miracidia preparation good spectra were generated for spots 359-361 (adenylate kinase) but 
the more heavily stained spot situated between them in the gel failed to do so. 
2.4.1 Chaperones 
Chaperones are the most abundant proteins in the egg, forming the largest functional 
category in the immature SEA, mature SEA and miracidial preparations. The hatch fluid 
contains very few chaperones and the egg secretions none. The two principal chaperones 
are HSP70 and Sm-p40. HSP70 is highly expressed throughout the egg's development, 
with cytosolic and mitochondrial forms making up 9.3% of immature SEA and 10.9% of 
mature SEA. Of the mature SEA components, HSP70 was only found in the miracidial 
preparation, but as it only made up 4.6% of the protein in the miracidial gel, the remaining 
HSP70 from mature SEA needs to be accounted for elsewhere. The most likely explanation 
is that the HSP70 is highly enriched in the envelope but it failed to appear amongst the 
hatch fluid proteins, perhaps because it is not soluble in water (Weinreb et al., 2001). 
HSP70 undertakes a wide range of folding processes, including the folding of nascent 
proteins and the translocation of secretory proteins (Mayer & Bukau, 2005) so it is logical 
that it would be enriched for in the envelope because this is where ESP production occurs. 
Unlike HSP70, Sm-p40 is more abundant in mature SEA (10.9% of the proteome) than in 
immature SEA (4% of the proteome). The Sm-p40 can be assigned to the miracidium 
because it makes up 15.2% of the miracidial soluble proteome, and so its lower level of 
expression in immature SEA reflects the less developed status of the miracidium in the 
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immature egg. These figures are consistent with an earlier report that 10% of SEA (made 
from a mixture of immature and mature eggs) is made up of Sm-p40 (Stadecker et al., 
2001). 
There are three immunodominant T cell epitopes in Sm-p40, which together account for 
most of the T-cell response to SEA in C3H and CBA mice, both of which produce a strong 
granulomatous response to S. mansoni eggs (Finger et al., 2005; Asahi & Stadecker, 2003). 
In contrast, T cell hybridomas derived from the smaller granuloma that develop in C57BL/6 
mice do not recognise Sm-p40 (Hernandez et al., 1997). Taken together, these results 
demonstrate that Sm-p40 is an important T cell antigen, likely to be responsible for much of 
the granuloma formation found in schistosomiasis. Sm-p40 is a member of the 
(cytoplasmic) small heat shock protein family because it contains the conserved internal a- 
crystallin domain, flanked by a variable N-terminal domain and a smaller C-terminal 
extension (Stamler et al., 2005; Abouel-Nour et al., 2006). Small heat shock proteins 
(sHSPs) play a crucial role in protecting proteins from physiological, stress-induced, 
irreversible aggregation without using ATP. Once suitable conditions pertain for continued 
cell activity protein refolding occurs, mediated by ATP-dependent chaperones such as 
HSP70 (Sun & MacRae, 2005). A unique group of sHSPs containing two a-crystallin 
domains and a truncated C-terminal extension is found in flatworms. In addition to Sm-p40 
in Schistosoma, homologous transcripts have been found in Taenia, Echinococcus and 
Paragonimus (Kappe et al., 2004; Merckelbach et al., 2003; Benitez et al., 1998; Accession 
no. AAK35217). The C-terminal extension is thought to be responsible for modulating 
oligomerization of sHSPs under non-stress conditions, disassembly of which occurs when 
chaperoning is required (Sun & MacRae, 2005). In S. mansoni, the immunodominant 
epitope is in this C-terminal extension region (Hernandez & Stadecker, 1999), probably 
because of its hydrophilic nature. Apart from the flatworm sHSPs, the only other sHSPs 
that don't have the C-terminal extension are the HSP 12.6 proteins of C. elegans, (Leroux et 
al., 1997). In the lifecycle of C. elegans, unfavourable growth conditions induce the 
development of specialised "dauer" larvae, which are adapted to survive long periods of 
diapause. Dauer larvae do not feed, have reduced metabolic activity, are resistant to 
environmental stresses such as changes in temperature, osmotic pressure and oxidative 
stress yet they maintain an active chemosensory system and are capable of rapid movement 
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(Cassada & Russell, 1975; Albert & Riddle, 1988). These environmental stresses are not 
dissimilar to those facing the S. mansoni egg as it passes through the gut wall, enters 
faecal matter, then water before rupturing to release the miracidium. It is therefore 
interesting that the a-crystallin-containing HSP20 is highly upregulated in the C. elegans 
dauer larvae (Burnell et al., 2005) as is Sm-p40 in S. mansoni miracidia. Thus, the reason 
that Sm-p40 is so highly expressed in miracidia could be because it offers protection 
against the extreme physiological stresses that the miracidium is subjected to. Furthermore, 
as Sm-p40 operates in an ATP-independent manner, the protection it offers will not deplete 
the non-replaceable glucose reserves of the miracidium. 
2.4.2 ATP Production 
Schistosomes undergo metabolic changes during their life cycle in that the cercariae and 
miracidia use oxidative metabolism whilst the adults and intra-molluscan stages 
predominantly use anaerobic metabolism (Van Oordt et al., 1989; Lawson & Wilson, 1980; 
Tielens et al., 1991; Tielens et al., 1992; Skelly et al., 1998; Skelly et al., 1993). This 
metabolic change makes sense in the context of the biological requirements of the parasite 
at each stage in its life-cycle. For the adult schistosome, glucose is a virtually unlimited 
resource because it is bathed in glucose-rich blood, and consequently there is no 
evolutionary pressure for it to continue to produce the tricarboxylic acid (TCA) cycle 
enzymes required for glucose-efficient, aerobic metabolism. The non-feeding miracidium 
on the other hand cannot replace its lost glucose yet it must be highly active as it emerges 
from the shell and locates, then penetrates a snail. By utilizing aerobic metabolism to 
generate (approximately fifteen times) more ATP per glucose molecule, the miracidium has 
an increased likelihood of reproducing itself. 
The egg therefore represents a transition stage between anaerobic and aerobic respiration. It 
will need to be able to respire anaerobically whilst crossing the gut wall because the gut 
lumen is an anaerobic environment, but the aerobic pathway must be present as well so that 
it can become activated as soon as the egg hatches. Of the metabolic enzymes in immature 
SEA, the following are involved in aerobic respiration, so the capacity for aerobic 
respiration is evident early in the egg development: dihydrolipoamide dehydrogenase 
(which is part of the pyruvate dehydrogenase complex), citrate synthase, aconitase and ATP 
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synthase. Together these made up 2.9% of the protein in immature SEA, and the 
glycolytic enzymes made up a further 4.8%. The same set of aerobic respiration proteins 
were found in mature SEA plus succinate-CoA ligase and (mitochondrial) malate 
dehydrogenase. Overall, 3.2% of mature SEA consisted of proteins involved in aerobic 
respiration and another 4.6% were glycolytic proteins. Therefore, the mature egg contains 
more aerobic respiration proteins and fewer glycolytic enzymes than the immature egg, 
which is consistent with a change from anaerobic to aerobic respiration as the egg develops. 
However, the picture becomes less clear when the miracidial metabolic enzymes are taken 
into account. Overall, aerobic respiration proteins make up only 1.7% of the soluble 
miracidial protein compared to the glycolytic enzymes which make up 6%. The explanation 
is likely to be that the glycolytic enzymes are also heavily involved in gluconeogenesis. 
Out of the ten glycolytic enzymes, seven are also used in the gluconeogenesis pathway and 
three are purely glycolytic (hexokinase, phosphofructokinase-1 and pyruvate kinase). None 
of the purely glycolytic enzymes were found in any of the egg preparations but two 
enzymes used during gluconeogenesis but not glycolysis were - namely 
phosphoenolpyruvate carboxykinase and cytosolic malate dehydrogenase. Gluconeogenesis 
occurs in the cytosol and its precursors include pyruvate, glycerol and lactate. When the 
precursor is pyruvate, gluconeogenesis requires it to be transported into the mitochondria 
where it is converted to oxaloacetate and then malate by the TCA cycle enzymes pyruvate 
carboxylase and malate dehydrogenase respectively. The malate is then transported back 
across the mitochondrial membrane into the cytosol, where it is converted back into 
oxaloacetate by cytosolic malate dehydrogenase. The cytosolic oxaloacetate is then 
converted into phosphoenolpyruvate by phosphoenolpyruvate carboxykinase and from 
there it proceeds along the gluconeogenesis pathway. Thus, mitochondrial malate 
dehydrogenase is required by the TCA and gluconeogenesis but cytosolic malate 
dehydrogenase is only involved in gluconeogenesis. It can be seen from Table 2.2 that 
mitochondrial malate dehydrogenase is present only in the miracidial and mature SEA 
preparations, demonstrating the relatively undeveloped state of the TCA cycle in the 
immature egg. Cytosolic malate dehydrogenase and phosphoenolpyruvate carboxykinase 
(another purely gluconeogenic enzyme) on the other hand are present in all of the egg 
preparations, so gluconeogenesis can be seen to be a process carried out by the egg in all its 
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stages of development. The proteomic study of the cercariae carried out by Curwen et al., 
(2004) found no proteins involved in aerobic respiration, three glycolytic/gluconeogenic 
enzymes and no purely glycolytic ones. This indicates that the cercaria, like the 
miracidium, might be using its glycolytic enzymes to carry out extensive amounts of 
carbohydrate synthesis. 
Proteins for aerobic respiration make up 3.2% of mature SEA but only 1.7% of the 
miracidium, so the metabolic process takes up a smaller proportion of the proteome of the 
miracidium compared to the mature egg. The "missing" respiratory proteins are probably 
contained in the envelope, which is therefore also likely to carry out aerobic respiration, 
although it is not part of a free-living stage of the parasite. This is supported by TEMs of 
the envelope that show abundant mitochondria, demonstrating the envelope's potential to 
carry out aerobic respiration (Ashton et al., 2001; Ashton, 2007 pers comm). 
2.4.3 Cytoskeletal Proteins 
Cytoskeletal proteins made up 9-11% of the SEA and the miracidial preparations but were 
completely missing from hatch fluid and the egg secretions (which is not surprising as 
cytoskeletal proteins are intracellular). Tubulin is the principal cytosketal protein, with 
three ß isoforms and one a isoform identified in the gels. As microtubules are made up of a 
and ß monomers in a 1: 1 ratio it stands to reason that similar quantities of each monomer 
should be found. However, as only 1% of the tubulin in immature SEA, 4% in mature SEA 
and 33% in the miracidial preparation was of the a-type, a monomers are under- 
represented. Therefore cytoskeletal proteins probably constitute a larger percent of the egg 
proteome than is indicated. Five tubulin a isotypes and six ß isotypes have been described 
and these differ in their amino acid sequences at the carboxyl end (Luduena et al., 1992). 
Unfortunately, the sequences of the identified tubulins are of insufficient length to include 
the diagnostic C-terminus, except for Sm10465 which is probably ß4 tubulin (the (34- 
specific sequence of EGEFXXX is present in Sm 10465, except the initial glutamic acid is 
substituted with aspartic acid). The idea that different tubulin isoforms perform different 
physiological functions is not (yet) generally accepted because too little work has been 
published proving a correlation between isoform and function (Jensen-Smith et al., 2003). 
However, only ßl and (34 tubulins have been found in motile cilia (Renthal et al., 1993; 
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Roach et al., 1998; Jensen-Smith et al., 2003), whilst sensory cilia have been found to 
contain all types (Woo et al., 2002). Therefore, the ß4-like Sm10465 could form the 
motile cilia that completely cover the external surface of the miracidium or be in its flame 
cells. This is consistent with the absence of Sm10465 from immature SEA. The tubulin in 
the immature egg is more likely to be involved in cell division and intracellular transport, 
because processes must be occurring at high rates as the embryo rapidly develops. 
The abundance of actin in immature SEA, mature SEA and the miracidial preparation (3 - 
3.5% of the total protein) is consistent with Curwen et al., (2004) who found it among the 
top 20 spots of gels of cercariae, adult worm and lung worm preparations. In the developing 
egg, actin is likely to be involved in morphogenesis but when fully developed the miracidia 
is covered by longitudinal and circular actin fibres, associated with smooth muscle and co- 
localised to flame cells (Bahia et al., 2006). 
2.4.4 Defence Proteins 
Defence proteins will be required to protect the egg from toxic compounds present in 
serum, produced by the leukocytes of the granuloma or by the egg itself as part of its escape 
mechanism. As discussed in Chapter 1 (Section 1.2.4), the immature egg is 
immunologically inert with a less well developed granuloma around it compared with the 
mature egg. A smaller granuloma will produce fewer toxins which the (small) embryo, 
embedded amongst vitelline cells is more isolated from anyway. The immature egg does 
not produce ESPs and so it does not need to protect itself from any toxic properties ESP 
may have. So, as the immature egg is not particularly vulnerable only a relatively small 
proportion of its proteome needs to be comprised of defence proteins (4%). The mature egg 
by contrast is more vulnerable because the miracidium must be protected. Defence 
therefore becomes a more important issue as the egg matures, so it is not surprising that the 
proportion of defence proteins increases to 7% in mature SEA. Some defence proteins must 
be contained within the miracidium because it needs to protect itself whilst it penetrates the 
snail (3% of the miracidial preparation consists of defence proteins). However, the hatch 
fluid contained by far the largest proportion of defence proteins (16%). This is not 
surprising because hatch fluid bathes the miracidium whilst it is still inside the egg, 
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providing an insulating and protective layer which isolates it from both the host cells and 
the envelope where ESPs are produced. 
The increase in proportion of defence proteins in hatch fluid compared to immature SEA is 
mostly due to increased quantities of the same proteins rather than the development of a 
more complex mixture of new defence proteins. However, as the identification of proteins 
in the experiment relied heavily on between-gel matching of spots there will be a bias 
towards proteins found in more than one gel. It is likely that the 314 spots which are only 
present in mature SEA will incorporate hatch fluid-specific, defence proteins. The only 
defence protein that was found in hatch fluid but not in immature SEA was thioredoxin 
(constituting 4.1% of the hatch fluid defence proteins). It is surprising that thioredoxin was 
not found in immature SEA because thioredoxin peroxidase uses thioredoxin as an electron 
donor and immature SEA contained two thioredoxin peroxidases. Of the thioredoxin 
peroxidases, SmPrx3 is mitochondrial and probably deals with self-generated oxygen 
radicals escaping from the mitochondrial electron-transport chain (Sayed & Williams, 
2004; Chang et al., 2004). It is therefore not surprising that SmPrx3 is more highly 
expressed in mature SEA and the miracidium compared to immature SEA, because the 
miracidium has switched to aerobic respiration. The expression level of SmPrx3 in hatch 
fluid is low, probably because hatch fluid SmPrx3 will have been derived from ruptured 
cells of the envelope and proteins from this source form a relatively small proportion of the 
total hatch fluid proteome. A second thioredoxin peroxidase (SmPrxl) which is cytosolic 
and resistant to over-oxidation (Sayed & Williams, 2004) is also present in the egg. 
SmPrxl is the version of thioredoxin peroxidase that was reported to be excreted from the 
egg into the granuloma (Williams et al., 2001) and discussed in Section 1.4.3, although it 
was not found in ESP (see Table 2.3). 
Another defence protein (Smp154260), found in similar quantities in immature SEA and 
mature SEA but upregulated in hatch fluid has homology to the wasp venom allergen 
antigen 5 (Lu et al., 1993), which forms part of the plant pathogenesis-related (PR1) family 
of proteins. These were originally described as being produced by plants in response to 
viral infections and are secreted by L3 hookworm larvae upon host entry (Eberle et al., 
2002; Asojo et al., 2005; Dillon et al., 2006). In S. mansoni, three PR-I proteins have been 
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found in secretions from newly-transformed cercariae and transcripts of a fourth have 
been found to be up-regulated in lung stage schistosomes (Curwen et al., 2006; Dillon et 
al., 2006). The PR-1 in hatch fluid is different to all of those previously found. Nothing is 
known about the function of PR-1 proteins, but it is clear that they are often characterized 
by their resistance to protease degradation (Eberle et al., 2002). The role of Smp154260 
could therefore be to protect the miracidium from ESP proteases. 
2.4.5 Host Proteins in the Egg 
Host proteins constitute a significant proportion of the hatch fluid (6.6% of the protein 
volume). As none were detectible in mature SEA, host proteins are not abundant in terms of 
the percentage of total protein in the egg. Host proteins could be located either side of the 
envelope - between the envelope and the shell or between the envelope and the miracidium. 
The area between the envelope and the shell is much smaller in terms of volume and will 
also contain ESPs. It is therefore likely that a substantial proportion of the host proteins are 
present between the envelope and the miracidium, so it follows that there must be active 
transportation across the envelope. The transport of host proteins across the envelope has 
been previously demonstrated in only one paper, in which host L-selectin and CD3 were 
found between the miracidium and envelope when liver granulomata sections were probed 
with mAbs (El Ridi et al., 1996). 
It is considered unlikely that the host proteins are contaminants or artefacts derived from 
the outside of the shell, because any material adhering to the exterior surface of the shell 
would have been removed during the preparation steps, which involved a three-hour 
incubation in trypsin and then repeated saline washing steps. Even if any host proteins had 
somehow remained stuck to the shell despite the preparative regimen it is extremely 
unlikely that they would then be solubilized when the eggs were placed in filtered water for 
hatching. The possibility that the host protein identities were incorrectly generated as a 
result of searching conserved murine/S. mansoni amino acid sequences can also be rejected 
because three out of the five host proteins are not present in the S. mansoni genome (the 
alpha/beta haemoglobin subunits and regucalcin). The controversial existence of S. 
mansoni-albumin will be discussed later (in Section 2.4.6), but the albumin found in hatch 
fluid is definitely of murine origin because two of the fragmented peptides identified by 
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MSMS contained sequences unique to mouse albumin (DVFLGTFLYEYSR and 
LSQTFPNADFAEITK). The other host protein, murine HSC70 (a member of the HSP70 
family) has some overall amino acid sequence homology to S. mansoni HSP70 (an E value 
of 7e"17 to Sm09042), but two of the four peptides that were fragmented 
(STAGDTHLGGEDFDNR and LLQDFFNGK) were in unconserved regions. 
2.4.5.1 Regucalcin 
Regucalcin (constituting 0.4% of hatch fluid) is a vertebrate Cat+-binding protein (Misawa 
& Yamaguchi, 2000). It is highly expressed in the liver where it regulates intracellular 
calcium homeostasis by activating calcium pump enzymes (Yamaguchi, 2005). Hepatic 
regucalcin is released into serum following chemically-induced liver damage in rats (Isogai 
et al., 1994a; Isogai et al., 1994b) and in humans suffering with hepatitis (Yamaguchi et al., 
1997). The quantity of regucalcin found in the hatch fluid suggests that it may be purified 
in the egg because a recent proteomic study of changes to the rat serum proteome during 
liver injury didn't find regucalcin amongst the proteins expressed at a detectible level 
(Merrick et al., 2006; Merrick pens comm., 2006). It is possible that the regucalcin is 
involved in protecting the egg from damage by superoxide, because it has been shown to 
increase the activity of superoxide dismutase (Fukaya & Yamaguchi, 2004), and this 
enzyme is present in large quantities in all of the morphological components of the egg (see 
Tables 2.4 - 2.7). 
2.4.5.2 HSC70 
HSC70 is a major cytoplasmic protein and is the most abundant a member of the HSP70- 
related proteins in mice, with particularly high expression in the liver, skeletal muscle and 
the kidney (Hunt et al., 1999). HSC70 is also found in exosomes secreted by tumour cells, 
reticulocytes, DCs and B cells (Hegmans et al., 2004; Geminard et al., 2001; Thery et al., 
2001; Clayton et al., 2005). At 40-90nm in diameter, intact exosomes are too large to enter 
the egg, so HSC70 must be present in reasonable concentrations in the extracellular fluid 
surrounding the egg, whether it be derived from burst exosomes or secreted via a different 
mechanism. At 70kDa, HSC70 is the largest host protein in the egg and indicates that the 
shell must be permeable to molecules of this size. It is unclear what benefit the egg obtains 
by sequestering HSC70 from the host, but as the concentration of serum HSC70 in the 
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hepatic granulomata of schistosome-infected mice is not known, it is possible that the 
quantity found in hatch fluid is consistent with passive absorption of serum proteins into 
the egg. 
2.4.5.3 Haemoglobin 
The presence of intact haemoglobin a and ß chains in the egg means that erythrocyte lysis 
must be occurring around the egg, because erythrocytes are far too large to enter the egg 
intact. Once lysed, the erythrocyte will lose its haemoglobin content, the a2ß2 structure 
break apart and the separate chains enter through the shell. There is an inherent risk for the 
egg in accumulating haemoglobin because degradation of haemoglobin releases the free 
haem group which is toxic. Haemoglobin is digested in the gut of adult schistosomes by 
aspartic and cysteine proteases such as cathepsins and Sm32, which are optimally active at 
pH4 but completely ineffective against haemoglobin at pH6.5 (Delcroix et al., 2006). Free 
haem released by the degradation of haemoglobin is detoxified in the adult worm by 
aggregating it into haemozoin (Oliveira et al., 2004). In the egg, the presence of intact 
haemoglobin chains and the absence of haemozoin indicate that the toxic effects of haem 
are avoided by preventing the degradation of haemoglobin in the first place. The failure to 
degrade haemoglobin is likely to be a consequence of the egg having an internal pH that is 
inappropriate for the requisite proteases to be active. There would be no reason for the egg 
to produce proteases that would be incapable of activity, so it is not surprising that no Sm32 
transcripts and only low levels of cathepsin B transcripts have been found in the egg 
(Dillon, pens comm., 2006). 
2.4.6 Albumin 
2.4.6.1 Host Albumin in the Egg 
Fatty acids are incorporated into the structure of phospholipids, which are themselves 
important components of cell membranes. Schistosomes can construct phospholipids from 
fatty acids, but they must obtain the fatty acids from the host because as they are incapable 
of producing them do novo (Brouwers et al., 1997). The egg therefore requires a 
mechanism to obtain host fatty acids and then transport them across the membrane to the 
developing miracidium. Albumin is a fatty acid-binding protein with five high-affinity 
ligands (Simard et al., 2005), and as the most abundant host protein in the egg (4.3% of the 
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protein in hatch fluid) its role could be to that of fatty acid importer. Albumin also has a 
potential role in defence because it has been shown to have anti-oxidant properties in that 
it can scavenge superoxide and hydrogen peroxide produced by neutrophils using an 
acellular mechanism (Kouoh et al., 1999). 
2.4.6.2 "S. mansoni-Albumin" 
In order to establish whether the "S. mansoni albumin" described by Williams et al., (2006) 
as being of parasite origin is actually of host origin, albumin from the common laboratory 
host Mesocricetus auratus (Golden Hamster) was isolated, trypsinised, analysed by 
MALDI-MS, Electrospray-MSMS and the peptide sequences compared to the "S. mansoni 
albumin" sequence deposited on NCBI. 
Williams et al., (2006) had obtained schistosomula by mechanical transformation from 
cercariae and adult worms by perfusing them from mice. The parasites were subjected to 
oxidative stress and albumin was detected by RT-PCR, but only when hydrogen peroxide 
was present in the culture medium. Consequently, the authors proposed that the albumin 
was produced by the schistosome as a sacrificial oxidant scavenger. The albumin was 
sequenced and was found to have the most homology with albumin from the "Red Vole 
Microtusfortis". It was then claimed that the gene had been acquired from a rodent host by 
lateral gene transfer and then undergone evolutionary change. (The authors presumably 
intended to refer to the Reed Vole Microtusfortis, because albumin from the Red Vole 
Clethrionomys rutilus has not yet been sequenced! ) 
The finding that the amino acid sequence of the proposed S. mansoni-albumin gene is 
identical to albumin from the Golden Hamster (see Figure 2.13) makes it extremely 
difficult to accept the gene transfer theory. Also, lateral gene transfer in schistosomes is 
controversial (see Section 2.1.4) and hamsters are unlikely ever to have been a natural host 
for schistosomes because their geographical distributions are different - hamsters, unlike S. 
mansoni, are found in southern Europe and west Asia. More specifically, the Golden 
Hamster is only found in the wild in Syria, where schistosomiasis is/was restricted to a few 
small foci of S. haemoatobium infections (Abdel-Azim & Gismann, 1956). Golden 
Hamsters are a well-used laboratory host for S. mansoni though, and PCR is an extremely 
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sensitive technique, so it is easy to see the potential for parasite samples or laboratory 
equipment to become contaminated with host material to generate an erroneous result. The 
results of the proteomic albumin experiment in this chapter are supported by data from 
further genomic experiments carried out by other members of this laboratory, in which no 
albumin gene could be detected in the S. mansoni genome either by in silico searching or 
Southern blotting (DeMarco et al., 2007). 
Nevertheless, no obvious route can be seen in which hamster albumin could have 
contaminated all of the experiments carried out by the Williams group. Both the Sayed et 
al., (2006) and the Williams et al., (2006) papers state that the parasites were maintained in 
a murine host and the schistosomula were transformed mechanically, so there was no direct 
physical contact between the parasite material and the host. The Sayed et al. study also 
report finding "S. mansoni albumin" using Electrospray-MSMS, but no fragmentation data 
was provided so an assessment of the quality of the data cannot be made. It is therefore 
possible that the albumin was derived from FCS, which was present in the culture medium. 
The Williams group also appear to have obtained their parasite material from an external 
source, so it is also feasible that they could have been provided with incorrect information 
with regard to the host species. 
2.4.7 The Proteome of the Female, Vitellaria-Enriched Preparation 
It was surprising that the preparation enriched in vitellaria bore so little resemblance to 
immature SEA that between-gel spot matching could not be carried out. Eight out of the 
nineteen different proteins from the female, vitellaria-enriched gel were not found in the 
egg, so there must be a significant quantity of non-vitelline material in the rear section of 
the female. This is despite the studies showing the vitellaria packing out this part of the 
worm (Spence & Silk, 1971). Two of the identified non-egg proteins (myosin light chain 
and Sm20.8) were among the twenty most abundant spots in cercariae and adult worms 
(Curwen et al., 2004) and another (leucine aminopeptidase) is the enzyme that Xu & 
Dresden (1986) state could be a miracidial-hatching enzyme. However, the transcript found 
in the female, vitellaria-enriched preparation encodes a cytosolic protein, so is unlikely be a 
candidate for a secreted version. 
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The egg's vitelline cells are degraded as the embryo develops, and so proteins exclusively 
found in vitelline cells will be present in the gels of the female, vitellaria-enriched 
preparation and immature SEA, but missing from the mature SEA, miracidial and hatch 
fluid gels. The only protein fitting this criterion is Ferritin 1. Ferritin exists in two isoforms, 
of which Ferritin 2 is fairly ubiquitously present in both S. mansoni sexes, whilst Ferritin 1 
is fifteen times more abundant in females and can be localised to the vitelline cells 
(Schussler et al., 1995; Winnen et al., 1995). Ferritin has also been found highly expressed 
in vitelline cells of Clonorchis sinensis and Paragonimus westermani (Tang et al., 2006; 
Kim et al., 2002). Therefore, Ferritin 1 appears to be the only protein identified from the 
female, vitellaria-enriched preparation which definitely forms part of the vitelline cell. The 
reason why so few vitelline cell proteins were found is probably due to the extensive 
changes that occur in vitelline cells as they develop (Erasmus, 1975) combined with the 
high production rate of 9,000 --12,000 cells/day (see 1.2.1). It is therefore unlikely that the 
proportion of fully-mature cells found in the vitellaria at any one point in time would be 
particularly large, and consequently their proteins will represent a small component of the 
whole and not well represented in the gel. 
2.4.8 The Proteome of Hatch Fluid 
Hatch fluid contains the greatest proportion of proteins that have an unknown function 
(20.4% of its proteome). This is probably a reflection of the unstudied status of hatch fluid 
in schistosomes, its lack of physical structure and the scarcity of an equivalent material in 
other organisms. None of the hatch fluid proteins of unknown function have homology to 
any non-schistosome proteins either. 
Smp170410 is the largest component of hatch fluid, making up 18.2% of the protein in the 
gel. It is more highly expressed in mature SEA than in immature SEA (1.8% compared to 
0.6% - see Figure 2.8), so it is unlikely to be a vitelline cell remnant. It is possible that 
Smp170410 is located in the prominent vesicles that are found between the envelope and 
the miracidium and it therefore might be involved in the hatching process - possibly by 
expanding under osmotic pressure when the egg contacts fresh water. 
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2.4.9 The Proteome of ESP 
Subjecting 75µg ESP to 2-DE demonstrated that the egg secretes more proteins than 
originally thought. Although 27 different spots can now be seen in the gel, 83% of the 
protein constituted the six ESP3-6 spots. It is therefore very likely that further ESPs will be 
discovered if ESP3-6 were to be separated from crude ESP and a larger quantity of non- 
ESP3-6 proteins separated by 2-DE. Apart from ESP1-2 (which is Omega 1) and ESP3-6 
(which is IPSE), none of the ESPs had significant homology to any proteins of known 
function. Thioredoxin peroxidase, described by Williams et al., (2001) as being secreted 
from the egg was not found. 
ESPs 13/14 (Sm11845) and ESP 17 (Sm12949) form a series of three adjacent, acidic spots 
on the gel of approx. 25kDa. The amino acid sequences of Sm12949 and Sm 11845 are 74% 
homologous and are found adjacent to each other on the same contig, although Sm11845 is 
shown as being transcribed from one DNA strand and Sm 12949 from the other strand. As 
well as being secreted by the egg, ESP13-14 (Sm11845) and its associate ESP18-19 
(Sm12949) have also been identified amongst the secretions from lung worms (Curwen, 
2006 pers comm. ). These proteins are clearly important to the parasite, and as they are also 
in the region of the zymogram where Ashton (2001) found proteolytic activity, it is possible 
that they may be involved in the proteolysis that is required for the egg to escape the host. 
No proteolytic domains were found when carrying out BLAST against the MEROPS 
protease database, but the Gene Ontology classification scheme 
(http: //www. geneontology. org) predicts that Sm 11845 (but not Sm 12949) has a potential 
subtilase pro-protein convertase functional domain. This finding raises the question of 
whether the role of ESP 13-14 might be to activate host proteases to aid the egg's passage 
across the gut wall. This idea is pursued further in Chapter 3. 
2.4.10 Vaccine Candidates in the Egg. 
Five out of the seven priority WHO vaccine candidates (Bergquist et al., 2002) were 
relatively abundant in the egg (paramyosin, GAPDH, GST, triose phosphate isomerase and 
Sm14). Another vaccine candidate, IrV5 (part of the myosin heavy chain) was not found, 
possibly because its large size would hinder its migration through the gel. However, myosin 
is definitely present in the egg, because mAbs have been used to localise it to actin-rich 
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tubules in the flame cells (Bahia et al., 2006). The presence of vaccine candidates in the 
egg means that they will be exposed to the host's immune system when eggs disintegrate 
in the liver during the normal course of infection. An adaptive immune response to the 
antigens would therefore be generated, and a consequential evolutionary pressure for the 
parasite to resist it would develop. It is therefore not surprising then that these vaccine 
candidates do not offer spectacular protection to the host (Pearce, 2003). Also, if vaccines 
were to be cross reactive to egg proteins there is a risk that the vaccine will sensitise 
individuals to egg proteins, causing an increased response to disintegrating eggs, thereby 
causing additional pathology. So, in future, vaccine candidates should consist of proteins 
that are not highly expressed in the egg. 
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Chapter 3 
Functional studies of ESP 
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3.1 Introduction 
The granuloma that forms around eggs is vital to both the host and the parasite: to the host 
because it forms a protective, isolating barrier around the egg and to the parasite because 
the leukocytes of the granuloma aid the passage of the egg through the gut wall (discussed 
below in Section 3.1.1). ESPs are a product of live eggs and so (unlike SEA) they represent 
the interface between the egg and the developing granuloma. 
3.1.1 ESP and the Granuloma 
The granuloma is the cellular focus that forms around the egg. In schistosomiasis, the 
principal cells of the granuloma are macrophages, T cells and eosinophils, the proportions 
of which differ depending on which tissue the granuloma develops in. For example, in 
CBA mice, liver granulomata mostly contain eosinophils, with smaller numbers of 
macrophages and T cells, but colonic granulomata contain more macrophages than 
eosinophils (Weinstock & Boros, 1983). These cellular differences could be attributable to 
local regulatory events (as the authors propose) but they could also reflect the longer 
developmental period of liver granulomata (that form around trapped eggs that eventually 
die and disintegrate) compared with those found in the intestine (where the eggs are in 
transit and most will be excreted whilst still alive). It is clear however that regardless of the 
location of the granuloma, macrophages are its principal antigen presenting cells (APCs). 
The roles T cells have in enabling the egg to escape from the host and in inducing the host's 
Th2 response to egg deposition have been discussed in Chapter 1 (Sections 1.2.5 and 1.1.4 
respectively). As these responses occur whilst the egg is still alive, it is likely macrophages, 
presenting ESPs to the T cells of the granuloma are important early events in the process. 
This chapter incorporates experiments aimed at establishing whether macrophages from 
na7ve mice are activated by ESP and whether this activation includes the up-regulation of 
MHCII. In another series of experiments the hypothesis that ESP (representing the live egg) 
is more immunogenic than SEA (representing the disintegrating egg) is tested. Leukocytes 
from mice at the acute stage of infection were used in these comparative assays because 
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they are at the point at which the adaptive immune response to egg antigens is at its peak 
(Boros et al., 1975; Sadler et al., 2003). 
3.1.2 ESP and the Escape of the Egg 
As discussed in Chapter 1 (Section 1.2.3), eggs probably require proteases to cross the gut 
wall. It is not known whether these proteases are secreted by the egg, by the cells of the 
granuloma or by both. Various in vitro experiments have reported protease activity in egg 
secretions (see Chapter 1, Part 4), the most convincing of which was a 2D casein 
zymogram of crude ESP (Ashton, 2001). Proteases derived from granuloma T cells have 
been implicated in egg-escape in an in vivo experiment in which mice deprived of T cells 
showed a drastically reduced ability to excrete eggs (Doenhoff et al., 1986). Whatever their 
origin, the proteases are likely to be of the metalloproteases class because metalloproteases 
have been localised to the granulomata of infected humans and mice (Singh et al., 2004; 
Gomez et al., 1999). They have also been implicated in the degradation of extracellular 
matrix in cancer (Chang & Werb, 2001). There are two closely related metalloprotease 
families: "A Disintegrin and Metalloproteases" (ADAMs) and MMPs. The ADAM family 
is subdivided into two groups: "ADAMs" and "ADAMs containing a thrombospondin 
domain" (ADAMTs). ADAMs are membrane-bound and process/activate other 
transmembrane proteins, thereby influencing cell adhesion and signalling events 
(Mochizuki & Okada, 2007). ADAMTs are usually secreted and have been implicated in 
the cleavage of von Willebrand factor and the processing of collagen pro-peptides 
(Mochizuki & Okada, 2007; Canty & Kadler, 2005). There are seventeen secreted MMPs 
with different substrate specificities (von Lampe et al., 2000). MMPs of potential interest in 
the transit of the schistosome egg are MMP-1, MMP-8 and MMP-13 (collagenases which 
cleave the triple helical structures in Collagen I, 11, III and X) and MMP-2 and MMP-9 
(gelatinases whose substrates include Collagen IV and denatured collagen of other types). 
All of these above-numbered MMPs are known to be secreted by macrophages, eosinophils 
and T cells, which as discussed above are the principal leukocytes making up the 
granuloma (von Lampe et al., 2000; Taylor et al., 2006b; Goetzl et al., 1996; Lacraz et al., 
1994; Okada et al., 1997; DiScipio et al., 2006). However, if MMPs and ADAMTs are 
involved in egg escape they will still need to undergo further processing steps because they 
are secreted as inactive precursors, requiring the cleavage of an amino-terminal domain to 
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be activated (von Lampe et al., 2000; Nagase, 1997). It is possible that ESP13-14 fulfils 
this role as it possibly contains a subtilase pro-protein convertase functional domain (see 
Chapter 2, Section 2.4.9). 
Activated MMPs and ADAMTs are regulated by inhibitors such as a2 macroglobulin and a 
family of secreted proteins called Tissue Inhibitors of Matrix Metalloproteinases (Gomez et 
al., 1997). So, if the egg is to commandeer host proteases, not only has it got to induce the 
granuloma cells to secrete the MMPs in the first place, but it also needs to create the right 
environment in which the pro-proteases can be activated whilst the concentration of the 
inhibitory proteins is maintained at a relatively low level. Although this seems to be a tall 
order, there is evidence that this is what occurs because in the murine model mRNA 
encoding MMP-2, MMP-3 and MMP-8 is up-regulated in the colonic tissues of infected 
animals (Singh et al., 2006). 
3.1.3 Experimental Aims and Objectives 
The work of this chapter aims at establishing whether leukocytes known to be present in the 
granuloma respond to ESP. The leukocytes were taken from naive mice in some assays and 
from infected mice in others, so the results can be seen in terms of ESP-innate immune 
system interactions and ESP-adaptive immune system interactions. The ESP-innate 
immune responses represent what would occur in a new infection when egg deposition 
begins. Macrophages would be the initial cells that adhere to the egg to start the 
inflammatory focus (Co et al., 2004), and the immediate egg products to which the 
macrophages could respond to will be ESP. The macrophages are likely to respond to the 
ESP by becoming activated and presenting ESP peptides on upregulated MHCII molecules. 
So, by measuring changes in MHCII expression and IL-6 production by naive macrophages 
cultured with ESP, the antigenicity of ESP was assessed. Other experiments using the naive 
macrophage model involved comparing the proteolytic activity in crude ESP with that in 
the supernatants from macrophage-ESP cultures, to establish whether ESP contained a 
subtilase-like pro-protein convertase. As it was not known what class of protease to assay 
for, the protease assays were carried out using the QuantiCleave universal protease assay 
(Pierce 23267) in fluorescence resonance energy transfer (FRET) mode. Classical FRET 
occurs when electron energy is transferred between two different fluorophors. In the 
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QuantiCleave assay, FRET events occur between adjacent fluorophors, so when the 
(casein) substrate is cleaved a reduction in FRET occurs, which is measured as an increase 
in fluorescence. The ability of ESP to stimulate naive T and B cells was also assessed by 
culturing splenocytes from naive mice with ESP. In this experiment, cell proliferation was 
taken as a measure of activation. 
After egg deposition has underway for several weeks some of the initially produced eggs 
will have died and disintegrated. After this point in time, all of the newly produced eggs 
will be in an environment where the host immune system will have seen and responded to 
both ESP and SEA. Although SEA is a more complex mixture than ESP and therefore 
containing more epitopes, it is not currently known whether ESP is more or less 
immunogenic. This question was addressed by stimulating mesenteric lymphocytes with 
both ESP and SEA and comparing their proliferative responses. 
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3.2 Methods 
3.2.1: Preparing ESP and SEA 
ESP was made as described previously (Chapter 2, Section 2.2.4), but in experiments 
involving the measurement of protease activity the ESP was made using Phenol Red-free 
RPMI-1640 (Gibco). SEA was made as described in Chapter 2, Section 2.2.3, except the 
eggs were not separated into mature and immature fractions before grinding and no PIC 
was added. 
3.2.2: The Stimulation of Macrophages from Naive Mice 
Cells were elicited into the peritoneal cavity of five naive, female C57BL/6 mice by 
injecting each mouse with 500µ1 of sterile, 3% Brewers thioglycollate medium (Sigma). 
Five days later the mice were killed and 10ml culture medium was injected into the 
abdominal cavity of each mouse. Culture medium was prepared as follows: RPMI 1640 
(Gibco), plus 10% low-endotoxin FCS (Harlan), 1% 10,000µg Streptomycin 
sulphate/10,000 units Penicillin G sodium per ml in 0.85% saline (Invitrogen) and 1% 
200nM Glutamine (Invitrogen) and 10ng/ml of rIFN-y (Pharmingen). Peritoneal exudate 
cells (PEC) were dislodged from the tissue by massaging the abdomen, then extracted 
through a 21G needle into a 15m1 falcon tube on ice and centrifuged at 350g for 5 min. The 
supernatant was removed, then the pellet was re-suspended in 2ml fresh culture medium 
and the cellular concentration of live, macrophages/monocytes was established by Trypan 
Blue exclusion using a haemocytometer. 
The cells were plated out in I ml aliquots at 1x 106 monocytes/granulocytes per ml in a 
plastic 12-well plate (Nunc) and incubated for 1 hour at 37°C and 5% CO2. The culture 
medium was agitated to dislodge the non-adherent cells, which were then removed in 
suspension leaving the plastic-adherent cells stuck as a monolayer to the base of the well. 
(This plastic-adherence purification method retains > 80% of monocytes/phagocytes in a 
cell suspension at > 95% purity (Treves et al., 1980)). The purified 
macrophages/monocytes were immediately re-immersed in lml of fresh culture medium at 
37°C, containing different concentrations of SEA or ESP. Polymyxin B (PMB) (Sigma) at 
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12.5µg/ml was added to all wells (except the appropriate controls) to eliminate endotoxin 
contamination. The positive control was lipopolysaccharide (LPS) at lOng/ml. 
The culture plate was then incubated for 18 hours, after which the supernatants were 
collected and stored at -18°C for cytokine analysis. The less-adherent macrophages were 
removed from the plate by rinsing them with ice-cold PBS. The more-adherent 
macrophages were removed by incubating them for 10 minutes with 125µl/well of 0.25% 
trypsin solution which contained 1mM Ethylene Diamine Tetraacetic Acid (EDTA) 
(Invitrogen) and then any remaining macrophages were gently dislodged with the plunger 
of a Iml syringe. The macrophages were centrifuged at 350g for 5min, re-suspended in 
PBS containing 1% FCS and blocked with heat inactivated rabbit serum, then stained with 
biotin-conjugated rat anti-mouse MHCII antibody (Caltag) followed by streptavidin- 
conjugated to allophycocyanin (Caltag). Isotype controls were stained with the anti MHCII 
antibody only. MHCII expression was assessed using a flow cytometer (Dako Cyan) with 
optimised voltage and flow rate settings. The concentration of IL-6 in the culture 
supernatant was measured by sandwich ELISA using rat anti-mouse IL-6 antibody with a 
biotinylated detecting antibody (Pharmingen) in flat bottomed 96-well plates (Nunc). 
3.2.3: The Stimulation of Splenocytes from Naive Mice 
Spleens were removed from three naive female C57BL/6 mice that had been reared 
together in individually-ventilated cages (Tecniplast). Culture medium was prepared as 
described in 3.2.3 except IFN-y was excluded and 0.1% 50mM ß-Mercaptoethanol 
(Invitrogen) was added. The spleen was teased apart in culture medium using the plunger 
from a Iml syringe and the splenocytes recovered by rinsing them through a stainless steel 
mesh (which removed the spleen tissue). The splenocytes were centrifuged at 200g for 7 
minutes then suspended in 2ml of ACK erythrocyte-lysing buffer (150mM NH4C1,10mM 
KHCO3,0.1mM EDTA, adjusted to pH7.2) for 2 mins. The ACK buffer was then diluted 
with 13m1 of culture medium, the centrifugation step repeated, the buffer replaced with 2ml 
culture medium and the pellet re-suspended. A small aliquot of cells was stained with 0.4% 
Trypan Blue solution (Sigma) and a haemocytometer used to assess the concentration and 
viability of the cells. The splenocytes were then plated out at 2x 105 cells/ml, in a 96-well 
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multi-well plate (Nunc) such that the volume in each well was 200µ1. with antigen (ESP at 
40µg/ml or hamster anti-mouse CD3c chain mAb (Pharmingen) at 0.33µl/well). 
The plate was incubated at 37°C and 5% CO2 for 72 hours. 0.25µl of (methy1_3 H) 
thymidine aqueous solution, specific activity 185GBq/mmol (Amersham), was then added 
to each well and a second 24-hour incubation step was carried out. A cell harvester 
(Packard Filtermate) was used to transfer the cells onto a Unifilter GF/C 96-well plate 
(Perkin Elmer), which was then washed and allowed to dry overnight. Microscint-20 LSC 
cocktail (Packard) was added at 20µl per well before the thymidine incorporation was 
measured on a Top Count NXT (Packard) scintillation luminescence counter (which 
expresses the data as counts per min. (cpm)). 
3.2.4: The Stimulation of Lymphocytes from Infected Mice 
Mesenteric lymph nodes were removed from female C57BL/6 mice that had been reared 
together in an individually-ventilated cage (Tecniplast) after they had been infected with 
180 cercariae/mouse seven weeks previously (using the protocol described in Chapter 2, 
Section 2.2.1). The lymphocytes were extracted and prepared for culture using the same 
method as Section 3.2.3 (except the ACK lysing buffer was not used and the cellular 
concentration was 1x 106 cells/ml). The lymphocytes were stimulated with ESP or SEA at 
0- 80pg/ml, or Concanavalin-A (Con A) (Sigma) at 2.5µg/ml and then incubated, 
harvested and their proliferation measured as described in Section 3.2.3. 
3.2.5: Protease Secretion from Naive Macrophages stimulated with ESP 
The extraction, purification and culture of naive macrophages was carried out as described 
in Section 3.2.2, except three mice were used and serum-free AimV culture medium 
(Gibco) was used instead of the RPMI-based medium (which contained FCS). The 
macrophages were stimulated with different concentrations of ESP or I OOng/ml phorbitol 
12-myristate 13 acetate (PMA) (Sigma). Flow cytometry (Dako Cyan) was used to 
establish the phenotypic profile and viability of the cells in the crude exudate from each 
mouse at the beginning of the experiment and for the cells from each well of the culture 
plate at the end of the experiment. The phenotypic profile of each sample was assessed 
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using the SSC/FSC plot and the % cell mortality was measured using 1% propidium 
iodide (PI) incorporation. Post-culture supernatants were immediately assayed for protease 
activity using the QuantiCleave Fluorescent Protease Assay Kit (Pierce), in which 100µl of 
culture supernatant and 100µl of substrate were incubated for 60 min at 26°C in white, flat- 
bottomed 96-well Multiwell plates (Nunc). Fluorescence was measured on a Polarstar 
Optima plate reader (BMG Labtech) with optimised gain adjustment and the results 
expressed as the change in fluorescence at the beginning and end of the incubation period 
(mean of duplicated wells). It was necessary to measure the protease activity of crude ESP 
in a separate plate (with a different gain adjustment) because the Aim V (macrophage) 
culture medium contained Phenol Red, whereas the RPMI-based ESP preparation did not. 
In order to compare the two sets of results, protease standards were made using sequencing 
grade porcine trypsin (Promega) that had been solubilized in the same culture medium as its 
accompanying test samples. 
125 
3.3: Results 
3.3.1: The Stimulation of Macrophages from Naive Mice 
MHCII expression on cultured naive macrophages was not influenced by the presence or 
absence of ESP (Figure 3.1). With a 1% gate, the mean percentage of MHCII+ve cells 
varied between 33.9% (40µg ESP/ml) and 40.2% (20µg ESP/ml) but there were no 
statistically significant differences between any of the assays (standard error of the mean). 
It was possible to obtain increases in the percentage of MHCII+ve cells by increasing the 
size of the gate, but still no statistically significant between-assay differences in expression 
emerged. No between-assay differences in staining intensity (calculated as the difference in 
mean APC units between each assay containing the MHCII antibody and its isotype 
control) was seen either. If the median difference rather than the mean difference in APC 
units was taken the results were even more homologous (due to larger error bars). When the 
experiment was repeated without IFN-y in the culture medium the MHCII expression levels 
were lower and more homologous in all of the assays (result not shown). 
Naive macrophages secreted IL-6 when stimulated with ESP, but not when stimulated with 
SEA (Figure 3.2). The differences in IL-6 production in response to each concentration of 
ESP and its immediate doubling dilution were not statistically significant, but the difference 
between 40µg ESP/ml and 10µg ESP/ml was, as were the differences between any assay 
containing ESP and the negative control. The secretion of IL-6 was dependent upon the 
presence of IFN-y in the culture medium as no IL-6 was produced when IFN-y was absent. 
3.3.2: The Stimulation of Lymphocytes from Naive and Infected Mice 
Splenocytes from naive mice did not proliferate in response to ESP (Figure 3.3). In 
contrast, cells from the mesenteric lymph nodes of acutely infected mice proliferated when 
stimulated with either ESP or SEA (Figure 3.4). A dose-dependent increase in proliferation 
occurred in the ESP assay at antigen concentrations up to 40µg/ml, but the extent of cell 
proliferation to 80µg ESP/ml and Con A was less than that seen at 40µg ESP/ml. Dose- 
dependent cell proliferation also occurred in the SEA assays but to a lesser extent than that 
induced by ESP. 
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Figure 3.1 ESP does not influence MHCII expression on naive macrophages. A: Typical 
FSC/SSC plot (Mouse 1,10µg ESP/ml). Cells within R2 were selected for analysis. B: 
Cells within R2: macrophages positively-stained with APC-conjugated anti-mouse MHCII 
(green diagonal shading) compared with the isotype control (red vertical shading). Cells in 
R3 (1% gate) were taken to be MHCll+ve C: Cells within R3: there is no relationship 
between the % of MHCll+ve macrophages and the presence of ESP. D: The mean staining 
intensity on MHCII+ve cells minus the mean staining intensity of isotype control cells. 
There is no relationship between the intensity of staining on MHClI+ve macrophages and 
the presence of ESP. (Data in C&D are mean of five mice +/- standard error of the 
mean). A medium control (i. e. cells only) was not carried out. 
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Figure 3.2 IL-6 production by 
naive macrophages in response to 
ESP and SEA. Ixl 06 macrophages 
were cultured with ESP (A) or SEA 
(B). IL-6 concentration in the 
supernatants was measured. Results 
are shown as the mean (+/- standard 
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experiments using five mice. C: 
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flow cytometry after culture. The 
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128 
Original in colour 
ö 
0 
0 
1 
E 
a 
CA 
c 
0 U 
C 
0 
0 
a 
0 
0 
M 
9.6 
9.4 
9.2 
9 
8.8 
8.6 
Figure 3.3 Splenocytes, taken from naive mice do not proliferate in 
response to ESP. When 2xl Os cells from the spleens of naive mice were 
incubated with 40µg/ml ESP there was no more proliferation than was 
seen with media only. The proliferation index is 0.97 for the ESP assay 
and 39.4 in the positive control. 
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The reduction in the proliferation seen at 80µg ESP/ml and in the positive control of the 
ESP series of assays did not occur in the SEA assays. The raw data from the ESP and SEA 
assays are not directly comparable however, because there was more background cell 
proliferation in the ESP assay than in the SEA one (1758 counts/min (ESP) compared to 
691 counts/min (SEA) in the negative controls). Proliferation index values (counts/min at 
each antigen concentration divided by the counts/min in the negative control) were 
therefore calculated to normalise the two sets of data (Figure 3.4C). The proliferation index 
values for the ESP assays were higher than those of the SEA assays at antigen 
concentrations <_40pg/ml, demonstrating that ESP is more immunogenic than SEA at the 
acute stage of infection, certainly at lower concentrations. 
3.3.3 Protease Secretion from Macrophages from Naive Mice 
Culture supernatants from naive macrophages that had been incubated with ESP contained 
proteases (Figure 3.5A). The amount of protease activity (as measured by the QuantiCleave 
fluorescent protease assay) was dependent upon the concentration of ESP, but the level of 
activity was low compared with the trypsin standards (all the ESP assays had less protease 
activity than Ing trypsin/ml). The culture supernatant in the negative control also contained 
proteases, but as the AimV media was protease-free these must have been secreted by the 
macrophages, indicating that some background stimulation had occurred. The same 
protocol was used to measure the protease activity of crude ESP (Figure 3.5B) and an 
inverse relationship between ESP concentration and protease activity was seen. At > 40µg 
ESP/ml the amount of fluorescence measured at the end of the protease assay was below 
that seen at its start. At <_ 20µg ESP/ml however, the amount of proteolysis in crude ESP 
was much higher (comparable with 16ng trypsin/ml) than that found in any of the culture 
supernatants of macrophages incubated with ESP (<Ing trypsin/ml). Therefore, ESP must 
contain proteases, but there must be some ESP-derived factor that had interacted with the 
fluorophor, the casein substrate or had interfered with transmittance at the wavelengths 
used in the assay. The latter possibility was addressed by measuring the absorbance of ESP 
on a Fluoromax-2 spectrofluorometer at 485nm and 520nm and then converting the data to 
% transmittance using the formula Absorbance. = logto x 100/%Transmittance. A broadly 
linear relationship between ESP concentration and % transmittance was seen with the ESP 
absorbing a greater percentage of light at the emission wavelength (Figure 3.5C). 
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However, even at 160µg ESP/ml, 93% of the light at the excitation wavelength and 91% 
at the emission wavelength was transmitted through the samples. Therefore, the 
absorbance spectrum of ESP does not substantially influence the fluorophor and can be 
discounted as the reason for the drop in fluorescence. 
Flow cytometry was used to assess the cellular makeup of the peritoneal exudate, the 
effectiveness of the plastic-adherence purification procedure and the percent of apoptotic 
cells from each mouse at the beginning of the culture period. The results for each mouse 
were similar and a random example (Mouse 1) is shown as Figure 3.6. The percentage of 
apoptotic cells was assessed by measuring PI incorporation and it was 3.6%, 5.0% and 
6.6% in the three mice. The SSC/FSC plot was used to categorise the cell-types in the crude 
peritoneal exudate, which was found to contain mostly monocytes, but significant numbers 
of macrophages and lymphocytes were also present. Selecting the plastic adherent cells 
successfully purified the monocytes and macrophages. At the end of the culture period the 
cells from each assay were again analysed by flow cytometry but now 40-50% of them 
were apoptotic (Figure 3.7). The extent of apoptosis was similar in all of the assays 
(including the negative controls) and so cannot be related to the presence or absence of ESP 
in the culture medium. No between-mouse differences were evident and as a similar 
proportion of apoptotic cells were in the serum-containing RPMI control, the serum-free 
medium was not responsible either. 
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Fig 3.6 Cellular make-up and mortality of newly-extracted PECs. A: A typical 
histogram of PEC cells (from Mouse 1). Pl+ve cells (red vertical hatching) gated at I% 
(R I) and control (green diagonal hatching) show that 6.6% of the cells were apoptotic. 
B: Ungated FSC/SSC plot of the PEC cells. Although no cell phenotyping was carried 
out, the size and granularity of the cells indicate that un-purified PECs consist of 
macrophages, monocytes and lymphocytes. C: Applying the RI gate (i. e. Pl cells) to the 
FSC/SSC plot demonstrates that the apoptotic cells cannot be assigned to a particular cell 
type. 
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3.4 Discussion 
3.4.1: ESP and the Innate Immune System 
When eggs are first deposited in an infection and ESP production begins for the first time 
any immediate response from the host will be via its innate immune system. In order to 
establish whether ESP is capable of inducing innate immune responses in vitro experiments 
were carried out in which splenocytes and macrophages from nave mice were stimulated 
with ESP. These cell-types were chosen because T cells have been implicated in the 
process of egg escape from the host and macrophages are the most abundant APCs in the 
granuloma (see Section 3.1.1). 
A radioactive-thymidine incorporation assay demonstrated that naive splenocytes did not 
proliferate in response to ESP. The splenocytes will have consisted of naive T cells, B cells 
and macrophages, although the macrophage population will include cells involved in the 
phagocytosis of old erythrocytes and so could be considered to be "activated". The situation 
in vivo when ESP is initially produced will be slightly different however, because (as 
discussed in Chapter 2, Section 2.4.9) two of the ESPs (ESP 13-14 and its associate ESP18- 
19) are also secreted by lung worms. The host may therefore have already become 
sensitised to these proteins before egg production commences, but as the lungs are 
physically remote from egg deposition sites the number of T cells reactive to these ESPs in 
the plasma surrounding the egg may be fairly low. There are also glycan epitopes on ESP 
1-2, ESP 3-6 and ESP 12 that are cross-reactive in terms of antibody-binding with those 
from cercariae (Jang-Lee et al., 2007; Eberl et al., 2001b). However, for a cross-reactive 
glycan to bind to aT cell receptor, the peptide backbone in the MHC cleft will need to be 
cross-reactive, as well as the glycan residue itself. Also, a cross-reactive glycan would need 
to be attached to an amino acid pointing away from the MHC if it were to interact with the 
T cell receptor. 
Flow cytometry was used to demonstrate that ESP did not up-regulate MHCII on naive 
macrophages, either in terms of the percentage of MHCII+ve cells or number of MHCII 
molecules expressed on the MHC1I+ve population of cells. These results are consistent with 
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a previous study (Trottein et al., 2004), where transcripts encoding MHCII were not 
increased in DCs stimulated with live eggs. However, the Trottein et al. study did find up- 
regulated transcription of H-2M (which is involved in loading peptides onto MHCII) and 
the co-stimulatory molecules CD40 and ICAM-1. It is therefore possible that the 
macrophage-ESP incubations were not carried out for a sufficient length of time for MHCII 
up-regulation to become evident, or that the macrophages had already been induced to up- 
regulate their MHCII expression by the thioglycollate used to elicit them into the peritoneal 
cavity. The latter explanation would account for why MHCII expression was similar in the 
experimental assays and the negative control. It would also explain why the expression 
levels were approximately 10% higher than those found on naive (alveolar) macrophages 
obtained without the use of thioglycollate (Fulton et al., 2004). 
The other assessment of macrophage activation (IL-6 secretion) produced a positive result 
in that macrophages secreted IL-6 when cultured with ESP, provided IFN-y was present in 
the culture medium. The lack of measurable IL-6 in cultures without IFN-y was also found 
by Trottein et al., (2004) when they cultured DCs with live eggs. The quantity of IL-6 
produced (0.1ng/ml at 40µg ESP/ml) is broadly consistent with the results of a study 
involving Trichinella spiralis, in which five times the number of naive rat peritoneal 
macrophages were cultured with 2.5 times the quantity of parasite secretions to produce 
1.2ng of IL-6 (Gruden-Movsesijan & Milosavljevic Lj, 2006). In contrast to the ESP 
assays, IL-6 was not produced when the macrophages were cultured with SEA, even in the 
presence of IFN-y. The IL-6-negative response to SEA is consistent with an experiment in 
which DCs were cultured with SEA but without IFN-y (van Liempt et al., 2007). In another 
study culturing DCs with SEA, again without IFN-y (MacDonald et al., 2001), no IL-4, IL- 
10 or IL-12 was produced (IL-6 was not measured) and nor were the co-stimulatory 
molecules CD80, CD86, CD54, CD40 or OX-40L up-regulated (although a small amount 
of MHCII up-regulation was seen). 
Taken together, these results show that ESP (a substitute for the live egg) induces a 
response from (naive) macrophages, which are the principal APCs of the granuloma. This 
response is not induced by SEA (a substitute for the dead egg). However, the amount of 
activation is low in its extent and difficult to observe - there was no up-regulation of 
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MHCII and what IL-6 production did occur (the extent of which is dwarfed by the positive 
control) could only be induced when the macrophages have the additional stimulation of 
IFN-y. The combination of lack of MHCII up-regulation but cytokine secretion suggests 
that ESP is probably binding to the macrophage's Pattern Recognition receptors (PRRs). 
PRRs are expressed on APCs and bind to conserved molecules (called pathogen-associated 
molecular patterns) which are commonly produced by micro-organisms but not by higher 
eukaryotes. The PRRs form part of the innate immune system and activate the APC upon 
ligation, inducing the secretion of cytokines and up-regulated expression of MHC and co- 
stimulatory molecules (Janeway & Medzhitov, 2002). ESP must contain a motif that is 
recognised by the PRR system on macrophages, but the lack of observable MHC up- 
regulation and the requirement for IFN-y to induce measurable IL-6 production indicates 
that the interaction is fairly weak, that the PRR(s) involved have a signalling pathway that 
is not particularly powerful or that the end product of the PRR pathway was not MHCII or 
IL-6 expression. 
The most studied PRRs are the family of Toll-like receptors (TLRs), which are generally 
associated with inducing a pro-inflammatory Th-1 response (Akira & Takeda, 2004). As 
egg deposition is associated with the switching of the response from Th-1 towards Th-2 it is 
logical that the PRRs activated by ESP are members of a different, more Th-2-inducing 
family. However, when DCs were cultured with live eggs it was transcripts for Th-1 
cytokines that Trottein et al., (2004) found up-regulated. Subsequent work from the same 
group, also using live eggs, found signalling occurring via TLR2, TLR3 and the TLR 
adapter molecule MyD88 (Aksoy et al., 2005). It is possible, however, that the TLR 
signalling Aksoy et al. observed was actually a response to contamination because the 
ligands for TLR-2 and TLR-3 are bacterial lipopeptides and dsRNA respectively (Takeda & 
Akira, 2004). A more likely ESP-recognising PRR is the C-type lectin (CTL) called 
"dendritic-cell-specific intercellular adhesion molecule 3-grabbing nonintegrin" (DC- 
SIGN), which recognises SEA components with the Lexis x motif (van Die et al., 2003). 
As Lewis x is also present in ESP3-6 (Jang-Lee et al., 2007; Wuhrer et al., 2006) a link 
between antigen and APC can be made. Although its name implies it is DC-specific, DC- 
SIGN has been found on macrophages from the lungs, placenta and inflammatory lesions 
and its expression can be induced in monocyte-derived macrophages by IL-13 
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(Rappocciolo et al., 2006; Soilleux et al., 2002), so peritoneal macrophages may also 
express the molecule or one of similar antigen specificity. 
3.4.2: ESP and the adaptive immune system 
Lymphocytes from acutely infected mice responded to both ESP and SEA by proliferating 
in a dose-dependent manner, with the exception of the assay at 80µg ESP/ml where the 
proliferation was less than that seen at 40µg ESP/ml. The lower proliferation at 80µg 
ESP/ml is likely to be because this quantity of ESP induced a more rapid and powerful 
response such that the cell proliferation had peaked and undergone a contraction phase, 
leaving behind dead and apoptotic cells that were too small to be retained on the cell 
harvesting plate. Reducing the incubation time might prevent this from occurring. The 
proliferation index values to the Con A positive control were not excessive compared with 
previous studies, the most comparable of which is a study where double the quantity of Con 
A was used to stimulate the same number of lymphocytes for the same period of time to 
induce a proliferation index of 92, measured using the same 3H-thymidine-incorporation 
assay (Lijnen et al., 1997). The high proliferative response of mesenteric lymph node cells 
to ESP compared to SEA demonstrated that a greater proportion of the T and/or B cells 
were responding to ESP than to SEA. ESP is a subset of SEA however (2.5% of mature 
SEA consists of ESP - see Chapter 2, Table 2.5), so an unknown proportion of the response 
to SEA will have been to ESP antigens. It can therefore be seen that although ESP is a 
small subset of SEA, lymphocytes from the mesenteric lymph nodes found it to be more 
antigenic than SEA. This may be because relatively few eggs had disintegrated in the gut 
wall so fewer lymphocytes were present to recognise SEA components, or it could be that 
SEA contains factors capable of down-modulating the immune response. If the latter were 
to be the case, it is possible that the down-modulation seen at chronic infection is induced 
by the build-up disintegrating eggs in the liver which release SEA. ' 
3.4.3: Proteases and ESP 
The egg must pass through the tissues of the gut wall to escape from the host. The proteases 
involved in degrading the tissue to achieve this could either be secreted by the egg itself, by 
the cells of the granuloma or by a combination of both. It was established by Ashton (2001) 
that ESP contains two proteases, and the egg proteome study of Chapter 2 has shown that 
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ESP 13-14 has a subtilase pro-protein convertase functional domain (Section 2.4.9). 
Experiments were therefore carried out with the aim of establishing whether ESP induces 
macrophages to secrete proteases or pro-proteases that could be activated by ESP13-14. 
Two completely different patterns emerged: the culture supernatants of macrophages 
incubated with ESP showed protease activity that was ESP-dose-dependent (but with very 
low activity compared to the trypsin standards) but the protease activity of crude ESP was 
inversely ESP-dose-dependent. The unexpected result in the crude ESP assays cannot be 
attributed to the absorbance spectrum of ESP because even at 160µg ESP/ml less than 10% 
of light at the excitation and emission wavelengths of the fluorophor is absorbed. The most 
likely explanation is that an ESP binds to the fluorophor and absorbs energy from it by 
FRET, a phenomenon expressed as a dose-dependent reduction in fluorescence. The 
binding must be to the fluorophor itself rather than to the casein substrate because at 
concentrations above 40µg ESP/ml, the amount of fluorescence is less than that seen in the 
negative control (when no proteolysis can be happening). The most likely fluorophor- 
binding candidate is ESP3-6, because this ESP is capable of binding to eosinophils 
(Schramm et al., 2003; Smith et al., 2005), chemokines (Smith et al., 2005) and to other 
ESPs (see the following Addendum). The reason why ESP3-6 has such universal binding 
characteristics may be because of its high pI, which means it would have a positive charge 
in solutions of pH < 9. It is clear however that ESP does have proteolytic activity because 
at concentrations below 20Vg/ml there is an increase in fluorescence compared with the 
negative control. The concentration of proteases was higher in crude ESP than that found in 
the culture supernatants of macrophages incubated with ESP, because even at 1.25µg 
ESP/ml, crude ESP had more proteolytic activity than any of the macrophage assays. The 
low amount of protease activity from the macrophage assays might have been influenced 
by the extent of cell death that occurred during the course of the incubation (40-50% of the 
macrophages were apoptotic or necrotic after the incubation, regardless of the antigen used 
or mouse from which they had been derived). It is not known whether the proteases in the 
macrophage supernatants were from residual ESPs or whether they had been secreted by 
the macrophages themselves. It would be necessary to submit the supernatants to MSMS in 
order to establish whether the proteases therein were of murine-macrophage or schistosome 
origin. 
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The experiments conducted in this chapter demonstrate that ESP does not induce naive 
macrophages to secrete significant quantities of proteases. It is possible that at the acute or 
chronic stage of infection macrophages would be maturing in a more stimulatory 
environment and this would induce them to be more reactive in terms of protease secretion. 
However, it is also possible that in fact CD4+ cells secrete the proteases that enable eggs to 
cross the gut wall. This would be consistent with the work of Doenhoff et al., (described in 
Chapter 1, Section 1.2.5) in which mice lacking T cells had impaired ability to excrete S. 
mansoni eggs. 
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Addendum to Chapter 3: Purification of ESP components using HPLC 
3.5: Introduction 
Crude ESP comprises 27 spots in a 2D gel, with the proteins having little homology to any 
other proteins of known function (Chapter 2, Section 2.3.4.3). Although the functional 
assays described in Chapter 3 went some way towards assigning functional characteristics 
to ESP as a whole, a method of fractionating ESP into its components was anticipated to be 
required if specific properties were to be attributed to individual ESPs. It was anticipated 
that by repeating the functional assays with individual ESPs rather than with the crude 
protein mixture a picture might emerge as to which ESPs were responsible for particular 
functional properties. It was with this aim in mind that the work of this Addendum was 
carried out. HPLC was the obvious method by which to carry out the fractionation because 
it can do so without altering the functional properties of the proteins. 
The work of this Addendum is the first attempt at fractionating crude ESP, but Schramm et 
al., (2003) had used HPLC to enrich for IPSE (aka ESP3-6), but with SEA as the source 
material. The paper describes using a cation exchange column to obtain an IPSE-enriched 
SEA fraction and then using lectin affinity chromatography to remove the IPSE from the 
other SEA components. The lectin that was used had been derived from Aleuria aurantia 
(Orange Peel Fungus) and is commercially available already bound to agarose beads. The 
authors abbreviated "agarose-bound Aleuria aurantia lectin" to "AAA". 
The protocol that was devised to purify ESP components is complex and involves up to five 
dimensions. The dimensions are described in their order (AAA-affinity -º AAA-affinity -º 
anion exchange ---* cation exchange --+ size exclusion) and a flow chart is provided, 
showing which ESPs were purified during each dimension (Figure 3.8, page 146). There is 
also a Table that lists each ESP and details the protocol that can be used to purify it (Table 
3.1, page 158). The success of each dimension and the logic used to decide on the 
following dimension are explained in the Results section. 
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3.6: Methods 
All HPLC was conducted on an AKTA10 purifier system (Pharmacia) at room temperature. 
3.6.1: Dimensions 1 and 2: Lectin-Affinity Chromatography 
An empty 1.25m1 HIS Select column (Sigma) was filled with AAA (Vector Laboratories). 
Dimension 1: 1mg crude ESP (approx. 800gl) was applied to the column at 0.2ml/min in 
PBS, pH7.2, then equilibrated with 2 column-volumes (cv) PBS and eluted over 10cv with 
a 0-100% continuous gradient of 100mM L-fucose (Sigma) in PBS. Fractions were 
collected in 0.5ml aliquots. 1001i1 of the protein-containing eluate (pooled fractions) and 
effluent were dialysed into 20mM Tris HCl pH7.2 using Slide-A-Lyzer mini dialysis units 
(Pierce), concentrated to 35gl with an Amicon Ultrafree centrifugal concentrator 
(Millipore), reduced and subjected to 2-DE using a 7cm, pH 3- 10 IEF strip (Bio-Rad) and 
7cm NuPAGE 4-12% Bis-Tris gel (Invitrogen) as described in Chapter 2 (Section 2.2.9.2). 
The gels were stained with Sypro Ruby (Bio-Rad), then Biosafe Coomassie (Bio-Rad), the 
visible spots excised and subjected to MALDI-MSMS, using the protocols described in 
Chapter 2 (Sections 2.2.10 and 2.2.11). 
Dimension 2: the remaining effluent (3ml) was then re-applied to the column in PBS, 
equilibrated with 7cv and eluted with a single step-gradient of 50mM L-fucose in PBS. 
200pl of effluent was separated by 2-DE and analysed by MALDI-MSMS (as described 
above). 40µl of eluate was concentrated, separated by 1-DE in a NuPAGE 4-12% Bis Tris 
gel (Invitrogen) using the protocol described in Chapter 2, Section 2.2.8.2 (except no 
reducing agent was added). The gel was then stained with Sypro Ruby. 
3.6.2: Dimension 3: Anion Exchange Chromatography 
The fractions containing the effluent from Dimension 2 were pooled (4m1) then applied to a 
Mono Q HR 5/5 (1ml) column (Pharmacia) with 8ml of 20mM Tris HCl pH7.5 at 
0.75ml/min. The column was equilibrated with 5cv, the effluent collected and the bound 
proteins eluted with a 0-100% gradient over 20cv with 20mM Tris plus IM NaCl, adjusted 
to pH 7.5 with 5M HCl. The eluate was collected in 0.5m1 fractions and pooled according 
143 
to the chromatogram peaks. 6Oµl of each aliquot was concentrated to 20µl using Amicon 
Ultrafree centrifugal concentrators and separated by 1-DE without reducing agent in a 
NuPAGE 10% Bis Tris gel (Invitrogen) using the same protocol as before. The gel was 
stained with Sypro Ruby and then with Silver (the MS-compatible protocol described in the 
PlusOne Silver Staining Kit (Amersham)). Both methods of staining were used because it 
was found that some protein bands were more sensitive to Sypro Ruby whilst others were 
more amenable to silver staining. The bands were excised, de-stained and subjected to 
MALDI-MSMS (as described in Chapter 2, Sections 2.2.10 and 2.2.11). 
3.6.3: Dimension 4: Cation Exchange Chromatography 
The fractions containing the effluent from the anion exchange column (Dimension 3) were 
pooled and subjected to three regimens of buffer exchange with 20mM sodium phosphate 
(8% Na2HP04,92% NaH2PO4) plus 25mM NaCI and adjusted to pH 5.8 (5M NaOH) using 
a 6m1,5kDa-cutoff Vivaspin centrifugal concentrator (Sartorius). The protein (6ml) was 
then applied to a Mono S HR 5/5 (Iml) column at 0.8m1/min with 12m1 of 20mM sodium 
phosphate buffer plus 25mM NaCI pH5.8 and the effluent collected. After equilibration 
(5cv), proteins were eluted with a 0-100% gradient of 20mM sodium phosphate buffer plus 
800mM NaCI pH5.8, over 20cv. The eluate was collected in 0.5m1 fractions, pooled 
according to the chromatogram peaks, concentrated then subjected to 1-DE followed by 
MALDI-MSMS using the same protocol described in Section 3.6.2 (except a 4-12% Bis 
Tris gel was used). 
3.6.4: Dimension 5: Size-Exclusion Chromatography 
Fractions from the cation exchange column containing more than one protein were applied 
to a Superdex HiLoad 75 HR 16x60 size-exclusion column (Pharmacia) at 0.2m1/min in 
100mM NaCI plus 25mM Tris, pH 7.2. The size-exclusion fractions were collected in Iml 
aliquots, pooled according to the chromatogram peaks concentrated to approx. 2511l initially 
with a 20m1 Vivaspin polyethersulphone centrifuge concentrator (Sartorius) and then with a 
4O0µ1 Amicon Ultrafree centrifugal concentrator (Millipore). The concentrate was 
separated by 1-DE, stained with Sypro Ruby and silver and the bands analysed by MALDI- 
MSMS as described above. 
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3.7: Results 
Several attempts were made to devise an effective protocol for purifying ESP components 
by HPLC, the most effective of which is illustrated in Figure 3.8. It was found to be 
absolutely imperative that ESP3-6 was removed from crude ESP in the first step. A failure 
to do so resulted in ESP3-6 appearing in all of the protein-containing fractions, regardless 
of whether ion exchange or size-exclusion steps were used. For example, the ubiquitous 
presence of ESP3-6 in almost all fractions after crude ESP was applied to a size-exclusion 
column is shown in Figure 3.9. 
3.7.1: Dimensions 1&2: Lectin-Affinity Chromatography 
Crude ESP was applied to the AAA column in Dimension 1 to remove (and hopefully 
purify) the ESP3-6. When the column-bound material was eluted with a linear gradient of 
L-fucose, subjected to 2-DE and then MALDI-MSMS it was seen that ESP3-6 had been 
purified in the eluate, along with some of the ESP 1-2 and ESP 12 (Figure 3.10). The 
effluent contained most of the ESP 1-2 and ESP 12 along with all the other ESPs. A shoulder 
can be seen on the chromatogram (illustrated by a black arrow in Figure 3.1 OA) indicating 
that the minority components (ESP1-2 and/or ESP12) bound to the column at a lower 
affinity than ESP3-6 did. As ESP3-6 makes up >80% of crude ESP in terms of protein 
quantity (see Chapter 2, Section 2.3.4.3) the eluate will contain more protein than the 
effluent, but this wasn't reflected in the 280nm trace. This is probably because light at 
280nm is principally absorbed by tryptophan, of which there are only two residues in 
ESP3-6. When the effluent (containing all the ESPs except ESP3-6) was re-applied to the 
AAA column all of the remaining ESP 1-2 became purified in the eluate and none was in 
the effluent (Figure 3.11). ESP12 (a small quantity of which was in eluate in the first 
chromatography run) was untraceable in the eluate of the second run: no proteins of l OkDa 
could be seen following 1-DE (Figure 3.11C). 
145 
1st 2 na 3' 4 m 5m 
dim dim dim dim dim 
S 
. . . . . . . . . . 
. . . . . . 13 . 1 . . . 9 
8 9: m 10 
g 
9 I S 
8 
S 
I I 101 ºx n 
m 
9 I (ý S 10 I . 9 
. 
I 
. 
I 
1 
12 I c 
10 11 
> ' 10 ' cý ' 
sn 10 
11 aý 
12 11 w 
12 
13 
12 I 1 12 Crude ' 
-; ýº 13 -º 
14 ' º 15 -'-º CD 
I 
17, ESP 14 15 x ý- 17 ' 18 CD 
0 
" 
18 
" =r I 19 
S 
\ 
7 18 19 c° 
8 19 20 ý 
m . 
9 ' 
20 
0 
: 
21 
1 
\ 
I 11 \ 
21 
S 
Figure 3.8 Diagrammatic illustration of the purification protocol that was 
devised to fractionate crude ESP, using up to five dimensions of HPLC. The 
circled ESPs have been purified whilst those that remain inside an ellipse have 
not. 
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Figure 3.9 Separating crude ESP using size-exclusion chromatography A: When applied 
to a Superdex column, crude ESP separates into seven peaks. The peaks at 45-55 mins and 
95-110 mins have distinct shoulders, indicating more than one protein is present. B: 1-DE 
(no reducing agent) was used to visualise the protein content of the chromatogram peaks 
as indicated. ESP3-6 was present in all of the fractions. The left hand gel was stained with 
silver and the right hand gel with Sypro Ruby. Although the OD280nm trace indicated 
peaks at 115 and 120 mins, no protein was detectible on the gel. 
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Figure 3.10 Separation of Crude ESP. A: Aleuria aurantia lectin affinity chromatogram. 
Img crude ESP was applied to an AAA column in PBS and eluted with 0-100% gradient of 
100mM L-fucose. The indicated fractions were pooled, subjected to 2-DE and the resulting 
spots analysed by MALDI-MSMS. The black arrow denotes the shoulder as discussed in the 
text. B: All the ESPs except ESP3-6 were present in the effluent, including ESP] -2 (a) and 
ESP 12 (b). C: The eluate contained ESP3-6 (c), but also ESP 1-2 (d) and ESP 12 (e). Some of 
the ESP3-6 failed absorb into the IEF strip so it did not focus (f). 
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3.7.2: Dimension 3: Anion Exchange Chromatography at pH7.0 
2-DE of the effluent from the second regimen of AAA chromatography (Figure 3.1113) 
showed that the protein mixture could be broadly grouped into acidic proteins of pI<5 
(ESPs 13-21) and basic proteins ofpl>8 (ESPs 8-12). Anion exchange at pH7.5 was 
therefore undertaken to separate the basic proteins as effluent and then purify the individual 
acidic proteins in eluate fractions (Figure 3.12). The OD280nm trace indicated that the 
eluate and effluent contained similar quantities of protein. The linear NaCI gradient eluted 
the bound proteins as four distinct peaks, the first of which (i. e. the least acidic) contained 
multiple components. The third peak had a distinct shoulder so it contained at least two 
components. When the eluate fractions were separated by 1-DE, only the content of the first 
peak could be visualised after staining (although the OD280nm trace indicated that there 
were broadly similar quantities of protein in each peak), but the bands contained 
insufficient protein to be identified by MS or MSMS. The fractionated ESPs were therefore 
identified by matching the chromatogram peaks (representing proteins eluted in order of 
charge) with the spots on the 2D gel. It could thereby be seen that the first eluate peak 
(eluted between 20 and 25 mins) was probably a series of 20kDa proteins too low in 
abundance to stain in the 2D gel, followed by ESP13. The second peak (eluted at 30 mins. ) 
probably represented ESP14, which was the most intensely-stained gel-spot that bound to 
the column so should have generated the most prominent peak in the chromatogram. The 
shoulder of the third peak probably represented ESPs 17 and 20, and the peak's apex ESPs 
15,18 and 19 (all of which have the same pl). The final peak, eluted after 40 mins was 
probably ESP21 (the most acidic ESP). Thus, the anion exchange step can be seen to have 
completely purified ESP 13, ESP 14 and ESP21. The acidic ESPs 15,17,18,19 and 20 
remain un-separated (there is no ESP16) and the effluent will contain the basic ESPs 8-12. 
3.7.3 Dimension 4: Cation Exchange Chromatography at pH5.8 
The effluent from the anion exchange step (containing ESPs 8-12, whose p1>7.5) was 
applied to the cation exchange column at pH5.8 (Figure 3.13). All of the material should 
have bound to the column, so it was surprising to find effluent containing proteins that 
resolved themselves into bands at 10,20 and 25kDa after 1-DE. However, the quantity of 
protein in the effluent of the anion exchange was relatively small compared to that seen in 
the effluent of the cation exchange step (50mAU as opposed to 120mAU). 
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Figure 3.12 Anion exchange at pH7.5 
of the effluent from Figure 3.11. A: 
Horizontally-flipped reproduction of 
Figure 3.11 B, showing the protein 
mixture that was applied to the column. 
B: Proteins were eluted from the 
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Figure 3.13 Cation exchange at pH5.8 of effluent from Figure 3.10. A: Reproduction of 
Figure 3.1 OB. The protein mixture applied to the column should consist of the proteins of 
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Unfortunately, the gel-bands contained insufficient protein to be identified by MS or 
MSMS, so identification of the purified ESPs had to be carried out as in the anion 
exchange step (by matching chromatogram peaks to 2D gel-spots). ESP11 had probably 
been purified successfully and could be seen as the first protein to be eluted in Figure 3.13C 
(lane ii). ESPs 9 and 10 probably eluted together in the second peak, 26 mins into the run 
(lanes iii and iv), the right shoulder of which probably consisted of ESP 9 (lane iv). 
However, another protein of approx. 25kDa was also present in both fractions. The most 
intense peak (200mAU) contained the most basic ESPs, including the 5kDa ESP12. This 
fraction also contained more heavily-staining proteins of 25 and 30kDa, the latter of which 
was probably ESP1-2, which had been insufficiently abundant to have been visible in the 
2D gel in Figure 3.11B. 
3.7.4: Dimension 5: Size Exclusion Chromatography 
The cation exchange fractions containing more than one protein can be seen in Figure 
3.13C, lanes i, iii, iv, v and vi. The differences in molecular mass between these ESPs make 
them potentially amenable to purification using size exclusion chromatography. The 
fractions from lanes iii and iv, each containing ESPs 9 and 10 plus the unknown 25kD 
protein were pooled, and so four size exclusion runs were carried out. The size exclusion 
run containing ESP8 plus the 25kda fraction (Figure 3.13C, lane vi) failed because the 
combination of the small quantity of protein that was applied to the column and the diluting 
nature of the technique resulted in only one peak appearing in the chromatogram (which 
emerged from the column at a point consistent with (the IOkDa) ESP8 rather than the 
25kDa component. However, when the fractions from this peak were concentrated and 
applied to a 1D gel there was insufficient protein to stain. The remaining size exclusion 
runs are shown as Figure 3.14 (the unexpected effluent from the cation exchange 
separation), Fig. 3.15 (ESP9, ESP 10 plus the unknown 25kDa protein) and Figure 3.16 
(ESP12, plus ESP1-2 plus the unknown 27kDa protein). 
The effluent from the cation exchange column (Figure 3.14) resolved into three peaks. The 
largest peak (30mAU) emerged from the column after 350 mins and contained a single 
protein of approx. l8kDa. This was subsequently identified as Sm 11845 by MSMS (i. e. an 
ESP13-14 homologue). 
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The second peak contained three proteins of 20,10 and 8kDa, the latter two which were 
identified by MSMS as thioredoxin and ubiquitin respectively. The resolution of the 
column was sufficient to separate proteins of 8-1OkDa from proteins of 20kDa, so the most 
likely explanation as to why the proteins appeared together was either that they formed a 
complex or that they bound to the column medium in some way. The time-point at which 
the peak occurred in the chromatogram (420 mins) is consistent with the proteins of approx. 
25kDa in Figure 3.15, but as the l8kDa protein was eluted at 370 mins in Fig. 3.14 the two 
chromatograms are not comparable in terms of elution times vs. protein size. 
Applying the pooled fractions from lanes iii and iv of Figure 3.13C (i. e. ESP9, ESP10 and 
the unknown 25kDa protein) to the size exclusion column produced a chromatogram with 
three peaks, the last two of which failed to completely resolve (Figure 3.15). Unfortunately, 
none of the peaks contained sufficient protein to stain after 1-DE, but the peak at 420mins 
was probably the 25kDa component and the second peak at 500-550 mins was probably 
ESP9 and ESP10. ESP10 consists of two isoforms with slightly different molecular mass 
but not charge (ESP I Ob has the same mass as ESP9 and ESP 1 Oa is slightly larger). It is 
therefore likely that ESP9 cannot be separated from ESP10, although the second peak in the 
chromatogram was probably enriched in ESP 1 Oa. 
The largest and most basic peak in the cation exchange chromatogram (Figure 3.13C, lane 
v) contained proteins of 5kDa (ESP 12), 25kDa (an unknown protein) and 30kDa (probably 
ESP1-2). When applied to the gel filtration column a relatively large quantity of protein 
was recovered at 350mins and a smaller quantity at 520mins (Figure 3.16). 1-DE 
demonstrated that the first peak contained the 25 and 30kDa components, plus a further 
60kDa protein. The second peak contained insufficient protein to stain, but it most likely to 
be the 5kDa ESP12. MSMS was used to identify the 25kDa protein as Sm00193 (an ESP15 
homologue) and the 30kda protein as ESP1-2. 
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Figure 3.14 Size exclusion chromatography of Fraction i from Figure 3.130. 
A: Reproduction of Fig 3.5C lane i, showing the proteins of approx. 12,20 and 
25kDa applied to the column. B: The three bands of A separate into three peaks 
when applied to the column. C: 1-DE of each of the three peaks from B shows that 
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Figure 3.16 Size exclusion chromatography of Fraction v from Figure 3.13C. 
A: Reproduction of Figure 3.13C, lane v, showing that proteins of approx. 30,28 
and 5 kDa were applied to the column. B: The three bands from A separate into 
two peaks, the largest of which has a shoulder suggesting it contains two 
components. C: I -DE of the two peaks shows that the largest peak contains the 
30kDa and 28kDa components and a further 60kDa protein has also been purified. 
The small peak contained insufficient protein to stain in 1-DE but is presumably 
the 5kDa protein. The proteins were identified by MALDI-MSMS as ESP 1-2 (a) 
and ESP 11/15 (b). 
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Table 3.1 A summary of the protocol devised to purify individual ESPs using HPLC. 
ESP 
no 
Purifiable? 
1" Dim. 
AAA 
2nd Dim. 
AAA 
3rd Dim. 
Anion 
exchange 
4`h Dim. 
Cation 
exchange 
5`h Dim. 
Size 
exclusion 
Notes 
1-2 yes effluent and eluate eluate 
I 
3-6 yes effluent 2 
8 no effluent effluent effluent eluate 3 
9 no effluent effluent effluent eluate 
Can't 
separate 
from 
ESPIOb 
10 partially effluent effluent effluent eluate 
ESP10a 
purified 
11 yes effluent effluent effluent eluate 
13 yes effluent effluent eluate 
12 yes effluent and eluate effluent effluent eluate 
purified 
13 yes effluent effluent eluate 
14 yes effluent effluent eluate 
15 no effluent effluent eluate 4 
17 no effluent effluent eluate 5 
18 no effluent effluent eluate 5 
19 no effluent effluent eluate 5 
20 no effluent effluent eluate 5 
21 yes effluent effluent eluate 
22 no unknown unknown unknown unknown unknown 6 
Notes 
1. Increasing the ionic strength of the buffer in Dimension 1 should retain all the ESP1-2 in 
effluent. 
2. The ionic strength of the buffer should be reduced for Dimension 2 to allow binding to the 
column. 
3. ESP8 is can probably be purified during size exclusion dimension. 
4. ESP15 likely to be purified by applying eluate from anion exchange to size exclusion 
column. 
5. Improvement of resolution should be possible by reducing the pH of the buffers and the rate 
of increase of the elution buffer concentration after 30 mins. 
6. ESP22 was not found. It should be capable of purification by applying the ESP13 fraction 
to the size exclusion column. 
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they are 95% homologous at the amino acid level (BLAST expect score of 2.9e- 
43). 
159 
Original in colour 
A 
pH3 pH10 
20 
18 1714 
4 
13 
w 
I. 
B 
250 
150 
100 
75 
O/ 50 
1 37 
25 
op* 20 
+º : 15 
"s 10kDa 
Mý R 
5211'_ 15 Sý. 'RTIT iFýLý, Iß'. LFTýt. I ILIISL`iSFIrFIý, KEIRAERE: F.! 3_EýPi2iEY', ZRY: 
Sm12949 ----SII iRL', ELF', 'ALZLIISL35Fý^, 'FTAREI---kQEý. R3" ýý ü1EYVlRYCýG 
. ýr}}Ir lr lrlAik*! lý1r 1rM*lf AfrklriºkM }! . }f . fM i. i! r*Ailrf iký 
Sr11845 LC'SSPiI2-FKIFYZYL2CS iPi:, SI Z_F2F! C-LFFC'rIiLRVk^LIEEId RtiDCRVIS3 ELM 
Srn12949 LýSGSI; -FkIFYCYLýýSitiAS2diýFýF! ýLFi! 'ýIdýSFkLIESSCwtI2ýSR; ýI3FELýý 
*******************!! "***********f*******ºif}i**f 
Sm11245 ýVýGýId3ýýSFFLýLiIiýýuE iFREYERGYLKýFýFýýY N. EýR 
Sm12949 I', 'Lýý21ýý SFFI: L NO ýkýI1S---SýNFýEýFrII{'ýYEN : vR 
Figure 3.18 The related Sm 11845 and Sm 12949 genes. A: Sm 11834 (ESPs 
13,14 & 17 arrowed in green) and Sm 12949 (ESPs 18 & 20 arrowed in pink) 
form a series of spots of similar size but slightly different p1 following 2-DE. B: 
Clustal W alignment of Sm 11845 and Sm 12949. The two genes are 74% 
homologous at the amino acid level (BLAST Expect score of 1.4e-66). The 
genes are located adjacent to each other on the contig, but are transcribed in 
opposite directions. 
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Figure 3.19 The ESP15 proteins. A: 2-DE of ESP3-6-deprived ESP with 
ESP15 isoforms arrowed in pink. B: In addition to the ESP15 variant found in A 
(Sm00193) the S. mansoni genome also contains a putative gene with significant 
homology to it. Although Smp_180310 was not identified by MSMS, it has 75% 
homology to Sm00193 at the amino acid level (BLAST expect score of 1.3e- 
17). 
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3.8: Discussion 
The purification of individual ESP components proved to be a lengthy and difficult exercise 
which was only partially successful. Various combinations of ion exchange and gel 
filtration protocols were initially attempted but they consistently failed because protein 
complexes formed that were too robust to be disassociated. Specifically, ESP3-6 appeared 
in almost all protein-containing fractions when crude ESP was applied to a cation 
exchange, anion exchange or size-exclusion column. However, by removing ESP3-6 using 
the AAA lectin affinity column in the first step an HPLC regimen was devised that can be 
used in the future to isolate specific ESPs (see Table 3.1). The limiting factor in developing 
the protocol was the low quantity of crude ESP which was available because many of the 
less abundant ESPs were lost entirely. 
The first two separation steps using the AAA column purified ESPs1-2,3-6 and ESP12, so 
these proteins must be glycosylated. ESP12 had already been shown to be a (smaller) 
isoform of ESP 1-2 in Chapter 2 (Section 2.3.4.3), but the binding of ESP 12 to the AAA 
column demonstrates that the larger size of ESP1-2 cannot be attributed to glycosylation 
alone. ESP3-6 has more affinity to AAA than ESP1-2 (because no ESP1-2 was present in 
the eluate in the first AAA regimen when the column was overloaded), so either ESP3-6 is 
more heavily glycosylated than ESP1-2 or its glycans have more affinity to A. aurantia 
lectin. 
Thioredoxin was purified in the size exclusion regimen but it has previously been 
demonstrated by Western Blotting to be found in S. mansoni egg culture supernatant (Alger 
et al., 2002). The authors proposed that the thioredoxin protects the egg by detoxifying the 
hydrogen peroxide produced by the cells of the granuloma. However, it is likely that the 
thioredoxin present amongst the actively-secreted ESPs is actually derived from damaged 
eggs. Thioredoxin is a small (approx l2kDa) and it makes up over 4% of hatch fluid protein 
(see Chapter 2, Section 2.4.4), so it is easy to see how a small tear in the envelope would 
result in its escaping to the external environment. If the thioredoxin does'have a protective 
role then it is more likely to be effective when it is concentrated between the envelope and 
the miracidium, rather than dissipated into the granuloma. Also, when in the egg the 
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the miracidium, rather than dissipated into the granuloma. Also, when in the egg the 
thioredoxin is in close proximity to thioredoxin peroxidase, which is also present in hatch 
fluid and is used to maintain thioredoxin in its reduced state. It is, however, possible that 
thioredoxin is indeed an actively-secreted ESP but its role is not that of an oxidant 
scavenger. Secreted thioredoxin has been described as a chemoattractant for leukocytes 
(Bertini et al., 1999) and when secreted by DCs it contributes to T-cell activation (Angelini 
et al., 2002). The problem with these studies was that the receptors and mechanisms by 
which extracellular thioredoxin operates was unknown. However, it has recently it has been 
reported that extracellular thioredoxin interacts with the TNF receptor CD30 on lymphoid 
cell lines (Schwertassek et al., 2007). CD30 is expressed on activated T cells in response to 
IL-4 and when ligated it induces cell proliferation and cytokine production (Watts, 2005). 
CD30 has also been implicated in the promotion of Th2 responses in humans (Duckett & 
Thompson, 1997). It is therefore possible that egg-secreted thioredoxin is involved in the 
process of granuloma formation, T cell activation and the maintenance of the Th2 bias in 
the immune response that is a characteristic of egg deposition. 
Ubiquitin was identified in the same HPLC fraction which contained thioredoxin. The UPP 
in the S. mansoni egg is the subject of the next chapter and so this finding will be covered at 
that point. 
Another important result of the ESP purification regimen has been the insight into gene 
families which it has provided. Specifically, ESP12 and ESP1-2 are closely related (see 
Figure 3.17). It has also been proven that ESPs 13,14 and 17 are all variants of Sm 11845, 
which itself has 74% homology to ESPs 18 and 20 (see Figure 3.18). ESP15 also has 
different secreted variants (see Figure 3.19). 
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Chapter 4 
The Ubiquitin-Proteasome Pathway 
in the S. mansoni Egg 
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4.1 Introduction 
There are three mechanisms of protein turnover in eukaryotic cells: apoptosis, autophagy 
and the ubiquitin-proteasome pathway (UPP). Apoptosis (the regulated self-destruction of 
cell) and autophagy (where a cell degrades and reuses its cytoplasmic proteins) have been 
described in some detail in Chapter 1 (Section 1.6.1 and 1.6.2). The UPP, which is 
responsible for the controlled intracellular degradation of targeted proteins is the subject of 
this chapter and so has not been described in detail until this point. The UPP uses a 
ubiqüitinylation enzyme cascade which attaches multiple copies of ubiquitin to a protein 
requiring degradation. The degradation is then carried out by the proteasome which is 
located in the cytosol or nucleus. The UPP is responsible for many cellular functions, such 
as protein quality control and regulating the cell cycle and transcription. The UPP is also 
vital for growth and development because in various parasite models (Entamoeba invadens, 
E. histolytica, Leishmania mexicana, Trypanasoma cruzi, T. brucei, Plasmodium berghei, 
Toxoplasma gondii and Schistosoma mansoni), blocking the UPP results in the cessation of 
growth (Makioka et al., 2002; Robertson, 1999; de Diego et al., 2001; Nkemngu et al., 
2002; Gantt et al., 1998; Shaw et al., 2000; Guerra-Sa et al., 2005). 
4.1.1 The Proteasome 
Proteasomes are abundant, non-specific proteolytic machines that are present in eukaryotic 
cells where they make up about 1% of the cellular protein (Tanahashi et al., 2000). 
Proteasomes are comprised of a and ß subunits that assemble as seven-member rings. Four 
of these rings stack together to form a cylinder in the conformation a 1.7, ß 1.7, P 1.7, a 1.7 to 
produce a barrel-like particle of approximately 750kDa (Hegerl et al., 1991; Kopp et al., 
1993; Zwickl et al., 1992). This four-ringed structure, called the 20S proteasome is named 
after its sedimentation coefficient (Tanahashi et al., 2000). The six proteolytic subunits are 
located at the ii', ß2 and ß5 positions with their active sites pointing towards the interior of 
the proteasome, so proteolysis is confined to an internal chamber and the uncontrolled 
degradation of proteins is avoided (Baumeister et al., 1998). The chamber is accessed 
through the hole in the centre of each of the outer a-subunit rings. As the entrance holes are 
only 2nm in diameter, only unfolded proteins can pass through them to enter the proteolytic 
chamber. The entry holes are also gated by projecting N-terminal extensions on the a 
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subunits (Groll et al., 1997). The three proteolytic subunits have different substrate 
specificities: caspase-like (ßl), trypsin-like (ß2) and chymotrypsin-like (05), which together 
degrade most proteins to peptides of 3-22 amino acids in length, depending on their amino 
acid sequence (Orlowski & Wilk, 2000). These post-proteasomal peptides are then further 
degraded into their constituent amino acids by conserved families of endopeptidases, 
aminopeptidases and carboxypeptidases (Chandu & Nandi, 2004). 
The 20S proteasome is only capable of degrading unfolded proteins, so if it was to act alone 
its proteolysis would be restricted to proteins such as 0-casein, phosphorylated casein and 
a- and ß-crystallin (Orlowski & Wilk, 2000). The 20S core therefore associates with a 
900kDa multi-subunit molecule called the 19S regulatory complex (also known as PA700), 
which caps one or both ends of the 20S proteasome. The 19S regulatory complex 
recognises the proteins requiring proteasomal destruction, unwinds them and feeds them 
into the 20S proteasome. The recognition signal which tags a protein for destruction is the 
covalent attachment of a string of ubiquitin molecules. 
Each 19S regulatory complex contains at least 17 subunits with diverse functions. The 
subunits include a ubiquitin ligase, a de-ubiquitinylation enzyme and several ATPases that 
unfold the target protein and interact with the N-terminal extensions of the 20S a-subunits 
to open the entrance to the proteasome core (Pickart & Cohen, 2004). So, the active 
proteasome consists of the 20S proteasome core plus its two 19S regulatory complexes. 
This mega-complex is called the 26S proteasome. Both the 20S proteasome core and the 
19S regulatory subunits also undergo post-translational modifications, including 
phosphorylation, N-acetylation and O-G1cNAc glycosylation (Mason et al., 1998; Rivett et 
al., 2001; Kimura et al., 2000; Sumegi et al., 2003; Zhang et al., 2003). It is not known 
how the post-translational modifications operate to influence proteasomal activity, but they 
are likely to have various regulatory roles. 
Proteasomal degradation of proteins is important in numerous processes in the cell. In 
addition to recycling damaged or mistranslated proteins, the proteasome regulates the cell 
cycle by degrading cyclins (Clurman et al., 1996), controls apoptosis by degrading pro- and 
anti-apoptotic molecules (Friedman & Xue, 2004) and influences transcription by 
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degrading transcription factors, transcription factor inhibitors and RNA polymerases 
(Muratani & Tansey, 2003). 
4.1.2 Ubiquitin 
Ubiquitin is an 8.5kDa protein of 76 amino acids, best known for its role in tagging 
misfolded proteins for proteasomal degradation. The process of conjugating ubiquitin to its 
target protein (illustrated in Figure 4.1 overleaf) is a multi-step process involving three 
enzymes. Firstly, a ubiquitin molecule is activated by an enzyme called E1, which uses 
ATP to catalyse the formation of an intermediate thioester bond between the C-terminus of 
ubiquitin and a cysteine on E1. The ubiquitin-E1 complex then binds to a ubiquitin- 
conjugating enzyme called E2. The El-bound C-terminus of ubiquitin is transferred to a 
cysteine in E2, forming a second intermediate thioester bond, but this time between 
ubiquitin and E2. El then disassociates from E2 and can be reused. A ubiquitin-substrate 
ligase called E3 then promotes the transfer of the ubiquitin from the E2-ubiquitin conjugate 
to the target protein. The ubiquitin-substrate bond is usually between the amino group of a 
lysine side chain on the target protein and the C-terminus of ubiquitin, but sometimes the 
ubiquitin is conjugated to the NH2-terminal amino group of the substrate (Glickman & 
Ciechanover, 2002). E3s contain binding sites for two substrates: the target protein and the 
E2-ubiquitin conjugate. In the commonest, RING (really interesting new gene)-finger 
domain family of E3s, the ubiquitin is brought into close proximity to the target protein's 
lysine and the ubiquitin is transferred directly from E2 to the target protein (Ozkan et al., 
2005). In the HECT (homologous to the E6-AP COOH terminus)-domain E3s, the 
ubiquitin is not transferred to its target directly, but via a third thiol ester intermediate bond 
to a cysteine residue on E3 (Glickman & Ciechanover, 2002). 
If the target protein is released from E3 with a single ubiquitin attached to it the process is 
called mono-ubiquitination. However, repeated cycles of ubiquitin-conjugation often occur 
whilst the target protein remains bound to E3. Several ubiquitin molecules can become 
attached to different lysines on the target protein (a process called multi-ubiquitination) or 
chains of ubiquitins can be generated when the C-terminus of another ubiquitin is attached 
to a lysine residue of the previously-conjugated ubiquitin (a process called poly- 
ubiquitination). 
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Figure 4.1 Ubiquitinylation of a substrate protein. Ubiquitin is activated by EI in a reaction 
requiring ATP, forming a ubiquitin-E l complex (i). The ubiquitin is transferred to a member 
of the E2 family (ii). The ubiquitin is then transferred from E2 to the substrate protein via a 
substrate-specific E3 ubiquitin-ligase (iii). The substrate is now mono-ubiquitinylated (iv). 
Possibly involving E4, repeated ubiquitinylation produces a poly-ubiquitinylated protein (v). 
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Although the ubiquitination of a protein is a progressive reaction that only requires EI, E2 
and E3, the presence of an additional ubiquitin-conjugation protein called E4 has been 
described. E4 is thought to make the production of poly-ubiquitin chains more efficient by 
aiding the binding of one ubiquitin to another whilst the target protein remains bound to E3 
(Kuhlbrodt et al., 2005; Koegl et a!., 1999). E4 ubiquitin ligases have been found in yeasts, 
mammals, Dictyostelium discoideum and C. elegans (Hoppe, 2005). There is also a gene 
encoding a putative E4 enzyme in the S. mansoni genome (Smp138830). 
Ubiquitin has seven lysine residues, all of which are potential conjugation sites, but most 
poly-ubiquitin chains are linked via lysine 48 or lysine 63 (Peng et al., 2003). A chain of 
four or more ubiquitins (where the C-terminus of each ubiquitin is linked to lysine 48 of the 
preceding ubiquitin) is the destruction signal recognised by the 26S proteasome (Thrower et 
al., 2000). By contrast, attaching a lysine-63-linked poly-ubiquitin chain to a substrate 
protein is associated with non-proteolytic mono- and multi-ubiquitination functions such as 
endocytosis, signal transduction, transcriptional regulation, ribosome function and DNA- 
repair pathways (Hicke, 2001). 
Although poly-ubiquitination for proteasomal destruction is ubiquitin's most well-known 
role, it is becoming increasingly recognised that the mono- and multi-ubiquitination of 
proteins is commonplace, so ubiquitin can be described as a multi-functional protein. 
Ubiquitin's central structure, the "ubiquitin superfold" has also been found incorporated 
into much larger proteins (collectively called "ubiquitons"). Ubiquitons are less-well 
studied, but they include kinases and kinase-interacting proteins, so ubiquitons are likely to 
be involved in signal transduction (Nassar et al., 1995; Cavanaugh, 2004; Hirano et al., 
2004). Ubiquitons have also been identified as transport proteins that bind to poly- 
ubiquitinylated proteins and transport them to the 26S proteasome for destruction 
(Hofmann & Bucher, 1996; Bertolaet et al., 2001; Wilkinson et al., 2001). 
The process by which the target proteins are selected for, ubiquitinylation in the first place 
involves molecular chaperones, but operates differently depending on whether the targets 
are cytosolic or in the secretory pathway. Overall, it has been estimated that 30% of new 
proteins are misfolded during their biogenesis, to be degraded by the UPP (Schubert et al., 
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2000). For cytosolic proteins the chaperones are HSPs, principally HSP70 and HSP90. 
Inhibiting the UPP induces the up-regulation of HSPs (including HSP70), and HSP70 and 
HSP90 are required for proteasomal degradation of some substrates (Lee & Goldberg, 
1998; Bercovich et al., 1997; Doong et al., 2003). A link between HSPs and the UPP has 
been demonstrated in that the co-chaperone CHIP (C-terminus of HSP70-interacting 
protein), which interacts with HSP70 and HSP90, is also a functional E3 ubiquitin ligase, 
which as discussed below is involved in attaching ubiquitin moieties to substrate proteins 
(McClellan & Frydman, 2001; Cyr et al., 2002). By ubiquitinylating misfolded proteins 
that associate with HSPs, CHIP transfers them to the UPP (Connell et al., 2001). 
In the secretory pathway, folding efficiency is regulated in the lumen of the endoplasmic 
reticulum (ER). Misfolded proteins are recognised, unfolded and retro-translocated to the 
cytosol for ubiquitinylation and proteasomal destruction in a process known as 
"endoplasmic reticulum-associated degradation" or "ERAD". ERAD of glycoproteins is 
initiated when misfolded proteins are recognised by a combination of ER mannosidase I 
and a mannose-specific lectin called EDEM, or by BiP when the misfolded proteins are not 
glycosylated (Romisch, 2005; Molinari & Sitia, 2005). After recognition, the misfolded 
proteins are unfolded by members of the protein disulphide isomerase family (whether or 
not they contain disulphide bonds) and are then exported across the ER-membrane (Gillece 
et al., 1999; Wang & Chang, 2003). It has been known for a long time that the unfolded 
proteins are retro-translocated from the ER through sec6l (Wiertz et al., 1996; Pilon et al., 
1997) but more recently another family of proteins called "derlins" have been described 
that can also form an export channel (Lilley & Ploegh, 2004; Ye et al., 2004). The energy 
required for retro-translocation is provided by Cdc48p (p97 in mammals), which is a 
member of the AAA-ATPase family of chaperones (Romisch, 2005). The process of 
ubiquitinylation takes place in the cytosol, with the initial ubiquitin moiety being attached 
to the substrate whilst it is still associated with the ER membrane-pore (Shamu et al., 2001; 
Jarosch et al., 2002; Herman et al., 2003). 
4.1.3 The Schistosome Proteasome 
The UPP in schistosomes has not been intensively studied until recently. The earliest paper 
describes the cloning and sequencing of the S. mansoni 20S a5-subunit as part of a study 
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that identified antigenic proteins present in the supernatants of lung-stage worms cultured 
in vitro (Harrop et al., 1999). A ubiquitin-binding subunit of the S. mansoni 19S 
regulatory complex has also been cloned and sequenced (Harrop et al., 1999; Nabhan et al., 
2001). Guerra-Sa et al., (2005) demonstrated that functional proteasomes are required for 
cercariae to successfully transform into lung-worms and also that 20S proteasomes in 
cercariae were less active than those of adults. Then, leading on from the Guerra-Sa et al. 
study, the 20S proteasome in S. mansoni was fully characterised (Castro-Borges et al., 
2007). In the Castro-Borges et al. paper, 20S proteasomes were purified from adult worms 
using a sequence of HPLC steps and then separated into their subunits using 2-DE. The 
subunits were identified using MALDI-MSMS. The fourteen 20S a- and ß-subunits 
appeared as fifty-eight spots on the 2D gel (reproduced overleaf as Figure 4.2). A search of 
the S. mansoni genome assembly revealed that each 20S subunit was only encoded by a 
single gene, so the multiple spots of each subunit represented different post-translational 
modifications. Each subunit's spot-pattern was one where a single large, intensely-staining 
spot was in close proximity to several smaller spots that differed slightly in charge but not 
mass, suggesting that the post-translational modifications consisted of different degrees of 
phosphorylation. When 2D Western Blots of S. mansoni adult and cercarial preparations 
were probed with an antibody that recognises S. mansoni a3 and a6 subunits, Castro- 
Borges et aL, (2007) were able to show that the spot patterns were different, thereby 
demonstrating that life-cycle stage-specific differences in expression occurred. 
4.1.4 Protein Turnover in the Developing Schistosome Egg 
When released by the female schistosome, the immature egg consists of a fertilised ovum 
plus about thirty nutritive vitelline cells. As the egg matures, the vitelline cells decrease in 
volume as their contents are degraded and exported as raw materials for the developing 
ovum (see Chapter 1, Sections 1.2.1 and 1.2.2 for a detailed description of the egg- 
development process). As a large proportion of this traffic must consist of amino acids, it 
follows that a mechanism of regulated protein degradation must be of huge importance in 
the developing egg. Despite this, no work has been done to study the mechanisms by which 
the protein degradation might be occurring. What little is known about protein turnover in 
the development of invertebrate eggs results from studies that have used insect models and 
have focussed on gaining a better understanding of apoptosis and (occasionally) autophagy 
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Figure 4.2 The 20S proteasome subunits in S. mansoni adults. 100µg of 20S 
proteasomes purified from adult worms, separated by 2-DE and stained with 
Sypro Ruby. The spots were excised from the gel, digested with trypsin and 
identified using MALDI-MSMS. The image is taken from Castro-Borges et 
al., (2007), who also demonstrate that the mAb used in this thesis (which 
recognises the human 20S subunits al, 2,3,5,6 and 7) only binds to the 20S 
a3 and a6 subunits in S. mansoni. 
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(Baum et al., 2005; McCall, 2004; Mpakou et al., 2006). As such, these studies do not 
even address the question as to whether the UPP is involved in oocyte development. 
In insects, eggs develop in an egg chamber, made up of the ovum and some nutritive nurse 
cells which is surrounded by a layer of somatic epithelial cells called "follicle cells". The 
egg chamber moves through the ovariole as it develops, from previtellogenesis, through 
vitellogenesis (yolk uptake) and choriogenesis (eggshell formation). The nurse cells play a 
similar nutritive role as vitelline cells in the schistosome egg and degenerate as the oocyte 
develops (Mahajan-Miklos & Cooley, 1994). The most detailed studies, involving 
Drosophila, show that cytoplasm is transferred from the nurse cells to the developing 
oocyte, after which DNA fragmentation begins in the nurse cells, they undergo apoptosis 
and their remnants are phagocytosed by the somatic follicle cells (Foley & Cooley, 1998; 
Nezis et al., 2000). Although these studies demonstrate that apoptosis is utilized in the final 
coup de gras of the nurse cells, they fall short of establishing the extent to which the UPP is 
involved in the earlier proteolytic degradation of the nurse cell's contents. Thus, the UPP 
could be a central part of the process by which nurse cell intracellular proteins are 
degraded. There is of course a fundamental difference between the situation in the 
schistosome egg and that in the insect egg in that the vitelline cells of the schistosome egg 
are not surrounded by follicular cells with a phagocytic capability. As neither the 
developing miracidium nor the envelope have been demonstrated to undertake 
phagocytosis, it is unlikely that apoptosis has evolved to become the principal mechanism 
by which vitelline cells degrade. 
4.1.5 Experimental Aims and Objectives 
The work in this chapter follows on from the Guerra-Sa et al., (2005) and Castro-Borges et 
al., (2007) papers and also links to the previous work in this thesis by studying the UPP in 
the S. mansoni egg. The extent to which 20S a-subunit expression changes as the egg 
develops is assessed by comparing 2D Western Blots of the female vitellaria-enriched 
preparation (representing the egg's vitelline cells), immature SEA (representing eggs at an 
intermediate stage of development) and mature SEA. In vitro assays using a fluorogenic 
substrate are then used to establish whether a-subunit expression changes seen by blotting 
can be linked to the proteolytic activity of the proteasome. Western Blotting is also used to 
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compare the expression patterns of the 20S a-subunits of the mature egg's components 
(ESP, miracidium and hatch fluid) to gain insights into how the UPP might be used by the 
egg to pass through the gut wall to emerge into the gut lumen. The pattern of 
ubiquitinylated proteins in each of the egg preparations is also visualised using blots and 
linked where possible to the information obtained with regard to proteasomal expression 
and activity. 
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4.2 Methods 
The methods that were used to obtain the biological material have already been described in 
the following sections of Chapter 2: obtaining S. mansoni eggs (Section 2.2.1), making 
soluble protein preparations (Sections 2.2.2 - 2.2.6) and determining protein concentrations 
(Section 2.2.7). 
4.2.1 Detecting Proteasome a-Subunits and Ubiquitinylated Proteins by Western 
Blotting 
35µg of female vitellaria-enriched preparation, immature SEA, mature SEA, miracidial 
preparation and hatch fluid were separated by 2-DE as described in Chapter 2, Section 
2.2.9.2. Immediately following the PAGE, each gel was removed from its plastic case, 
separated from its IEF strip and placed on 8.3cm x 7.3cm Invitrolon 0.2µm 
polyvinylidenefluoride (PVDF) membrane (Invitrogen) that had been equilibrated in 
NuPAGE Transfer Buffer (Invitrogen). The gel/membrane was sandwiched firstly between 
the membrane's filter papers and then between fibre pads before being installed into an 
XCell II Blot Module (Invitrogen). The blot module was filled with transfer buffer and the 
proteins transferred from the gel to the membrane by applying a constant current of 30V for 
75 mins. Successful protein-transfer was confirmed by staining the membrane with Sypro 
Ruby protein blot stain (Invitrogen) as per the manufacturer's instructions and imaging it 
using a Versa Doc (Bio-Rad). The blot was washed, incubated overnight in blocking 
solution (100mM NaCI/50mM Tris HCl pH7.5 plus 5% milk powder and 0.05% Tween 20) 
and then probed with mouse anti-human 20S proteasome IgG, specific for human subunits 
al, 2,3,5,6 and 7 (Biomol PW8195), but which only recognises a3 and a6 subunits in S. 
mansoni (Castro-Borges et al., 2007). The antibody was diluted 1: 4000 in blocking 
solution. Probing was carried out over 3 hours on a rocking agitator set at a slow speed, 
after which the unbound antibody was removed by washing the blot three times in 200m1 of 
10mM Tris pH7.5. The blot was then incubated for 90 mins in goat anti-mouse IgG 
peroxidase conjugate (Sigma A8924) that had been diluted 1: 4000 in blocking solution. 
The image was visualised using the "Enhanced Chemiluminescent" ECL Plus Western 
Blotting Detection System with Hyperfilm ECL paper (both Amersham) processed in an 
Compact X4 automatic film processor (Xograph). Each blot was then washed three times in 
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300m1 ddH2O, incubated for 20 mins in Restore Western Blot Stripping Buffer (Pierce), 
washed again (three times in 10mM Tris HCl pH7.5) and blocked overnight with blocking 
solution. The blots were then probed for a second time using the same protocol used for the 
proteasome immunodetection, but with a 1: 1000 dilution of rabbit anti-ubiquitin IgG 
(Sigma U5379), which recognises mono-, multi- and poly-ubiquitinylated proteins. The 
detection antibody was goat anti-rabbit IgG alkaline phosphatase conjugate, diluted 1: 500 
in blocking solution. The image was detected using the chromogenic substrate 5-Bromo-4- 
Chloro-3-Indolyl phosphate/Nitro Blue Tetrazolium (Sigma). 
4.2.2 Probing ESP for Poly-Ubiquitin 
15µg of ESP, mature SEA and cercarial secreted protein (a gift from Dr. Rachel Curwen) 
were reduced and then separated by 1-DE as described in Chapter 2, Section 2.2.8.2. The 
proteins were then blotted onto a PVDF membrane, stained with Sypro Ruby, blocked and 
probed for poly-ubiquitin using the protocol described in Section 4.2.1. Probing was carried 
out using a 1: 4000 dilution of mouse anti-poly-ubiquitin IgM (Biomol PW8805) which was 
detected by a 1: 10000 dilution of goat anti-mouse IgM peroxidase conjugate (Sigma 
A8786). The poly-ubiquitin image was visualised using the ECL procedure, after which the 
blot was stripped and re-probed for all forms of ubiquitin as described in Section 4.2.1. 
4.2.3 Measuring Proteasomal Activity in Immature and Mature SEA 
Approximately 3 million eggs were extracted from the livers of seven-week infected mice 
then separated into mature and immature fractions as described in Chapter 2, Sections 2.2.1 
and 2.2.2. The immature and mature egg fractions was then ground for three minutes in 
200µl of 40mM Tris HCl pH7.5 plus 5% glycerol and 1mM DTT using a polypropylene 
pestle (Sigma) attached to Kontes motor (Fisher). The grinding took place on ice, in three 
cycles consisting of a minute's grinding followed by a minute's rest. Protein concentrations 
were assayed using the Coomassie Plus Protein Assay (Pierce) and then adjusted to 
350pg/ml with the same 40mM Tris/glycerol/DTT buffer used to make the SEA. 
Chymotrypsin-like activity was measured by incubating 75µg of immature and mature SEA 
at 37°C for 1 hour in a 96-well microtitre plate (Nunc), with 25µM of the fluorogenic 
substrate N-Succinyl-Leu-Leu-Val-Tyr-7-amino4-methylcoumarin (Biomol P802) plus 
5mM MgC12 (making a total volume of 240µl per well). In order to distinguish between 20S 
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proteasomal activity and non-proteasomal chymotypsin-like activity, the assay was carried 
out in the presence and absence of 0.02% SDS (see the following paragraph for the 
rationale). After incubation, the reactions were stopped with 240µl/well of 1% SDS and the 
fluorescence measured on a Polarstar Optima plate reader (BMG Labtech) set at 320nm 
excitation and 460nm emission wavelengths. The fluorescence of the blank was deducted 
from the fluorescence of each assay and the results expressed as means (+/- standard error 
of the mean) of duplicated assays. 
The SDS is important in this assay because it enables the non-proteasomal, chymotryptic 
enzymes to be controlled for. In the SDS 've assays, no proteasomal degradation of the 
substrate occurs because the substrate is not ubiquitinylated and the 20S proteasomes are 
capped by the 19S regulatory subunits. So, all the substrate degradation is caused by non- 
proteasomal chymotryptic proteases. In the SDS+ve assays however, proteasomal 
degradation of the substrate does occur. Although it is not known how the SDS operates, it 
is likely that it causes the 19S regulatory subunits to disassociate from the 20S proteasome 
core, enabling the 20S proteasomes to degrade the substrate; and as the concentration of 
SDS is low, the 20S proteasomes remain intact and functional (Tanaka et al., 1989; Stein et 
al., 1996). So, the fluorescence in the SDS 've assays represents the activity of the non- 
proteasomal chymotryptic proteases only, and the fluorescence in the SDS +ve assays 
represents the activity of all the chymotryptic-like enzymes, including the 20S proteasome. 
Therefore, it is the difference between the fluorescence in the SDS 've assays and that in the 
SDS +ve assays which represents the activity of the 20S proteasome. 
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4.3 Results 
4.3.1 Western Blots of Proteasomal a-Subunits in the Developing Egg 
Proteasomal 20S a-subunits were found in all of the egg preparations except ESP, but the 
spot-pattern on each blot was different. The ECL image of the female vitellaria-enriched 
preparation blot (representing the vitelline cells) contained seven spots, comprising five 
20S proteasome a6 and two a3 isoforms, two of the former being much fainter spots. This 
spot pattern was distinctive, so shared spots could be matched exactly when the ECL 
images from the immature and mature SEA blots were superimposed onto that of the 
female vitellaria-enriched preparation. This spot-matching exercise enabled changes in 
expression of the individual isoforms to be linked to egg maturation (Figure 4.3). In the 
immature SEA blot all the spots had diminished in both size and intensity except that of the 
most acidic a3 isoform, which was now the largest spot by far. The more acidic of the two 
small, faint a6 isoform spots in the female vitellaria-enriched preparation had disappeared 
in the immature SEA blot. Spots continued to diminish in number between the immature 
and mature SEA blot images such that only a single a3 isoform and a single a6 isoform 
were visible in the latter. Although the a6 spot had diminished in size, the a3 spot had not 
and remained the same size as it was in the female vitellaria-enriched preparation blot. 
4.3.2 In Vitro Assessment of the Proteasomal Activity in Immature and Mature SEA 
As the immature SEA blot contained more proteasomal a-subunit isoforms than the mature 
SEA blot, an assay was carried out in which the levels of chymotrypsin-like activity in 
immature and mature SEA were compared, using a fluorogenic substrate in the presence 
and absence of 0.02% SDS. As shown in Figure 4.3D, the amount of fluorescence in the 
SDS 've assays was 6% higher in mature SEA compared to immature SEA (36013 vs. 
33998 fluorescence units), demonstrating that non-proteasomal chymotryptic proteases are 
slightly enriched for in mature SEA. In the SDS +ve assays the fluorescence increased by 
12.5% in mature SEA (from 36,013 to 40,535 units), which is only a fifth of the 66% 
increase (from 33998 to 56446 units) that SDS induced in the immature SEA assays. It can 
therefore be seen that immature SEA has five times more 20S proteasomal activity than 
mature SEA. 
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Figure 4.3. The 20S proteasome in the developing egg. A: Blot of 35µg of female, 
vitellaria-enriched preparation, stained with Sypro Ruby protein stain. B ECM of 
the blot from A, probed with an antibody that recognises 0 and a6 subunits of the 
20S proteasome. C: Enlarged section of the blot from B, compared with similar 
blots of immature and mature SEA. Matching subunits are linked by red arrows. 
The a3 and 0 group of isoforms could be distinguished because of their different 
molecular weights and p1. D: Chymotrypsin-like activity in immature SEA 
compared with that in mature SEA. Regulatory subunits prevent proteasomal- 
degradation of the substrate in the SDS -ve assays, but these are thought to 
disassociate in the SDS +ve assays, enabling 20S proteasomal degradation of the 
substrate to occur. Therefore, the 20S proteasomal activity is represented by the 
difference between the fluorescence in the SDS +ve and SDS -ve assays. 
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4.3.3 Western Blots of Proteasomal a-Subunits in Hatch Fluid and the Miracidium 
Hatch fluid and the miracidium are components of the fully-developed egg. By comparing 
the spot-patterns on the hatch fluid and miracidial blots with each other and with the mature 
SEA blot it was possible to see which preparation was enriched with 20S a3 and a6 subunit 
isoforms (Figure 4.4). The hatch fluid's spot-pattern was completely different to that of any 
of the other blots, with three horizontal rows of spots containing sixteen spots, ten of which 
(including the largest 5OkDa spots) were not present in any of the other preparations. An 
identical spot pattern occurred when the 2D hatch fluid blot was repeated, but in an earlier 
1D hatch fluid blot the antibody only recognised bands at 25kDa and 30kDa (results not 
shown). The miracidial blot contained six visible spots, all of which could be matched to 
hatch fluid spots and three of which could be matched to the spots on the mature SEA blot. 
Five out of the six miracidial spots also matched to spots on the female vitellaria-enriched 
preparation blot. 
4.3.4 Western Blots of Ubiquitinylated Proteins 
As there was a considerable variation in the expression of proteasome a-subunits between 
the various egg preparations, the blots were stripped and re-probed with an anti-ubiquitin 
mAb that recognises mono-, multi- and poly-ubiquitinylation (Figure 4.5). The ubiquitin 
blots demonstrated that ubiquitinylated proteins were abundant in all of the preparations, 
with many spot patterns being distinctive and present in more than one preparation. For 
example, the l5kDa slightly acidic proteins (annotated as "A" in Figure 4.5) were in all of 
the preparations except ESP, and the series of spots "B" were present in all of the blots 
except that of the miracidial preparation. The very acidic protein of 50-1 OOkDa "C" was the 
most heavily staining protein on the blots and was highly ubiquitinylated in both the 
immature and the mature egg, where it can be assigned to ESP and hatch fluid, but not the 
miracidium. It also appeared in the female, vitellaria-enriched preparation but it was not 
heavily ubiquitinylated. The location, size, shape and pattern of expression of the spotwas 
similar to that of Smp 170410, the most abundant hatch fluid protein (of unknown- function) 
'described in Chapter 2 (Section 2.4.8) and annotated as Spot 519 in the 2D hatch fiui4,0l 
(Figure 2.6, page 77). 
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Figure 4.4. Proteasome 20S a-subunit isoform expression in the mature egg. A: Blots of the 
hatch fluid and miracidial preparations were probed with anti 20S proteasome CO and a6-subunit 
mAb and imaged using ECL reagents. The areas inside the green boxes are enlarged in B. B: 
The proteasome a-subunit-containing sections of A with shared subunit isoforms shown in pink 
arrows. For comparison, the mature SEA blot from Figure 4.3C is also shown. C: A similar 
comparison, but between the miracidial and female, vitellaria-enriched blots. 
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Figure 4.5 Ubiquitinylated proteins in the egg. 2D blots of 35µl; of protein from each 
egg preparation were probed with an anti-ubiquitin mAb that recognises mono-, multi- 
and poly-ubiquitinylated proteins. The blots were imaged using alkaline phosphatase 
reagents. The spots annotated A-F are discussed in the text. 
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Some ubiquitinylated proteins were very abundant in the female, vitellaria-enriched 
preparation and immature SEA but declined in abundance as the egg matured (e. g. the 
spots annotated as "D" in Fig. 4.5). Free ubiquitin (i. e. unbound ubiquitin) could be seen in 
the blots of immature SEA and the miracidial preparation ("E" in Fig. 4.5). 
4.3.5 Ubiquitinylation of ESP 
It was surprising to find large numbers of ubiquitinylated proteins in ESP because the UPP 
operates in the cytosol. In order to rule out leakage from dead eggs as the source of the 
ubiquitinylated proteins in ESP a comparison was made between ubiquitin blots of ESP and 
mature SEA (Figure 4.6A). As the banding patterns in the mature SEA and ESP blots 
differed, the ubiquitinylated proteins in ESP cannot be sourced to ruptured eggs in culture. 
When a 2D blot of ESP was probed with the same anti-ubiquitin mAb used in Section 4.3.4 
(i. e. one that recognises all forms of ubiquitinylation) and then compared to a 2D protein 
gel it could be seen that many of the previously described ESPs were ubiquitinylated 
(Figure 4.6B). There were differences in the relative staining intensities of spots on the gel 
compared with those on the blot so there was no obvious relationship between the levels of 
protein expression and ubiquitinylation. For example, the most heavily ubiquitinylated spot 
in ESP was the very acidic protein of 50-100kDa (probably Smp170410), which was only 
just detectible in the protein gel, whereas ESP 13 stained heavily in the protein gel but was 
difficult to detect in the blot. Another series of spots of pI4-5 and of approx 250kDa were 
also heavily ubiquitinylated but failed to stain visibly for protein. 
As the anti-ubiquitin antibody used in the previous experiments cannot distinguish between 
mono-, multi- and poly-ubiquitinylated proteins, IOpg of ESP was separated by 1-DE (with 
mature SEA and cercarial secreted protein for comparison), blotted, probed with anti-poly- 
ubiquitin IgM, stripped and then re-blotted with the anti ubiquitin IgG used previously 
(Figure 4.6C). The anti-poly-ubiquitin IgM only binds to poly-ubiquitinylated proteins and 
does not recognise either mono- or multi-ubiquitinylated proteins. Consequently, the nature 
of the ubiquitinylation was established by using the antibodies in concert. Apart from faint 
bands at approx. 22kDa in ESP and 15kDa in the cercarial secretion preparation (boxed in 
pink in Fig. 4.6B), no proteins in the secretory preparations were poly-ubiquitinylated. 
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Figure 4.6 Ubiquitinylation of ESP. A: ESP has a different ubiquitinylation pattern 
compared with mature SEA. B: Ubiquitinylated proteins in ESP include Smp 170410, 
ESP 1-2, ESP3-6, ESP 13, ESP 15, ESP 17, ESP20 (annotated in pink) plus two of the new 
ESPs described in Chapter 2 (annotated as "). Unbound ubiquitin is annotated as Ub 
C: Cercarial secreted proteins (CSP), ESP and mature SEA blotted for poly-ubiquitinylated 
proteins only. Proteins at 22kDa in ESP, I OkDa (CSP) and a smear of mature SEA proteins 
at >75kDa were poly-ubiquitinylated. 
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The mature SEA blot reacted positively to the poly-ubiquitin antibody, producing a smear 
of proteins of >75kDa. It was not possible to assign identities to the poly-ubiquitinylated 
proteins because it is not known how many ubiquitins were attached to each substrate, and 
therefore the substrate's molecular weight cannot be established. The band at l5kDa in the 
cercarial secretion preparation has a molecular weight consistent with ubiquitin dimers that 
were not attached to substrate proteins. The smear at >75kDa in the mature SEA blot 
demonstrates that it contains numerous poly-ubiquitinylated proteins. As the molecular 
weight of ubiquitin is 8.5kDa, a poly-ubiquitin chain of four ubiquitins adds 35kDa to the 
substrate's molecular weight. As the smear of proteins started at 75kDa, it can be estimated 
that most of the poly-ubiquitinylated substrates were >40kDa in size, which is consistent 
with the banding pattern in the protein stain. After the blot had been probed for poly- 
ubiquitinylated proteins the membrane was stripped, re-probed with the anti-mono-, multi- 
and poly-ubiquitin IgG used in the previous experiments, and the same spot pattern seen 
previously in Fig 4.6A re-emerged. Therefore, the negative result from the poly-ubiquitin 
blot of ESP cannot be attributed to poor protein transfer from the gel to the membrane. A 
2D gel of 35µg ESP was subsequently blotted and probed with the anti-poly-ubiquitin 
antibody but on this occasion there was no reactivity at all (result not shown). It is therefore 
probable that the 22kDa band seen in the poly-ubiquitin blot of ESP in Figure 4.6C could 
be an artefact. 
An attempt was made to assess the extent of ubiquitination in ESP using LC-MALDI-MS 
and MSMS. 7.5µg of crude ESP was digested with trypsin, desalted, separated with a 
monolith reverse phase column and eluted onto a MALDI plate over 180 spots, each of 
which was firstly analysed by MALDI-MS. The MS spectra from all of the spots were then 
manually searched for peaks that had m/z ratios (with a tolerance of +/- 0.2Da) that 
corresponded with those expected from a tryptic digest of ubiquitin (as calculated by the 
ProteinProspector v. 4.0.8 program). Then, by comparing the strength of the signals 
generated from ubiquitin peptides with the strength of signals from ESP peptides an 
estimation of the relative abundance of ubiquitin compared with each ESP was made. 
Although a tryptic digest of ubiquitin could theoretically generate 29 peptides of > 800Da 
in mass (allowing for <_2 missed cleavages) only one peptide was found. The peptide had a 
MS peak of 1787.9 Da, equating to the sequence TITLEVEPSDTIENVK (which 
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ProteinProspector calculates to have a mass of 1787.93Da). This peptide appeared in a 
total of 17 spots, the most intense signal of which was in Spot 140, generating a signal-to- 
noise ratio of 16.2 (Figure 4.7A). The peak at 1787.9Da could be seen in the MS spectrum 
of Spot 140 (Figure 4.7B), with a slightly more intense peak Ma larger and a third, less 
intense peak which was 2Da larger. The sum of all three peaks represents the signal from 
the ubiquitin peptide, with the different masses representing peptides containing zero, one 
or two C14 atoms respectively. An attempt was made to subject the peptide to MSMS but it 
was too low in abundance to fragment sufficiently well. By way of comparison, a tryptic 
peptide of 1276.6Da from ESP3-6 was much more abundant. It was eluted over 43 spots 
(so was more dilute compared with the ubiquitin peptide) yet it achieved a maximum 
signal-to-noise ratio of 960, which was more than sixty times higher than the ubiquitin peak 
(Figure 4.8A). This more intense signal means that the MS spectrum from the most intense 
spot (Spot 120) was much clearer than that seen in the ubiquitin peptide with no 
background noise evident (Figure 4.8B). The much greater abundance of the ESP3-6 
peptide is also demonstrated because there are discernable variants of the peptide 
containing up to four C14 atoms. 
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Figure 4.7 Identification of a ubiquitin peptide in ESP by LC-MALDI-MS. A: The 
elution pattern of ubiquitin peptides of 1787.9Da. The strongest signal was found in Spot 
140 on the MALDI plate, generating a signal-to-noise ratio of 16.2. B: The 1780-1800Da 
region of the MS spectrum of Spot 140 showed the 1787.9Da ubiquitin peptide plus its 
other isoforms that were either I or 2Da larger, depending upon whether they contained one 
or two C14 atoms. The small quantity of protein means that the signal/noise ratio is low. 
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Figure 4.8 Identification of an ESP3-6 peptide by LC-MALDI-MS. A: ESP3-6 
peptides of 1276.6Da were eluted onto the MALDI plate between Spot 107 and Spot 
150. The maximum signal-to-noise ratio was 960. B: The 1275-1283Da region of 
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signal. Isoforms of the peptide containing up to four C14 atoms can be seen. 
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4.4 Discussion 
4.4.1 The Ubiquitin-Proteasome Pathway and the Developing Egg 
Western blots have shown that the 20S proteasome is more highly expressed in the 
immature egg than in the fully-developed egg. The results from the fluorogenic substrate 
assays reinforces the blotting evidence in that 20S proteasomal chymotryptic-like activity 
was higher in immature SEA than in mature SEA. The decline in the activity of the UPP as 
the egg matures is consistent with two scenarios. There could be a reduction in the extent to 
which the embryo is damaged by the host's immune system, or the vitelline cells of the 
immature egg could utilize the UPP more actively than the cells of the miracidium and 
envelope of the mature egg. 
Granulomata do not form around immature eggs (Boros et al., 1975), so the immature egg 
will be surrounded by fewer host cells than the mature egg. It therefore follows that the 
immature egg will be in an environment that has lower concentrations of toxic compounds 
than the mature egg. Also, as the embryo is small in the immature egg, the thick, protective 
layer of vitelline cells would buffer it from any external toxic compounds which enter the 
shell. Thus, the embryo of the immature egg is at less risk of being damaged by the 
products of host cells than the miracidium and envelope of the mature egg. Consequently, 
the more active UPP in the immature egg can be attributed to some factor(s) relating to the 
purpose of the vitelline cells. As the vitelline cells provide an auto-degrading reservoir of 
nutrients for the developing ovum (Smyth & Halton, 1983), it is hypothesised that that the 
relatively high activity of the UPP in the immature egg is due to the degradation of the 
contents of the vitelline cells. ' 
It makes sense in that the UPP would be used for vitelline cell degradation because the 
process is highly regulated. The regulation can occur at the stage of substrate 
ubiquitinylation or at the proteasome itself. At the ubiquitinylation stage, the substrate 
specificities of the E3 ubiquitin ligases determine which proteins become ubiquitinylated, 
and then the rate of their ubiquitinylation will also depend upon the availability of free 
ubiquitin. At the proteasome level, regulation can occur via a family of proteins called 
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"proteasome interacting proteins" that associate with the 19S regulatory complex (Verma 
et al., 2000). These proteins include de-ubiquitinylation enzymes such as Ubp6, which can 
progressively remove ubiquitin moieties from substrate proteins to delay their proteasomal 
degradation (Hanna et al., 2006). Also, as proteasomal degradation is highly ATP- 
dependent (Benaroudj et al., 2003), intracellular ATP concentration will also regulate 
proteasomal function. Thus, by using the UPP, the contents of the vitelline cells would 
degrade slowly, forming an amino acid-concentration gradient between the vitelline cells 
and the developing miracidium, capable of delivering the amino acids that the miracidium 
requires for its growth. 
The other potential mechanisms by which vitelline cells degrade could be apoptosis and/or 
autophagy. There is little evidence that apoptosis is particularly active in schistosomes. The 
S. mansoni transcriptome was found to contain some but not all of the components of the 
apoptotic pathway (Verjovski-Almeida et al., 2003). Also, the apoptotic pathway is 
relatively uncontrollable once it has begun, with the process of caspase activation taking 
minutes to complete and then, once a cell has undergone a commitment to undergo 
apoptosis the process is complete within several hours (Tyas et al., 2000). So, even if the 
apoptotic pathway was utilised in the egg, it is difficult to reconcile such a rapid and 
uncontrollable mechanism of protein degradation with the slow and steady release of amino 
acid that the developing miracidium would require. 
Autophagy is more likely than apoptosis to be involved in vitelline cell degradation because 
almost all of the autophagic components have been found in the transcriptome and studies 
have found autophagy occurring in adult schistosomes (Verjovski-Almeida et al., 2003; Al- 
Adhami et al., 2003; Bogitsh, 1975). Autophagy is known to function as a mechanism to 
eliminate unwanted cells during developmental cell death in various taxa, including the 
ovarian nurse cells in Bombyx mori and Ceratitis capitata (Levine & Klionsky, 2004; 
Mpakou et al., 2006; Velentzas et al., 2007). It is therefore quite likely that both autophagy 
and the UPP are involved in the degradation of vitelline cells, perhaps with the UPP at the 
earlier stages and autophagy operating at a later time point. The egg does not contain any 
phagocytic cells, so after their degradation, any remnants of vitelline cells will probably 
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remain inside the egg. It is possible that these vitelline cell remnants go on to form the 
vesicles of the fully mature egg. 
The relative expression levels of ubiquitin in immature and mature SEA also supports the 
hypothesis that the UPP is more active in the immature egg. Unbound ubiquitin was found 
in both the immature and mature SEA gels, where it constituted 0.4% of the former but 
only 0.2% of the latter (see Chapter 2, Tables 2.4 and 2.5). The larger pool of free ubiquitin 
in immature SEA is indicative of fast protein turnover whilst the smaller pool in mature 
SEA suggests a build up of ubiquitinylated proteins awaiting degradation because the UPP 
is operating more slowly. 
Although more proteasome a3 and a6 subunit isoforms were expressed in the immature egg 
than in the mature egg, the greatest expression was seen in the blots of the female, 
vitellaria-enriched preparation. The female, vitellaria-enriched preparation contains 
vitelline cells in various stages of development as well as the vitelline follicles, which 
actually produce the vitelline cells. It is therefore impossible to proportion the proteasome 
subunit isoforms seen in the blot between the vitelline cells and the vitelline follicles. 
However, the vitellaria must be very active in terms of protein production because it 
produces 9,000 - 12,000 vitelline cells per day (discussed in Chapter 1, Section 1.2.1). 
Such a high rate of protein production is inevitably going to mean that large numbers of 
misfolded proteins are constantly going to be produced and these will quickly need to be 
degraded. The UPP is inevitably going to be highly active in this process so consequently, 
it is not surprising that the female, vitellaria-enriched preparation contains more proteasome 
a-subunit isoforms than either the immature egg or the mature egg. It can also be argued 
that the female, vitellaria-enriched preparation is more enriched in vitelline cells than 
immature SEA, and as the vitelline cells themselves are enriched in proteasomes, the blot of 
the female, vitellaria-enriched preparation will have more visible proteasome subunit 
isoforms for this reason alone. 
4.4.2 The Ubiquitin-Proteasome Pathway in Hatch Fluid and the Miracidium 
The mature egg can be sub-divided into the miracidium, the hatch fluid and ESP, all of 
which have different proteasomal and ubiquitin blots. The spot pattern on the 20S 
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proteasome a-subunit isoform blot of the miracidial preparation was a sub-set of that of 
hatch fluid. This could partially due to the methods adopted to make each preparation. 
Hatch fluid only contains water-soluble proteins (including the proteasome) whilst the 
miracidial preparation was made using a buffer containing urea, thiourea and CHAPS, 
which will also have solubilized some hydrophobic proteins. So, as the two blots contained 
the same quantity of crude protein, the proteasome will be more enriched in the hatch fluid 
preparation. However, the difference between the blots was too dramatic to be solely due 
to the more complex nature of the miracidial preparation (hatch fluid contained 433 spots in 
the 2D gels of Chapter 2 whilst the miracidial preparation contained 602 spots). It is more 
likely that hatch fluid contained more 20S a-subunit isoforms because the UPP is highly 
active in the envelope, the intracellular content of which forms part of hatch fluid. The 
envelope is responsible for producing the ESPs, so it has a high rate of protein production, 
and will consequently need to have an active UPP in order to degrade those that become 
misfolded. By contrast, the miracidium is short-lived and does not secrete proteins whilst it 
is in the egg. The miracidium's principal requirement is to find and penetrate an 
intermediate host, and as it does so without feeding it will need to conserve ATP. It has 
been calculated that 300-400 ATP molecules are used during the degradation of one 
substrate protein through the UPP (Benaroudj et al., 2003), so for the miracidium it could 
be that operating the UPP is just too expensive in terms of ATP expenditure. Instead, the 
miracidium might utilize its high levels of the non-ATP-requiring chaperone p40 to store its 
misfolded proteins. It is likely that any misfolded proteins associating with p40 are 
effectively removed from the UPP because p40 does not contain the tetratricopeptide repeat 
motifs that are found in HSP70 and HSP90. The tetratricopeptide repeats are important 
because they interact with the E3 ubiquitin ligase CHIP and thereby form the bridge 
between chaperones and the UPP. (The link between chaperones and the UPP and the 
involvement of CHIP has been described in Section 4.1.2). CHIP is present in the S. 
mansoni transcriptome (Sm03288). 
4.4.3 Ubiquitin in ESP 
It was surprising that the blot of ESP contained more than 100 ubiquitinylated proteins and 
unbound ubiquitin, firstly because the UPP is intracellular and secondly because only 
twenty-seven spots are visible in protein gels of ESP (see Chapter 2, Figure 2.7). The ESP 
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blots that were probed for poly-ubiquitin and 20S proteasomal a3 and a6 subunit isoforms 
were both negative (except for the faint 23kDa band in the poly-ubiquitin blot), which 
demonstrates that ESPs are either mono- or multi-ubiquitinylated. It is not clear how 
ubiquitinylated proteins could be secreted because proteins must be retro-translocated from 
the ER (i. e. removed from the secretory pathway) prior to their ubiquitinylation. It is 
possible that a failure of E2 and/or E3 to complete the poly-ubiquitinylation process might 
lead to the inability of mono-ubiquitinylated proteins to disassociate from sec6l and their 
consequential return into the secretory pathway. This theory is supported by a study in 
which it was demonstrated that poly-ubiquitinylation was required if a misfolded protein 
emerging from sec6l was not to be returned back into the ER lumen (Shamu et al., 2001). 
There is other evidence which demonstrates that ubiquitin is not exclusively intracellular. A 
proteomic study of the content of secretory vesicles found ubiquitin, but it was impossible 
to establish whether the ubiquitin was unbound or had been conjugated to substrate proteins 
(Wegrzyn et al., 2007). The plasma of patients suffering from diabetes, alcoholism and 
schistosomiasis mansoni contains unbound ubiquitin (Akarsu et al., 2001; Takagi et al., 
1999; Asseman et al., 1994) but none of these studies could demonstrate that the ubiquitin 
had not leaked from ruptured cells. Ubiquitinylated membrane proteins have been found on 
the external surface of sperm and are used as a measure of sperm quality (Muratori et al., 
2005). So, the mono-ubiquitinylated ESPs could be misfolded ESPs that failed to become 
poly-ubiquitinylated and proteasomally degraded and so they became secreted instead. 
However, if this were to be the case, then the relative abundances of the proteins on the 
ubiquitin blot should be similar to that seen in the protein gel. This was not the case 
however - the spot patterns on the ESP blot and gel were different. 
It is therefore most likely that the mono- or multi-ubiquitinylated proteins seen in the ESP 
blot were intracellular proteins, derived from ruptured cells leaking into the culture media. 
It is unlikely that the leakage was from dead eggs that had ruptured and disintegrated 
because the pattern of mono-ubiquitinylation in ESP differed from that of mature SEA (see 
Figure 4.6A) and also because 97% of eggs remained viable after the culture period (see 
Chapter 2, section 2.2.4). It is more likely that the envelope had become damaged whilst 
the eggs were being prepared for culture, resulting in leakage across the envelope's 
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membrane on the side facing the eggshell as opposed to that facing the miracidium. Such 
damage could have been caused when the liver tissue was undergoing tryptic digestion to 
retrieve eggs because the porcine trypsin that was used has a molecular weight of 23.8kDa, 
which is sufficiently small to pass through the eggshell and attack any membrane proteins 
in the envelope. The similarity between the ubiquitin blots of ESP and hatch fluid add 
weight to this possibility because the water soluble intracellular envelope proteins form part 
of hatch fluid. 
It is logical that intracellular ubiquitinylated proteins, ultimately destined for proteasomal 
degradation would include mono-ubiquitinylated proteins awaiting poly-ubiquitinylation 
and poly-ubiquitinylated proteins awaiting proteasomal destruction, both of which could 
leak into the ESP cultures. However, the blots demonstrated a dearth of poly- 
ubiquitinylated proteins compared to those that had been mono-ubiquitinylated. No work 
has been done to establish the timing of the various ubiquitinylation events in the UPP, but 
it is likely that the process of generating a poly-ubiquitin chain is lengthy compared with 
the time it takes between poly-ubiquitinylation and the removal of the ubiquitin moieties by 
the 19S regulatory subunit. The 26S proteasome is very abundant (Tanahashi et al., 2000) 
so the transit time to the proteasome will consequently be short, particularly for protein 
substrates removed from the secretory pathway, where the 26S proteasomes are in very 
close proximity to the ER membrane (Romisch, 2005). Consequently, it is not surprising 
that poly-ubiquitinylated proteins were scarce in the blots compared with mono- 
ubiquitinylated proteins. The partial loss of the membrane's integrity need not be fatal for 
the miracidium because the eggs were cultured in a non-hostile environment where neither 
the hatch fluid's defence role nor its ESPs are obviously required for miracidial survival. 
The finding that the envelope becomes damaged during the extraction of eggs from liver 
tissue leading to envelope-leakage into egg cultures is important. It explains why 
intracellular proteins such as thioredoxin peroxidase, histones, HSP70 and p40 have all 
been found in egg cultures (Williams et al., 2001; Cass et al., 2007). These proteins were 
all identified using Western blots or non-gel-based MSMS, which are more sensitive, but 
less quantifiable techniques than the gel-based proteomics that was used in Chapter 2. 
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Chapter 5 
Concluding Discussion 
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This chapter summarises the rationale behind this thesis and places it in the context of 
preceding work. The most important results and the limitations of the work are highlighted 
and attention is drawn to potential future avenues of research. 
The aims of the study were to characterise the proteome of S. mansoni egg and then to 
establish whether any of the egg's proteins could be assigned specific biological activities. 
The schistosome egg is important for two principal reasons: it forms the focus of the host's 
immune response (which in turn causes the pathology in schistosomiasis) and it is the 
means by which the parasite transmits itself between hosts. Egg proteins involved in these 
functions were therefore of particular interest. 
When it is released from the female worm the S. mansoni egg is completely undeveloped. It 
comprises of a fertilised ovum surrounded by thirty-forty vitelline cells, encapsulated in a 
cross-linked protein shell. The ovum and vitelline cells are produced by different organs 
spatially separated from each other. The vitelline cells are produced by a large organ called 
the vitellaria, which occupies the posterior two-thirds of the worm. The oocyte is produced 
by the ovary which is situated above the vitellaria. Both the ovary and vitellaria are linked 
via ducts, with the oviduct incorporating a dilated region where sperm are stored. The egg 
is packaged together at a point just downstream of where the oviduct (discharging the 
oocyte and sperm) and the vitelline duct (discharging mature vitelline cells) meet. The shell 
is also formed from precursors in the vitelline cells at this point. The newly-packaged egg 
then passes along the uterus and is deposited by the worm against the epithelium of the 
mesenteric veins. At this point, no observable intra-egg structures can be seen under 
compound microscopy. Then, as the egg starts to develop, the vitelline cells collapse as 
their contents are degraded. The mechanism by which the degradation occurs has never 
been studied, but it is unlikely to be apoptotic because this pathway is rapid and 
uncontrollable once underway and there is little evidence from the S. mansoni 
transcriptome that apoptosis is used by schistosomes. The degradation is therefore probably 
dependent upon autophagy or the UPP. Concurrent with the degradation of the vitelline 
cells the oocyte starts to develop into a miracidium. An envelope forms between the 
developing miracidium and the shell, which thickens, acquiring structures associated with 
protein production such as rough endoplasmic reticulum. The envelope then starts to 
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secrete a protein mixture called "ESP", which emerges through the eggshell. A viscous 
liquid containing vesicles forms in the area between the miracidium and the envelope. If 
the egg is still located at its site of deposition in the mesenteric veins it crosses the blood 
vessel wall, the mesenteric tissues and the gut wall to emerge in the lumen of the gut, from 
where it is excreted from the host. If the egg encounters fresh water the vesicles swell, the 
shell ruptures and the miracidium swims away in search of a snail intermediate host, tearing 
through the envelope if it remains structurally intact. Fresh water floods into the shell 
causing the vesicles to burst and many of the cells of the envelope to lyse. So, at hatching 
the egg releases not only the miracidium but also a milieu of other water-soluble proteins 
called "hatch fluid". Hatch fluid is therefore derived from the envelope, those egg 
secretions that had been produced by the envelope but had not yet emerged from the shell, 
the liquid that surrounded the miracidium and the vesicles. Unlike the undifferentiated 
immature egg, the mature egg can therefore be seen as consisting of the miracidium, the 
hatch fluid and the secreted proteins, each of which are likely to have different biological 
functions - the secretions in orchestrating the transit of the egg from the blood vessels to 
the lumen of the gut, the hatch fluid in protecting the miracidium and aiding shell rupture 
and the miracidium which transmits the parasite's genes to the next stage of the life cycle. 
Previous work focussing on S. mansoni egg proteins has almost invariably involved 
homogenizing thousands of intact eggs of mixed ages to produce a standardised egg 
preparation known as SEA. Although some individual SEA proteins have been described 
on a paper-by-paper basis, no overall picture of protein expression in the egg has previously 
emerged. Little was known about how abundant each of the egg proteins actually are, to 
what extent their expression levels change as the egg matures and which proteins are 
enriched in the different components or structures in the egg. These are important questions 
because the pathology in schistosomiasis can be linked to egg deposition and destruction. 
For example, the host's immune response changes from being of a polarised ThI-type to 
becoming a more balanced Th-I/Th-2 type when egg deposition begins, and it is then 
down-regulated at a point in time when large numbers of mature eggs that have become 
embolised in the liver die and disintegrate, releasing their protein content. 
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The work in this thesis is the first detailed characterisation of the S. mansoni soluble egg 
proteome. It achieves this by using a combination of 2-DE, software capable of comparing 
multiple gel images and MALDI-MSMS. Preparations were made representing eggs at 
different stages of development. These were then separated by 2-DE and their spot-patterns 
compared using the gel analysis software. Identities for the spots were sought using 
MALDI-MSMS and sequencing data generated by the S. mansoni genome project, 
annotated with gene predictions and ESTs representing over 90% of the transcriptome. 
Each of the identified proteins was then assigned to one of eleven categories, based on its 
molecular function. The proteomes of each of the egg preparations were then compared in 
terms of function by using the normalised volumes of the gel-spots as a measure of protein 
expression levels. Another set of preparations representing the mature egg's constituents 
(the miracidium, hatch fluid and the ESP) was also made, analysed in the same way and 
their gel spot-patterns matched back to the gel of the mature egg preparation. A picture then 
emerged; firstly of how the egg's proteome changed as it developed, and secondly of how 
the mature egg's proteome is portioned into the ESP, the hatch fluid and the miracidium. 
By comparing the expression levels of specific proteins or functional categories between 
the preparations it was possible to link the egg's biological requirements and functions to 
its proteome at the appropriate time-point. For example, uniquely vitelline cell proteins can 
now be distinguished from miracidial proteins so the former can be eliminated as potential 
candidates in influencing events such as the transit of eggs across the gut wall or driving 
particular immune responses at the point of egg disintegration. Alternatively, proteins only 
present in the miracidium cannot be involved in the early events of granuloma formation. 
As the newly-released egg mostly contains vitelline cells, the preparation representing the 
earliest time-point in the egg's development was made from the vitellaria-containing 
section of gravid worms that had been severed just below the ventral sucker. It was 
anticipated that this "female, vitellaria-enriched preparation" would have many proteins in 
common with the preparation representing the next stage in the egg's development 
("immature SEA"), but surprisingly this was not the case. Immature SEA was made from a 
population of eggs, 92% of which could be seen to be immature in that their embryo was 
undeveloped. However, despite the obviously undeveloped state of these eggs, the resulting 
gel was so different from the gel of the female, vitellaria-enriched preparation that spot- 
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matching could not be undertaken. Therefore, the shared spots remained unidentified. The 
extreme between-gel differences demonstrate that the vitellaria-containing region of the 
worm is not highly enriched in mature vitelline cells, despite the published TEM images 
that show the vitellaria to completely occupy the posterior two-thirds of the worm. 
Presumably, the production rate of eggs is so high that the mature vitelline cells are used up 
in egg production immediately they are produced, and therefore, the population of vitelline 
cells in the vitellaria at any one time consists of immature cells with a different proteome. 
The eggs making up immature SEA were at the point in their development when the 
vitelline cells were being degraded to provide amino acids for the developing miracidium. 
The eggs making up mature SEA were fully developed however, with no vitelline cells 
remaining. It was therefore possible to link UPP activity to egg development by using the 
immature SEA and mature SEA preparations as the basis of a comparison. The comparison 
involved assaying the 20S proteasomal activity using a fluorogenic substrate and probing 
Western blots with antibodies recognising proteasomal subunit isoforms and ubiquitin. 
Taken together, the results demonstrated for the first time that the level of UPP activity 
decreases as the egg matures, and furthermore, that the UPP is involved in the process of 
vitelline cell degradation. This is an important finding, not only because the mechanisms by 
which vitelline cells degrade have never been studied before, but also because experiments 
investigating the degradation pathways used by insect nurse cells have not incorporated the 
UPP either. 
Meanwhile, the proteomic comparison between immature SEA and mature SEA 
demonstrated that although both preparations mainly consisted of chaperones, cytoskeletal 
proteins and enzymes involved in ATP production, more subtle changes were happening in 
the background. In terms of the functional categories, the mature egg contained secretory 
proteins (whereas the immature egg had none), more defence proteins and proteins without 
a known function. These developmental proteomic changes could then be assigned to the 
miracidium, the hatch fluid or the ESP. It could be seen for example that the defence 
proteins were primarily in the hatch fluid, highlighting the role that hatch fluid plays in 
protecting the miracidium. Changes within the functional categories could also be seen in 
context of the biology of the egg. For example, the proteomes of both immature and mature 
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SEA contained a similar proportion of enzymes involved in ATP production, but 
immature SEA was enriched in enzymes for anaerobic respiration whilst mature SEA had 
more TCA cycle enzymes. This illustrates how the egg is undergoing transition from the 
anaerobic adult which produced it to the aerobic miracidium it releases. 
ESP is the only egg preparation whose proteome has previously been studied. This is not 
surprising because ESP represents the interface between the live egg and the host so it is 
likely to be involved in both granuloma formation and the egg's escape from the host. 
Although the existence of ESP was first proven in the 1950s, little work was done to follow 
it up and it was not until 2001 that ESP was demonstrated to be a distinct subset of egg 
proteins, produced by the envelope located between the miracidium and the shell (Ashton et 
al., 2001). Work in this thesis follows on from both the Ashton et al., study and other 
research carried out in the Wilson laboratory that had shown ESP to consist of 15 proteins, 
all of which were unique and had no known function judging by their PMFs, but two of 
which exhibited proteolytic activity in vitro (Ashton, 2001). ESP3-6 is the most abundant 
ESP, making up about 80% of the total secreted protein. It is not one of the proteases, but it 
has been studied by two other groups, one of whom think it induces basophils to 
degranulate and the other who consider it to bind to and inactivate chemokines (Schramm 
et al., 2003; Smith et al., 2005). Various other proteins have been detected in egg cultures 
over the years, and these have also been described as "secreted", but in all of these 
instances the proteins in question could have leaked from damaged or dead eggs. The 
proteomic work of this thesis obtains the amino acid sequences of each ESP for the first 
time and establishes that no ESP has any homology to any known protein from another 
organism, apart from ESP1-2 which has homology to an RNAse (Fitzsimmons et al., 2005). 
The amino acid sequence of another of the ESPs might contain a subtilase-like pro-protein 
convertase functional domain. This finding raises the question as to whether the proteolytic 
activity of ESP might be more indirect than previously thought. If the egg were to secrete a 
subtilase-like protein it could be activating pro-proteases secreted by the host cells of the 
inflammatory focus. Such a mechanism could be beneficial for the egg because it would 
enable the envelope and miracidium to be spatially separated from the active site of the 
protease, which might not be the case if the egg were to produce its own, active protease. A 
series of functional assays was therefore carried out that aimed to establish whether ESP 
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could induce the secretion of proteases from macrophages and furthermore, to answer the 
more general question of whether ESP was immunogenic to cell-types known to be 
present in the granuloma. An attempt was also made to fractionate crude ESP into its 
components using HPLC so that any functionality observed in crude ESP could potentially 
be attributed to a particular ESP by using the enriched fractions in place of crude ESP. 
The results from the functional ESP work demonstrated that ESP3-6 binds to other ESPs, 
which in turn indicates that rather than having a specific affinity as proposed by Schramm 
et al., (2003) and Smith et al., (2005), ESP 3-6 is probably a fairly ubiquitous binding 
protein. As ESP3-6 has a pI at approximately pH 10, it would be positively charged at 
physiological pH and so it is possibly its charge that mediates its ubiquitous binding 
characteristics. The binding might occur for reasons of protection, by binding to proteins 
that otherwise might enter the egg and damage the envelope of miracidium. Alternatively, 
ESP3-6 might bind to the proteases that enable the egg to transit the gut wall, keeping them 
attached to the inflammatory focus and preventing them from being solubilized and lost in 
the blood stream. The functional experiments also show that ESP is enriched in a factor(s) 
that is/are recognised by macrophages of the innate immune system. This result indicates 
that ESP might be involved in the early events of granuloma formation, but further 
experiments will be required to strengthen this hypothesis because the level of activation, as 
measured by IL-6 secretion and MHCII upregulation, was low. A more realistic situation 
could be achieved in vitro if five-week infected mice (at the point just before egg 
deposition commences) rather than uninfected mice are used as the source of the 
macrophages. Also, expression levels of co-stimulatory molecules such as CD80, CD86, 
CD54, CD40 or OX-40L might prove to be a better method of assessing macrophage 
stimulation. Unfortunately, the assays that were intended to establish whether ESP induced 
protease secretion from macrophages were unsuccessful in that an ESP component (likely 
to be ESP3-6) bound to the substrate's fluorophor and hindered its operation. However, the 
protease assay could be repeated with ESP fractions, purified using the HPLC purification 
protocol that was established in this thesis and described in the Addendum to Chapter 3. 
The leukocyte protease assay could also be applied to cultures of CD4+ cells obtained from 
infected mice or indeed from cells obtained from granulomata themselves. 
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Unlike ESP, the miracidial and hatch fluid proteomes have never previously been studied. 
It was evident that most of the proteins in mature SEA were miracidial and these 
principally consisted of cytoskeletal proteins, chaperones and enzymes involved in ATP 
production. The cytoskeletal proteins were mostly tubulin, likely to make up the 
locomotory cilia that cover the miracidium and actin, which would form cytoskeletal 
microfilaments and muscle fibres used by the miracidium to change direction while 
swimming, extract itself from the ruptured shell and aid its penetration into a snail. The 
most abundant protein in the miracidial preparation (making up fifteen percent of the 
soluble proteome) is Sm-p40, which is a non-ATP-requiring chaperone and a major T cell 
antigen (Hernandez & Stadecker, 1999). Sm-p40 production begins fairly early in 
miracidial development (it makes up four percent of immature SEA) but by the time the 
egg has matured its expression levels have increased such that ten percent of mature SEA is 
Sm-p40. The localisation of Sm-p40 to the miracidium demonstrates that it is not going to 
be presented to host cells until the egg has died and ruptured, so consequently it cannot be 
involved in creating the T cell-rich inflammatory focus that initially forms around the live 
egg. It is not known why Sm-p40 is so enriched in the miracidium, but its high level of 
expression is indicative of it being a protein of vital importance. I propose that Sm-p40 is a 
vital part of an energy-conservation strategy adopted by the miracidium. The miracidium is 
quiescent whilst it is in the egg but once hatched it is very active, short-lived and non- 
feeding. Its likelihood of finding a snail will depend upon its lifespan, which in turn will 
depend upon how quickly its glycogen reserves are exhausted. So, by having high 
intracellular concentrations of Sm-p40, the miracidium can quarantine its damaged proteins 
without expending ATP, rather than having to degrade them via the UPP, which is an ATP- 
expensive business. The low utilisation of the UPP by the miracidium was also 
demonstrated by probing Western Blots with the same anti-proteasomal subunit isoform 
and anti-ubiquitin antibodies discussed previously in relation to the developing egg. It was 
found that compared with hatch fluid, the miracidium expressed few proteasome subunit 
isoforms, consistent with its reduced utilization of the UPP. 
The reason why the hatch fluid blot contained more proteasome subunit isoforms than the 
miracidial blot is likely to be because the hatch fluid contains intracellular envelope 
proteins, and the envelope will have to use the UPP to degrade misfolded ESPs. In addition 
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to containing proteins involved in protein turnover, the hatch fluid proteome was also 
found to contain most of the mature egg's compliment of defence proteins, its proteins of 
unknown function plus some proteins that the egg had taken up from the host. The defence 
proteins are most likely to be located in the liquid between the miracidium and the 
envelope. Here they would be able to protect the miracidium from damage from toxins 
produced by the cells of the granuloma. The reason why there are so many proteins of 
unknown function in the hatch fluid is less obvious, but presumably relates to its unstudied 
nature and the lack of similar material in other animals. The most highly expressed protein 
of unknown function is Smp170410, which is a large, acidic, glycosylated protein that 
makes up over 18% of hatch fluid. Smp170410 is not a remnant of degraded vitelline cells 
and nor is it secreted by the egg, but it is produced by the egg in increasing quantities as it 
matures. It is quite possibly located in the egg's vesicles and involved in the hatching 
process. Localisation studies and gene silencing could be used to address these hypotheses. 
Finding host proteins of up to 70kDa in the hatch fluid was surprising because it 
demonstrates that the egg shell is more porous than previously thought. Some of the host 
proteins probably have value to the egg (such as albumin, which can bind to and transport 
fatty-acids) but others are potentially hazardous (such as haemoglobin, which contains a 
potentially toxic haem group). Albumin is currently a topical subject with schistosome 
researchers because it has recently been claimed that an albumin gene was acquired by S. 
mansoni from its host by lateral gene transfer (Williams et al., 2006). Chapter 2 includes a 
proteomic analysis of hamster albumin which demonstrates that the claimed "schistosome 
albumin" is identical at the amino acid level to hamster albumin and so is probably a 
laboratory artefact. 
The work of this thesis is also of value with regard to the processes of drug design and 
vaccine development. Chemotherapy using the drug praziquantel is the mainstay of 
schistosomiasis control programs because an effective vaccine has yet to be developed 
(Fenwick & Webster, 2006). Praziquantel is used because it is easy to store and administer, 
it has a long shelf life, is well tolerated and is effective against all schistosome species. 
Also, as the patent on the drug has expired, cheap generic variants are available for as little 
as US$0.065 per tablet (WHO, 2002). However, reliance on praziquantel raises concerns as 
to whether schistosome resistance to it has or will evolve. Low cure rates in Senegal have 
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largely been explained in terms of high transmission rather than resistance (Danso-Appiah 
& De Vlas, 2002), but laboratory-maintained parasite strains originally obtained from 
patients with low cure rates appear to have some resistance to praziquantel (Ismail et al., 
1996). Other reports of resistant parasites emerge from time to time, such as one where a 
traveller returning from Kenya had a S. mansoni infection which resisted three consecutive 
regimens of praziquantel treatment (Lawn et al., 2003). Thus, the discovery that the anti- 
malarial drug artemisinin also has anti-schistosomal activity is generating considerable 
interest in the schistosome-research community. Studies into the mechanisms by which 
artemisinin compounds operate have shown that it reacts with heure to produce toxic free 
radicals (Meshnick, 2002). The work of Chapter 2 demonstrates that host haemoglobin is 
present inside the egg, so this raises the possibility that artemisinin might have an anti-egg 
activity. This hypothesis is supported by a study demonstrating that the livers of infected 
mice treated with artemisinin contained no eggs, that the granulomata had dissipated and no 
liver pathology was observable (Botros et al., 2007). If artemisinin kills eggs, and if its 
efficacy at the different stages of egg development can be established, then knowing how 
the egg's proteome alters over time will provide indications as to which proteins are 
targeted by artemisinin. The dead egg will then leak its contents, so studies looking at the 
immunogenicity of the egg's proteome at that point in the egg's development can also be 
facilitated. 
The concept of a schistosomiasis vaccine is attractive because protective immunity 
develops naturally in some individuals (Butterworth et al., 1985) and can be induced in 
mice by infecting them with irradiated cercariae (Smythies et al., 1996). The WHO has 
designated seven proteins as vaccine candidates, but none have proved to be effective. The 
work in this thesis demonstrates that five out of these seven proteins are highly expressed in 
the egg. This finding is important because vaccinating with a protein found in the egg could 
induce sensitisation, so any vaccinated individuals who later become infected could find 
themselves facing severe immune responses to disintegrating eggs. Alternatively, any 
individuals who were already infected with S. mansoni before vaccination took place may 
fail to respond to the vaccine because their immune systems had already become anergic to 
the vaccine's epitopes. The author therefore proposes that the egg proteins characterised in 
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this thesis should form an exclusion list, from which any prospective vaccine candidates 
should not be taken. 
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